risperidone has been researched along with olanzapine in 1561 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 108 (6.92) | 18.2507 |
| 2000's | 848 (54.32) | 29.6817 |
| 2010's | 492 (31.52) | 24.3611 |
| 2020's | 113 (7.24) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A | 1 |
| Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
| Bregna, DE; Burgher, KL; Corbett, R; Hartman, HB; Hrib, NJ; Jurcak, JG; Kafka, S; Kerman, LL; Kongsamut, S; Roehr, JE; Szewczak, MR; Woods-Kettelberger, AT | 1 |
| De Loore, K; Gommeren, W; Janssen, PF; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van Gompel, P | 1 |
| Cai, J; Hartman, HB; Kerman, LL; Kongsamut, S; Roehr, JE; Sandrasagra, A; Tang, L; Weissensee, P | 1 |
| Arnt, J; Skarsfeldt, T | 1 |
| Brown, AM; Collin, LL; Ellis, CE; Forbes, IT; Gittins, SA; Gloger, I; Hagan, J; Middlemiss, DN; Riley, G; Thomas, DR | 1 |
| Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
| Birch, AM; Bradley, PA; Gill, JC; Kerrigan, F; Needham, PL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Grinde, E; Herrick-Davis, K; Teitler, M | 1 |
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Boulton, DW; DeVane, CL; Liston, HL; Markowitz, JS | 1 |
| Chen, XL; Kang, J; Kongsamut, S; Rampe, D; Roehr, J | 1 |
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Keserü, GM | 1 |
| Wermuth, CG | 1 |
| Alonso, JM; Andrés, JI; Cid, JM; Díaz, A; Fernández, J; Gil, P; Iturrino, L; Megens, A; Sipido, VK; Trabanco, AA | 1 |
| Herrick-Davis, K; Purohit, A; Smith, C; Teitler, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Huang, AS; Kim, SF; Snowman, AM; Snyder, SH; Teuscher, C | 1 |
| Coolen, HK; Glennon, JC; Kruse, CG; Lange, JH; Reinders, JH; Tolboom, JT | 1 |
| Farasati, NA; Huang, Y; Randhawa, P | 1 |
| Shahid, M; Walker, GB; Wong, EH; Zorn, SH | 1 |
| Jia, L; Sun, H | 1 |
| Ablordeppey, SY; Altundas, R; Bricker, B; Jackson, T; Khan, A; Kumar, EV; Roth, BL; Zhu, XY | 1 |
| Andreasen, JT; Bernetti, M; Borriello, M; Brindisi, M; Butini, S; Cagnotto, A; Campiani, G; Ceres, N; Coccone, SS; De Angelis, M; Fattorusso, C; Fiorini, I; Franceschini, S; Gemma, S; Mennini, T; Mikkelsen, JD; Nacci, V; Novellino, E; Ros, S; Sandager-Nielsen, K; Scheel-Kruger, J; Trotta, F | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Giordanetto, F; Leach, AG; Zachariae, U | 1 |
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Jensen, AA; Kehler, J; Krogsgaard-Larsen, N | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A | 1 |
| Andreassi, M; Brindisi, M; Brogi, S; Butini, S; Cagnotto, A; Campiani, G; Casagni, A; Franceschini, S; Gemma, S; Gorelli, B; Mikkelsen, JD; Novellino, E; Ros, S; Salmona, M; Sandager-Nielsen, K; Saponara, S; Scheel-Kruger, J; Trotta, F; Weikop, P | 1 |
| Bojarski, AJ; Bucki, A; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Satała, G; Siwek, A; Wesołowska, A; Zagórska, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cools, AR; Ellenbroek, BA; Prinssen, EP | 1 |
| Borison, RL | 1 |
| Benvenga, MJ; Leander, JD | 1 |
| Skarsfeldt, T | 1 |
| Marr, I; Schlicker, E | 1 |
| Casey, DE | 2 |
| Aquila, R; Standard, J; Weiden, P | 1 |
| Lehman, AF | 1 |
| Tamminga, CA | 2 |
| Borsini, F; Cerutti, M; Fodritto, F; Monferini, E; Volonté, M | 1 |
| Andersen, SW; Beasley, C; Hamilton, SH; Kuntz, AJ; Potvin, JH; Tollefson, GD; Tran, PV | 1 |
| Davidson, M; Levy, A; Weizer, M | 1 |
| Finkel, SI | 1 |
| Schooler, NR | 2 |
| Daniel, DG; Whitcomb, SR | 1 |
| Tohen, M; Zarate, CA | 1 |
| Hillard, JR | 1 |
| Ballús, C | 1 |
| Pollock, BG; Sweet, RA | 1 |
| Josefson, D | 1 |
| Altshuler, LL; Corá-Locatelli, G; Denicoff, K; Dunn, RT; Frye, MA; Ketter, TA; Kimbrell, TA; Post, RM | 1 |
| Zito, JM | 1 |
| Gheuens, J; Grebb, JA | 1 |
| Brar, JS; Ganguli, R | 1 |
| Wirshing, WC | 1 |
| Deirmenjian, JM; Erhart, SM; Spellberg, BJ; Wirshing, DA; Wirshing, WC | 1 |
| Kasper, S; Küfferle, B | 1 |
| Finkel, B; Lerner, A; Oyffe, I; Rudinski, D; Sigal, M; Weizman, A | 1 |
| Lemon, MD | 1 |
| Lewis, R | 1 |
| Hersch, MI; Phan, TG; Yu, RY | 1 |
| Canuso, CM; Green, AI; Hanau, M; Jhamb, KK | 1 |
| Rudnick, A | 1 |
| Sharif, ZA | 2 |
| Marsh, J; Meyer, JM; Simpson, G | 1 |
| Rosen, EH | 1 |
| Depoortere, R; Perrault, G; Sanger, DJ | 1 |
| DeQuardo, JR | 1 |
| Kinon, BJ | 1 |
| Brewerton, TD; Jefferson, AM; Markowitz, JS | 1 |
| de Boer, P; de Vries, JB; Kruse, CG; Long, SK; Westerink, BH | 1 |
| Kasper, S | 1 |
| Gazzola, LR; Opler, LA | 1 |
| Harris, MJ; Jeste, DV; Lacro, J; Lohr, JB; Rockwell, E | 1 |
| Laor, N; Toren, P; Weizman, A | 1 |
| Abraham, D; Kissling, W; Leucht, S; Pitschel-Walz, G | 1 |
| Kapur, S; Remington, G; Zipursky, RB | 1 |
| Glazer, WM; Voris, JC | 1 |
| Malone, RP; Sheikh, R; Zito, JM | 1 |
| Dickson, RA; Glazer, WM | 1 |
| Brown, RE; Genduso, LA; Hamilton, SH; Palmer, CS; Revicki, DA | 1 |
| Citrome, L; Volavka, J | 2 |
| Purdon, SE | 1 |
| Marder, SR | 1 |
| Revicki, DA | 2 |
| Andersen, SW; Tollefson, GD | 1 |
| Kane, JM | 2 |
| Breier, A | 1 |
| Kuntz, AJ; Tollefson, GD | 1 |
| Jibson, MD; Milner, K; Tandon, R | 1 |
| Kapur, S; Remington, G | 3 |
| Stahl, SM | 2 |
| Buckley, PF | 2 |
| Aquila, R; Emanuel, M | 1 |
| Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
| Cockburn, I; Edgell, ET; Gregor, KJ | 1 |
| Berisford, MA; Goldstein, D; Kysar, L; Marder, SR; Mintz, J; Pashdag, J; Wirshing, DA; Wirshing, WC | 1 |
| Maneeton, N; Srisurapanont, M | 1 |
| Carboni, E; Di Chiara, G; Rolando, MT; Silvagni, A | 2 |
| McGurk, SR; Meltzer, HY | 1 |
| Baker, GB; Chue, PS; Prior, TI; Tibbo, P | 1 |
| Andersen, SW; Tollefson, GD; Tran, PV | 1 |
| Dresel, S; Hahn, K; Mager, T; Meisenzahl, E; Möller, HJ; Rossmüller, B; Tatsch, K | 1 |
| Kalinyak, CM | 1 |
| Foucher, J; Vercueil, L | 1 |
| Brenner, R; Madhusoodanan, S; Pillai, R; Suresh, P | 1 |
| Yui, K | 1 |
| Andreasen, NC; Ho, BC; Miller, D; Nopoulos, P | 1 |
| Masand, PS | 1 |
| Fukuda, K; Hondo, H; Kuroki, T; Nakahara, T; Tsutsumi, T; Uchimura, H; Yao, H | 1 |
| Boulay, LJ; Labelle, A; Lapierre, YD | 1 |
| Labbate, LA; Snoddgrass, PL | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Azorin, JM; Hale, A; Kasper, S; Möller, HJ | 1 |
| Altson, K; Bootle, A; Culhane, C; Doherty, P; Hope, J; Keks, NA; Krapivensky, N; Tanaghow, A | 1 |
| Ahlenius, S; Oerther, S | 1 |
| Kulkarni, SK; Ninan, I | 1 |
| Booij, J; Gersons, BP; Lavalaye, J; Linszen, DH; Reneman, L; van Royen, EA | 1 |
| Awad, AG; Voruganti, LN | 1 |
| Schulz, SC | 1 |
| Addington, D; Breier, A; David, SR; Jones, BD; Labelle, A; Purdon, SE; Stip, E; Tollefson, GD | 1 |
| Hashimoto, K; Hirano, M; Hondo, H; Kuroki, T; Motomura, K; Nakahara, T; Tsutsumi, T; Uchimura, H; Ueki, H | 1 |
| Keck, PE; McElroy, SL; Strakowski, SM | 1 |
| Glazer, WM | 2 |
| Duncan, GE; Leipzig, JN; Lieberman, JA; Miyamoto, S | 1 |
| Jeste, DV | 2 |
| Simpson, GM | 1 |
| Clement, HW; Heiser, P; Hennighausen, K; Remschmidt, H; Schulz, E | 2 |
| McCallum, SE; Porter, JH; Vann, RE; Varvel, SA | 1 |
| Gram, LF | 1 |
| Braff, DL; Cadenhead, KS; Clementz, BA; Geyer, MA; Light, GA | 1 |
| Philibin, SD; Porter, JH; Vann, RE; Varvel, SA; Wise, LE | 2 |
| Conley, RR | 1 |
| Conley, RR; Meltzer, HY | 1 |
| Zarate, CA | 1 |
| Kameda, K; Koyama, T; Kusumi, I; Suzuki, K; Takahashi, Y | 1 |
| Izgur, Z; Preskorn, SH; Shad, U | 1 |
| Kofoed, L; Misra, LK; Oesterheld, JR; Richards, GA | 1 |
| Booij, J; de Haan, L; Dingemans, PM; Lavalaye, J; Linszen, D | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| Kaplan, M | 1 |
| Baldessarini, RJ; Tarazi, FI; Zhang, K | 4 |
| Fujimura, M; Hashimoto, K; Yamagami, K | 1 |
| McAskill, R; Taylor, DM | 1 |
| Gómez, JC; Gregor, KJ; Montejo, AL; Sacristán, JA; Vieta, E | 1 |
| Bouras, N; Clarke, R; Holt, G; Martin, J; Williams, H | 1 |
| Bagnall, AM; Duggan, L; Gilbody, SM; Tuunainen, A | 1 |
| Elliott, MA; Koran, LM; Ringold, AL | 1 |
| Almond, S; O'Donnell, O | 1 |
| Iskandar, H; Lal, S | 1 |
| Dernovsek, MZ; Tavcar, R | 1 |
| Kahn, RS | 1 |
| Finkel, J; Hird, S; Solhkhah, R | 1 |
| Ghaemi, SN; Guille, C; Sachs, GS | 1 |
| Aubry, JM; Bertschy, G; Simon, AE | 1 |
| Mullen, A | 1 |
| Breier, A; David, SR; Kinon, BJ; Taylor, CC | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Basson, BR; Gilmore, JA; Kinon, BJ; Malcolm, S; Stauffer, VL | 1 |
| Robinson, KA | 1 |
| Kaplan, Z; Lichtenberg, P; Rabinowitz, J | 1 |
| Lapierre, Y; Ramasubbu, R; Ravindran, A | 1 |
| Nemeroff, CB | 1 |
| Feifel, D | 1 |
| Ghaemi, SN | 1 |
| Davidson, M; Kaplan, Z; Lichtenberg, P; Mark, M; Nahon, D; Rabinowitz, J | 1 |
| Booij, J; Dingemans, PM; Gersons, BP; Habraken, JB; Lavalaye, J; Linszen, DH; Reneman, L; van Royen, EA | 1 |
| Charney, DS; Sernyak, MJ; Stolar, M; Woods, SW | 1 |
| Jureidini, JN | 1 |
| Alméras, N; Bouchard, RH; Cadrin, C; Demers, MF; Després, JP; Lemieux, I; Mottard, JP; Simoneau, I; Villeneuve, J | 1 |
| Hilger, E; Kasper, S | 1 |
| Bhana, N; Foster, RH; Olney, R; Plosker, GL | 1 |
| Andersen, SW; Breier, A; Dulisse, B; Edgell, ET; Johnstone, BM; Revicki, D | 1 |
| Kapur, S; Seeman, P | 1 |
| Belmaker, RH; Dossenbach, MR; Grundy, SL; Kratky, P; Metcalfe, S; Schneidman, M; Tollefson, GD | 1 |
| Basson, BR; Crawford, AM; Jones, B; Kinon, BJ; Walker, DJ | 1 |
| Bonaccorso, S; Fowler, WL; Ichikawa, J; Ishii, H; Meltzer, HY; O'Laughlin, IA | 1 |
| Hale, D; Kunik, ME; Molinari, VA; Orengo, CA; Verma, S | 1 |
| Lamberti, JS; Seger, A | 1 |
| Herbert, P; Kruse, D; McKinley, M; Pantelis, C; Quek, J; Rudd, R | 1 |
| Cuesta, MJ; Peralta, V; Zarzuela, A | 1 |
| Beasley, CM; Berg, PH; Czekalla, J; Dellva, MA; Grundy, S | 1 |
| Conley, RR; Mahmoud, R | 1 |
| Conley, RR; Kelly, DL; Love, RC; Nelson, MW; Yu, Y | 1 |
| Ayrton, Z; Brar, JS; Ganguli, R | 1 |
| Lieberman, JA | 1 |
| Basson, BR; Gilmore, JA; Kinon, BJ; Szymanski, KA; Taylor, CC; Tollefson, GD | 1 |
| Agarwal, V; Kumar, P | 1 |
| Advokat, C; Comaty, JE; Vesce, J | 1 |
| Compton, MT; Miller, AH | 1 |
| Birsöz, S; Ipekçi, S | 1 |
| Leslie, DL; Rosenheck, R | 1 |
| Deslandes, M; Edwardes, MD; Laporta, M; Ricard, N; Sauriol, L; Suissa, S | 1 |
| Heeley, EL; Pickering, RM; Shakir, SA; Wilton, LV | 1 |
| Duchesne, I; Kasper, S; Rosillon, D | 1 |
| Duchesne, I; Jones, M; Kasper, S | 1 |
| Booij, J; Lavalaye, J; Linszen, DH; Reneman, L; van Royen, EA | 1 |
| Howard, HR; Lebel, LA; Schmidt, AW; Zorn, SH | 1 |
| Reuss, B; Unsicker, K | 1 |
| Brown, WA; Khan, A; Khan, SR; Leventhal, RM | 1 |
| Cilia, J; Hagan, JJ; Jones, DN; Reavill, C | 1 |
| Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C | 1 |
| Hong, X; Wang, X | 1 |
| Miranda-Sousa, A; Nadelhaft, I; Vera, PL | 1 |
| Arnold, LM; Keck, PE; McElroy, SL | 1 |
| Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR | 1 |
| Griffiths, J; Springuel, P | 1 |
| Badía, X; Gómez, JC; Kind, P; Sacristán, JA | 1 |
| Devlin, MJ; Goetz, RR; Goetz, SA; Simpson, MM; Walsh, BT | 1 |
| Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, J; Sheitman, B; Volavka, J | 1 |
| Burns, T | 1 |
| Friedlander, R; Klancnik, J; Lazar, S | 1 |
| Hatzimanolis, J; Lykouras, L; Markianos, M | 1 |
| Bauzon, D; Bymaster, FP; Cohen, ML; DeLapp, NW; Falcone, JF; Kennedy, JS; Schenck, K | 1 |
| Dagerman, KS; Davis, KL; Davis, S; Hsiao, JK; Jeste, DV; Katz, IR; Lebowitz, B; Lieberman, JA; Lyketsos, CG; Olin, JT; Pollock, BG; Rabins, PV; Rosenheck, RA; Schneider, LS; Small, GW; Tariot, PN | 1 |
| Chroni, E; Economou, A; Lekka, NP; Paschalis, C; Tsibri, E | 1 |
| Weizman, A; Weizman, R | 1 |
| Litvintsev, SV; Snedkov, EV | 1 |
| Flint, AJ; Kapur, S; Seeman, MV; Turrone, P | 1 |
| Lam, RW; Miller, DS; Yatham, LN | 1 |
| de Boer, A; Herings, RM; Jansen, PA; Leufkens, HG; Roos, RA; Schillevoort, I | 1 |
| Arndt, S; Ekstam-Smith, K; Ellingrod, VL; Kutscher, E; Schultz, SK; Turvey, C | 1 |
| Malhi, G; Parker, G | 1 |
| Krausz, M; Moritz, S; Naber, D; Woodward, TS | 1 |
| Kuroki, T; Tashiro, N | 1 |
| Frangou, S; Lewis, M; McCrone, P | 1 |
| Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, JP; Sheitman, B; Volavka, J | 3 |
| Boulton, DW; Devane, CL; Liston, HL; Markowitz, JS; Risch, SC | 1 |
| Bromet, EJ; Davidson, M; Rabinowitz, J | 1 |
| Edgell, E; García-Cabeza, I; Gómez, JC; González de Chavez, M; Sacristán, JA | 1 |
| Dai, J; Fowler, WL; Ichikawa, J; Meltzer, HY; O'Laughlin, IA | 1 |
| Ermilov, M; Heresco-Levy, U; Javitt, DC; Shapira, B; Shimoni, J; Silipo, G | 1 |
| Beuk, N; de Haan, L; Dingemans, P; Hoogenboom, B; Linszen, D | 1 |
| Zhao, Z | 2 |
| Briken, P; Krausz, M; Naber, D; Nika, E | 1 |
| Apter, A; Brand-Gothelf, A; Gal, G; Gothelf, D; Kikinzon, L; Phillip, M; Ratzoni, G; Reidman, J; Weizman, R | 1 |
| Berg, PH; Glick, ID | 1 |
| Yatham, LN | 1 |
| McIntyre, RS | 1 |
| Campbell, EC; Caroff, SN; Mann, SC; Sullivan, KA | 1 |
| Alarcon, RD; Leslie, DL; Losonczy, MF; Rosenheck, R; Sernyak, MJ | 1 |
| Nomikos, GG; Rodriguez, DE; Shirazi-Southall, S | 1 |
| Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP | 1 |
| Braus, DF; Cavus, I; Thome, J; Weimer, E | 1 |
| Bour, LJ; Dingemans, PM; Koelman, JH; Linszen, DH; Nieman, DH; Ongerboer de Visser, BW | 1 |
| Miledi, R; Nguyen, QT; Yang, J | 1 |
| Bahk, WM; Chae, JH; Dickson, RA; Jun, TY; Kim, DJ; Kim, KS; Pae, CU | 1 |
| Meyer, JM | 2 |
| Bilder, RM; Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Goldman, RS; Hoptman, M; Horowitz, TL; Kunz, M; Lieberman, JA; Lindenmayer, JP; McEvoy, J; Sheitman, B; Volavka, J | 1 |
| Sharma, T | 1 |
| Bopp, JH; Daniels, A; Dinakar, HS; Mauro, S; Sobel, RN | 1 |
| Weissman, EM | 1 |
| Beasley, CM; Breier, A; Cavazzoni, P; Dananberg, J; Mukhopadhyay, N; Shankar, S; Sowell, MO; Steinberg, HO | 1 |
| Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM | 1 |
| Demotes-Mainard, J; Henry, C | 1 |
| Devarajan, S; Gallant, J; Harris, A; Kopala, LC; Webster, D | 1 |
| Durkin, MB; Fuller, MA; Laich, JS; Secic, M; Shermock, KM | 1 |
| Crismon, ML; Dorson, PG; Edwards, N; Mendelson, S; Patel, NC | 1 |
| Brown, TL; Daskalakis, ZJ; Fitzgerald, PB; Kulkarni, J | 1 |
| Chiu, FC; Mahadik, SP; Wakade, CG; Waller, JL | 1 |
| Shaw, JW | 1 |
| Brandman, D; Canuso, CM; Dawson, R; Goldstein, JM; Green, AI; Klibanski, A; Schildkraut, JJ; Wojcik, J | 1 |
| Buchanan, RW; Fedder, DO; Koro, CE; Kreyenbuhl, J; L'Italien, GJ; Magder, LS; Revicki, DA; Weiss, SS | 1 |
| Quartermain, D; Rosengarten, H | 1 |
| Jessen, LM | 1 |
| Tang, WK; Ungvari, GS | 1 |
| Awad, A; Cernovsky, Z; Cortese, L; Kotteda, V; Owyeumi, L; Voruganti, L; Zirul, S | 1 |
| Briken, P; Haasen, C; Krausz, M; Moritz, S; Naber, D; Nika, E; Perro, C; Yagdiran, O | 1 |
| Fernandez, HH; Friedman, JH | 1 |
| Dresel, S; Frodl, T; Hahn, K; Meisenzahl, EM; Möller, HJ; Preuss, UW; Rossmüller, B; Schmitt, GJ; Tatsch, K | 1 |
| Bullock, R; Saharan, A | 1 |
| Jørgensen, JI; Sindø, I | 1 |
| Bailey, PE; Crocq, MA; Guillon, MS; Leclercq, P | 1 |
| Livingston, H; Livingston, M | 1 |
| Ballon, JS; Boyd, JA; Marder, SR; Meng, LR; Wirshing, DA; Wirshing, WC | 1 |
| Gianfrancesco, FD; Grogg, AL; Mahmoud, RA; Nasrallah, HA; Wang, RH | 1 |
| Buchanan, RW; Fedder, DO; Koro, CE; Kreyenbuhl, J; L'Italien, GJ; Magder, LS; Revicki, D; Weiss, S | 1 |
| Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M | 1 |
| Broerse, A; Crawford, TJ; den Boer, JA | 1 |
| de Haan, L; van Amelsvoort, T | 1 |
| Hardoby, W; Masand, PS; Saba, M; Schwartz, TL; Virk, S | 1 |
| Hägg, S; Hedenmalm, K; Mortimer, O; Spigset, O; Ståhl, M | 1 |
| Berk, M; Malhi, GS | 1 |
| Bardgett, ME; Csernansky, JG; Humphrey, WM | 1 |
| Cunningham, F; Hamed, A; Huang, YH; Kazis, LE; Lee, AF; Miller, DR; Ren, XS | 1 |
| Chiu, NY; Hsiao, MC; Liao, O; Liu, CY; Wu, CK; Yuan, LM | 1 |
| Duncan, GE; Lieberman, JA; Marx, CE; Morrow, AL; VanDoren, MJ | 1 |
| Casey, DE; Daniel, DG; Sommerville, KW; Tracy, KA; Wassef, AA; Wozniak, P | 1 |
| Good, CR; Krecko, VF; Petersen, CA | 1 |
| Aguglia, E; De Vanna, M; Ferrara, D; Onor, ML | 1 |
| Campbell, C; King, DJ; Silke, B | 1 |
| Barbui, C; Danese, A; Guaiana, G; Mapelli, L; Miele, L; Monzani, E; Percudani, M | 1 |
| Caro, JJ; Levinton, C; Robinson, K; Ward, A | 1 |
| Danileviciūte, V | 1 |
| Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE | 1 |
| Green, MF; Harvey, PD; McGurk, SR; Meltzer, HY | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Feng, W; Hudson, TJ; Owen, RR; Sullivan, G; Thrush, CR | 1 |
| Meibach, RC | 1 |
| Messori, A | 1 |
| Gupta, S | 2 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| Kelly, DL; Love, RC | 1 |
| Gilmore, JA; Halbreich, UM; Kinon, BJ; Liu, H | 1 |
| Kores Plesnicar, B; Krajnc, I; Tomori, M; Zalar, B | 1 |
| Messori, A; Santarlasci, B | 1 |
| Brown, CM; Gibson, PJ; Opolka, JL; Rascati, KL | 2 |
| Leander, JD; Wolff, MC | 1 |
| Brooks, D; Byerly, MJ; Casey, SB; Elliot, S; Hawkins, J; Weber, M | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Apter, A; Bloch, Y; Brand-Gothelf, A; Gal, G; Gothelf, D; Kikinzon, L; Ratzoni, G; Reidman, J; Tyano, S; Weizman, R | 1 |
| Andersen, S; Catts, S; Crawford, AM; Fraser, A; Grainger, D; Gureje, O; Hustig, H; Keks, N; Lambert, T; McGrath, J; Miles, W; Tran, P | 1 |
| Lublin, H; Søholm, B | 1 |
| O'Sullivan, RL; Potkin, SG; Simpson, GM; Weiden, PJ | 1 |
| Libretto, SE; Taylor, DM; Wright, T | 1 |
| Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B | 1 |
| Bailey, RK | 1 |
| Bobes, J; Fernández, I; Garcia-Garcia, M; García-Portilla, MP; Hernández, G; Rejas, J; Rico-Villademoros, F | 1 |
| Ames, D; Chiu, E; Hall, K; Harrigan, S; Hassett, A; Macfarlane, S; Mastwyk, M; O'Connor, DW; Opie, J; Ritchie, CW | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Edell, WS; Rupnow, MF | 1 |
| Jerrell, JM | 1 |
| Lacy, TJ; Motsinger, CD; Perron, GA | 1 |
| Gianfrancesco, F; Grogg, A; Mahmoud, R; Meletiche, D; Wang, RH | 1 |
| Woods, SW | 1 |
| Fontaine, CS; Hynan, LS; Koch, K; Martin-Cook, K; Svetlik, D; Weiner, MF | 1 |
| Lindborg, SR; Purdon, SE; Stip, E; Woodward, N | 1 |
| Barber, BL; Crismon, ML; Johnsrud, MT; Lage, MJ; Rascati, KL | 1 |
| Baldessarini, RJ; Kula, NS; Tarazi, FI; Zhang, K | 1 |
| Conley, RR; Kelly, DL; Love, RC; McMahon, RP | 1 |
| Nishikawa, T; Takeuchi, T | 1 |
| Ahnaou, A; Drinkenburg, WH; Megens, AA | 1 |
| Canale, A; Crucitti, D; D'Arrigo, C; Malara, G; Muscatello, MR; Spina, E; Torre, DL; Zoccali, R | 1 |
| Khan, MM; Mahadik, SP; Parikh, VV | 1 |
| Bokszanska, A; Bouras, N; Holt, G; Martin, G; Taylor, D; Vanstraelen, M | 1 |
| Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J | 1 |
| Fuller, MA; Grogg, AL; Secic, M; Shermock, KM | 1 |
| Azzoni, A; Raja, M | 1 |
| Beasley, CM; Berg, PH; Carlson, CD; Cavazzoni, PA; Kane, JM; Wei, H | 1 |
| Becker, D; Liver, O; Mester, R; Rapoport, M; Weiss, M; Weizman, A | 1 |
| Gharabawi, G; Harvey, PD; Mao, L; Napolitano, JA | 1 |
| Isaac, MB; Isaac, MT | 1 |
| Hedges, D; Jeppson, K; Whitehead, P | 1 |
| Fric, M; Laux, G | 1 |
| Brunnauer, A; Geiger, E; Laux, G | 1 |
| Burge, MR; Clark, C | 1 |
| Lieberman, JA; Stroup, TS | 1 |
| Blow, FC; Copeland, LA; Valenstein, M; Zeber, JE | 1 |
| Acholonu, WW; Bengtson, MA; Renner, BT; Ried, LD; Wilcox, BM | 1 |
| de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A | 1 |
| Hasegawa, K; Hosojima, H; Iseki, E; Kase, A; Kojima, K; Kosaka, K; Miura, S; Shoji, M; Togo, T; Uchikado, H | 1 |
| Busiello, L; Cascella, M; De Robertis, E; Di Domenico, MG; Palmese, S; Pezza, M | 1 |
| Dingemans, P; Gersons, B; Linszen, D; Tijssen, J; van Bruggen, J | 1 |
| Dittmann, S; Grunze, H | 1 |
| Bashford, RA; Hamer, RM; Lieberman, JA; Sheitman, BB; Sikich, L | 1 |
| Hamann, J; Kissling, W; Leucht, S; Rummel, C | 1 |
| Apiquian, R; de la Fuente-Sandoval, C; Fresán, A; Gutiérrez, D; Herrera, K; Lóyzaga, C; Nicolini, H; Ulloa, RE | 1 |
| Even, S; Fortier, P; Mottard, JP; Trudel, G | 1 |
| Dimelis, D; Fokas, K; Garyfallos, G; Giouzepas, J; Karastergiou, A; Kouniakis, P; Lavrentiadis, G; Sidiropoulos, N | 1 |
| Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ | 1 |
| Breier, A; Feldman, PD; Kaiser, CJ; Kennedy, JS; Sutton, VK; Tollefson, GD; Tran, PV; Zhang, F | 1 |
| Conley, RR; Kelly, DL; Kreyenbuhl, J; Love, RC; Van-Duong, Q | 1 |
| Khan, MM; Mahadik, SP; Parikh, V; Terry, AV | 1 |
| Gyulai, L; Hoeh, N; Streim, J; Weintraub, D | 1 |
| Breier, A; Carlson, C; Cavazzoni, P; Chinnapongse, S; Dananberg, J; Davis, T; Henry, RR; Mudaliar, S; Mukhopadhyay, N; Ray, A; Sowell, M | 1 |
| Czimmer, C; Janka, Z; Juhász, A; Kéri, S; Rimanóczy, A; Szekeres, G; Szendi, I | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Kabanov, SO; Mosolov, SN | 1 |
| Messori, A; Pelagotti, F; Santarlasci, B; Trippoli, S; Vacca, F | 1 |
| Anziano, R; Cutler, NR; Harrigan, EP; Miceli, JJ; Middle, M; Reeves, KR; Shiovitz, T; Sramek, J; Watsky, E | 1 |
| Bar, G; Ermilov, M; Heresco-Levy, U; Javitt, DC; Lichtenberg, P | 1 |
| Christensen, DB; Liu, GG; Luo, X; Sun, SX | 1 |
| Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, JP; Sheitman, B; Volavka, J | 1 |
| Cohen, D | 1 |
| Aizenberg, D; Barak, Y; Knobler, HY; Mirecki, I; Natan, Z | 1 |
| Barber, BL; Breier, A; Loosbrock, DL; Namjoshi, M; Tunis, SL; Zhao, Z; Zhu, B | 1 |
| Mandrioli, R; Pucci, V; Raggi, MA; Sabbioni, C | 1 |
| Buckley, PF; Glazer, W; Sebastian, CS | 1 |
| Berardi, D; De Ronchi, D; Lorenzi, C; Serretti, A | 1 |
| Flanagan, S; Keeling, F; Kinsella, U; Ryan, MC; Thakore, JH | 1 |
| Casey, DE; Citrome, L; Daniel, DG; Kochan, LD; Tracy, KA; Wozniak, P | 1 |
| Compton, MT; Hill, HA | 1 |
| Cheng, Z; Li, H; Li, K; Li, X; Peng, W; Wang, F; Xie, Z; Zhou, Z; Zhu, R | 1 |
| Bitter, I | 1 |
| Harvey, PD; Loebel, A; Meltzer, H; Potkin, SG; Romano, SJ; Simpson, GM; Siu, C | 1 |
| Gharabawi, G; Lasser, RA; Mao, L | 1 |
| Burnet, PW; Harrison, PJ; Hutchinson, LJ; Law, AJ | 1 |
| Abi-Dargham, A; Cangiano, C; Frankle, WG; Gil, R; Gorman, JM; Hackett, E; Kochan, LD; Laruelle, M; Mawlawi, O; Slifstein, M; Zea-Ponce, Y; Zhu, Z | 1 |
| Advokat, C; Comaty, JE; Dixon, D; Schneider, J | 1 |
| Bitter, I; Boland, J; Dossenbach, M; el Mahfoud Kessaci, M; Erol, A; Hodge, A; O'Halloran, RA; Shaheen, MO; Sunbol, MM | 1 |
| Diaz, E; Neuse, E; Pearsall, HR; Sullivan, MC; Woods, SW | 1 |
| Chopde, CT; Hirani, K; Morelli, M; Ugale, RR | 1 |
| Iseki, E; Kase, A; Katsuse, O; Kojima, K; Kosaka, K; Shoji, M; Togo, T; Uchikado, H | 1 |
| Findling, RL; McNamara, NK | 1 |
| Bressan, RA; Jones, HM; Pilowsky, LS | 1 |
| Citrome, L; Czobor, P; Kennedy, JL; Lieberman, JA; Lindenmayer, JP; McEvoy, J; Ni, X; Nolan, K; Sheitman, B; Volavka, J | 1 |
| Mensink, GJ; Slooff, CJ | 1 |
| Anil, AE; Ertugrul, A; Jayathilake, K; Meltzer, HY; Roy, A; Sumiyoshi, T | 1 |
| Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T | 1 |
| Alméras, N; Bouchard, RH; Cadrin, C; Demers, MF; Després, JP; Mottard, JP; Roy, MA; Villeneuve, J | 1 |
| Harman-Boehm, I; Liberty, IF; Todder, D; Umansky, R | 1 |
| Fowlie, D; MacEwan, T; Mowat, D | 1 |
| Herrmann, N; Lanctôt, KL; Mamdani, M | 1 |
| Assion, HJ; Schwenkreis, P | 1 |
| Kang, BJ; Kim, YT | 1 |
| Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, JP; Nolan, K; Sheitman, B; Volavka, J | 1 |
| Cotroneo, A; De Sarro, G; Gareri, P; Lacava, R; Loiacono, A; Marigliano, N; Seminara, G | 1 |
| Barzotti, T; Ettorre, E; Gargiulo, A; Lamenza, F; Marigliano, V; Marotta, MG; Silvestri, A; Zannino, G | 1 |
| Joyce, AT; Ollendorf, DA; Rucker, M | 1 |
| Franklin, DL; Maguire, GA; Riley, GD; Yu, BP | 1 |
| Martí Massó, JF | 1 |
| Cramer, JA; Sernyak, M | 1 |
| Tariot, PN | 1 |
| Ismail, MS; Profenno, LA; Tariot, PN | 1 |
| Baskys, A | 1 |
| Barnes, M; Burton, SC; Lawford, BR; Noble, EP; Ritchie, T; Ward, WK; Young, RM | 1 |
| Lee, E; Leung, CM; Wong, E | 1 |
| Duggal, HS; Gandotra, G | 1 |
| Barbee, JG; Conrad, EJ; Jamhour, NJ | 1 |
| Richman, AV | 1 |
| Agid, O; Houle, S; Hussain, T; Kapur, S; Remington, G; Tauscher, J; Verhoeff, NP; Wilson, AA; Zipursky, RB | 1 |
| Leslie, DL; Rosenheck, RA | 1 |
| Allingham, B; Citrome, L; Jaffe, A; Levine, J; Robinson, J | 1 |
| Altar, CA; Burris, KD; Hirose, T; Kikuchi, T; Kitagawa, H; Miwa, T; Nabeshima, T; Uwahodo, Y; Yamada, S | 1 |
| Ciudad, A; Gómez, JC; Montes, JM; Olivares, JM | 1 |
| Curtis, LH; Dans, PE; Hutchison, S; Krishnan, RR; Masselink, LE; Schulman, KA; Wright, A; Østbye, T | 1 |
| Conn, PJ; Mallorga, PJ; Pettibone, DJ; Sur, C; Williams, JB | 1 |
| Adler, LE; Bowles, A; Cawthra, EM; Freedman, R; Hall, MH; Harris, JG; McRae, KA; Nagamoto, HT; Olincy, A; Ross, RG; Waldo, MC; Woodward, L | 1 |
| Goghari, VM; Honer, WG; Kopala, LC; Lang, DJ; Lapointe, JS; Rui, Q; Smith, GN; Vandorpe, RA | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Shayegan, DK; Stahl, SM | 1 |
| Hamed, A; Herz, L; Huang, YH; Kazis, LE; Lee, AF; Miller, DR; Ren, XS | 1 |
| Lara, DR; Souza, DO; Tort, AB | 1 |
| Barbui, C; Fortino, I; Percudani, M; Petrovich, L | 1 |
| Chau, A; Fortin, P; Jenkins, W; Procyshyn, RM | 1 |
| Breekveldt-Postma, NS; Herings, RM; Nolen, WA; Schillevoort, I; Veraart, CP | 1 |
| Kennedy, SH; Konarski, JZ; Mancini, DA; McCann, S; McIntyre, RS; Srinivasan, J | 1 |
| Antończyk, A; Kochman, K; Magdalan, J; Porebska, B; Przewłocki, M; Wasyko-Smolarek, M | 1 |
| Gibel, A; Jabarin, M; Kurs, R; Perelroyzen, G; Ratner, Y; Ritsner, M | 1 |
| Finkel, S | 1 |
| Katz, IR | 1 |
| Mori, K; Morinobu, S; Nagao, M; Okamoto, Y; Yamashita, H; Yamawaki, S | 2 |
| Aubry, JM; Bertschy, G; Bondolfi, G; Rachid, F | 1 |
| Lawrie, S; McIntosh, A; Nadeem, Z | 1 |
| Messer, T; Schmauss, M; Strasser, O | 1 |
| Köhnlein, O; Lutz, R; Messer, T; Schmauss, M | 1 |
| Hynan, LS; Martin-Cook, K; Rice-Koch, K; Svetlik, DA; Weiner, MF | 1 |
| Byerly, M; Carmody, T; Holland, R; Li, B; Miller, DR; Montgomery, JH; Varghese, F | 1 |
| Bobes, J; Cañas, F; Mackell, J; Rejas, J | 1 |
| Haricharan, R; Malla, A; Manchanda, R; Norman, R; Scholten, D; Takhar, J; Townsend, L | 1 |
| Farwell, WR; L'Italien, G; Stump, TE; Tafesse, E; Tierney, WM; Wang, J | 1 |
| Allison, DB; Anderson, EJ; Borba, CP; Cagliero, E; Copeland, PM; Daley, TB; Evins, AE; Goff, DC; Hayden, D; Henderson, DC; Schoenfeld, D; Weber, MT | 1 |
| Elbogen, EB; Swanson, JW; Swartz, MS; Van Dorn, RA | 1 |
| Bastean, JN; Bossie, CA; Gharabawi, GM; Greenspan, AJ; Mao, L; Martinez, RA; Mulsant, BH; Pollock, BG; Tune, LE | 1 |
| Al-tawarah, Y; Belgamwar, R; Hodgson, R; MacKenzie, G | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Haeno, M; Kaminiwa, S; Kohara, K; Kuroki, T; Ninomiya, H | 1 |
| Huang, YH; Kazis, L; Lee, AF; Miller, DR; Qian, S; Ren, XS | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Dunayevich, E; Karagianis, JL | 1 |
| Ahl, J; Kinon, BJ; Liu-Seifert, H | 1 |
| Ahl, J; Ahmed, S; Baker, RW; Kinon, BJ; Liu-Seifert, H | 1 |
| Herrmann, N; Lanctôt, KL | 1 |
| Abekawa, T; Kitaichi, Y; Koyama, T; Matsuyama, T | 1 |
| Pandurangi, A; Silverman, JJ; Sood, AB; Vieweg, WV | 1 |
| Edgell, ET; Haro, JM; Kennedy, L; Lambert, M; Naber, D; Novick, D; Ratcliffe, M | 1 |
| Degen, K; Grogg, AL; Irish, WD; Lopez, RB; Mladsi, DM; Nimsch, CT; Swann, A | 1 |
| Jansen, PA; van Marum, RJ | 1 |
| Berry, S; Brar, JS; Ganguli, R; Mahmoud, R; Pandina, G; Turkoz, I | 1 |
| Grootens, KP; Verkes, RJ | 1 |
| Lacomblez, L | 1 |
| Ader, M; Bergman, RN; Catalano, KJ; Hucking, K; Ionut, V; Kabir, M; Kim, SP; Richey, JM | 1 |
| Conley, RR; Kelly, DL; Lambert, TJ; Love, RC | 1 |
| Namjoshi, M; Russo, PA; Smith, MW | 1 |
| Keck, PE | 1 |
| Curtis, V | 1 |
| Meltzer, HY | 2 |
| Bar, G; Catinari, S; Ebstein, R; Ermilov, M; Heresco-Levy, U; Javitt, DC; Lichtenberg, P; Vass, A | 1 |
| Meltzer, HY; Purdon, SE; Woodward, ND; Zald, DH | 1 |
| Cooper, D; Gaudet, M; Grégoire, JP; Moisan, J | 1 |
| Carson, W; Chang, KY; Chou, CH; Lambert, BL; Tafesse, E | 1 |
| Bakos, CD; Berecz, R; Degrell, I | 1 |
| Allison, DB; Casey, DE; Cope, MB; Fernández, JR; Geary, N; Nagy, TR | 1 |
| Dubois, D | 1 |
| Gianfrancesco, F; Pesa, J; Wang, RH | 1 |
| Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, SJ; Lim, HK; Pae, CU; Paik, IH | 1 |
| Frenchman, IB | 1 |
| Hafkamp, GJ | 1 |
| van der Mast, RC | 1 |
| Bubeníková, V; Dockery, C; Horácek, J; Pálenícek, T; Votava, M | 1 |
| Arriaza, E; Bolaños, E; Ciudad, A; Hesen, W; López-Carrero, C; Municio, M; Ramos, J | 1 |
| Hosalli, P; Jayaram, MB | 1 |
| Cacciola, M; D'Arrigo, C; La Torre, D; Migliardi, G; Pacetti, M; Rosaria Muscatello, M; Spina, E; Zoccali, R | 1 |
| Lawrie, S; McIntosh, A | 1 |
| Eckert, K; Haasen, C; Kiefer, F; Mass, R; Naber, D; Stritzky, AV; Wiedemann, K; Wolf, K | 1 |
| Cunningham, F; Hamed, A; Herz, L; Huang, YH; Kazis, LE; Lee, AF; Miller, DR; Ren, XS | 1 |
| Gibson, JP; Gibson, PJ; Hargreaves, WA | 1 |
| Kuehn, BM | 1 |
| Leslie, DL; Miller, EA; Rosenheck, RA | 1 |
| Ascher-Svanum, H; Correll, C; Faries, D; Kane, J; Zhu, B | 1 |
| Citrome, L; Czobor, P; Kline, L; Lieberman, JA; Lindenmayer, JP; McEvoy, J; Nolan, KA; Sheitman, B; Volavka, J | 1 |
| Edgell, ET; Gasquet, I; Haro, JM; Kennedy, L; Lepine, JP; Novick, D | 1 |
| Ballard, C; Cream, J | 1 |
| Shah, A; Suh, GH | 1 |
| Goikolea, JM; Vieta, E | 1 |
| Melkersson, K | 1 |
| Cho, SC; Chungh, DS; Kim, BN | 1 |
| Matsui-Sakata, A; Ohtani, H; Sawada, Y | 1 |
| Conus, P; Lambert, M; Lubman, DI; McGorry, PD; Moritz, S; Naber, D; Schimmelmann, BG; Wade, D; Yuen, H | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Bersani, G; Clemente, R; Conti, CM; Conti, P; Di Giannantonio, M; Doyle, R; Exton, MS; Gherardelli, S; Grilli, A; Pancheri, P | 1 |
| McGrath, BM; Tempier, RP | 1 |
| Herrmann, N; Mamdani, M; Rapoport, M; Rochon, PA; Shulman, KI | 1 |
| Ahmadpour, O; Bresee, CJ; Delrahim, K; Dolnak, D; Maddux, RE; Rapaport, MH | 1 |
| Chen, CC; Chou, YH; Laio, YC; Lee, SM; Liu, CY; Tarn, YH; Wang, TY; Yang, YK | 1 |
| Raskind, MA; Rosin, RA | 1 |
| Adams, AS; Kanavos, P; Park, S; Ross-Degnan, D; Sabin, J; Soumerai, SB | 1 |
| Cameron, ID; Chen, JS; Cumming, RG; Hien, le TT; Le Couteur, DG; Lord, SR; March, LM; Sambrook, PN; Schwarz, J | 1 |
| Bitter, I; Czobor, P; Dossenbach, M; Volavka, J | 1 |
| Breier, A; Deberdt, WG; Degenhardt, EK; Dossenbach, M; Dysken, MW; Feldman, PD; Hay, DP; Lehman, DL; Rappaport, SA; Young, CA | 1 |
| Dardennes, R; Faucher, S; Ghaëm, O; Guelfi, JD | 1 |
| Aguilar, J; Arango-Dávila, C; Assunção, S; Caro, O; Dossenbach, M; Landa, E; Leadbetter, J; Silva Ibarra, H | 1 |
| Chabot, B; Déal, C; Dollfus, S; Olivier, V; Perrin, E | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Frazzingaro, S; Gastpar, M; Latif, MA; Lombertie, ER; Masiak, M; Medori, R | 1 |
| Crosby, RD; de Zwaan, M; Gosnell, BA; Mitchell, JE; Roerig, JL; Steffen, KJ; Wonderlich, SA | 1 |
| Barbui, C; Fortino, I; Percudani, M; Petrovich, L; Tansella, M | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Harris, S; Layton, D; Shakir, SA; Wilton, LV | 1 |
| Kovács, G | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Honer, W; Sepehry, AA; Thornton, AE; Van Snellenberg, JX | 1 |
| Altman, C; de Nayer, A; Jones, AM; Larmo, I; Lindenbauer, B; Platz, T; Rittmannsberger, H; Windhager, E | 1 |
| Ball, MP; Bodfish, JW; Heeth, WL; Mahorney, SL; McKee, JR | 1 |
| Conus, P; Edwards, J; Eide, P; Lambert, M; McGorry, PD; Naber, D; Schacht, M; Schimmelmann, BG; Ward, J; Yuen, H | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
| Andersen, TH; Bech, P; Larsen, NE | 1 |
| Baser, O; Engelhart, L; Finkel, S; Greenspan, A; Kozma, C; Long, S; Mahmoud, R | 1 |
| Breier, A; Gold, JM; Keefe, RS; Purdon, SE; Rock, SL; Young, CA | 1 |
| Basu, A; Dukic, V; Meltzer, HY | 1 |
| Danielyan, A; Kowatch, RA | 1 |
| Balit, CR; Isbister, GK; Kilham, HA | 1 |
| Crismon, ML; Grogg, A; Johnsrud, M; Thompson, A | 1 |
| Aleardi, M; Biederman, J; Dougherty, M; Hammerness, P; Harpold, T; Mick, E; Wozniak, J | 1 |
| Pariante, CM; Su, KP; Wu, PL | 1 |
| Calabrese, JR; Post, RM | 1 |
| Ascher-Svanum, H; Kinon, BJ; Stensland, MD; Tollefson, GD | 1 |
| Delisi, LE; Nasrallah, HA | 1 |
| Booij, J; de Haan, L; Lavalaye, J; Linszen, D; van Amelsvoort, T | 1 |
| Howland, RH | 1 |
| Byerly, MJ; Fisher, R; Magouirk, B; Nakonezny, PA; Rush, AJ | 1 |
| Klebovich, A; Reszegi, CA; Zelkó, R | 1 |
| Deadman, K; Fenwick, S; Jones, DN; Reavill, C; Rourke, C; Starr, KR | 1 |
| Kozian, R | 1 |
| Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R | 1 |
| Adams, DH; Kinon, BJ; Liu-Seifert, H | 1 |
| Harvey, PD; Pogge, DL; Singer, MB | 1 |
| Durković, M; Fijacko, M; Filaković, P; Koić, O; Laufer, D; Radanović-Grgurić, L | 1 |
| Cook, A; Kraus, JE; Lieberman, JA; Reviere, R; Sheitman, BB | 1 |
| Bennett, GW; Green, W; Marsden, CA; Patil, P; Wigmore, PM | 1 |
| Ames, D; Chiu, E; Hall, K; Halliday, G; Harrigan, S; Hassett, A; Hustig, H; MacFarlane, S; Mastwyk, M; Nagalingam, V; O'Connor, DW; Opie, J; Ritchie, CW; Snowdon, J | 1 |
| Shah, A | 1 |
| Caleo, S; De Graeve, D; Lecompte, D; Mehnert, A; Miadi-Fargier, H; Mosqueda, GJ; Peuskens, J; Smet, A | 1 |
| Heeg, B; Laux, G; Mehnert, A; van Hout, BA | 1 |
| Calabrese, JR; Elhaj, O; Gajwani, P; Gao, K | 1 |
| Basu, D; Gupta, N | 1 |
| Covell, NH; Essock, SM; Jackson, CT | 1 |
| Baer, L; Borba, CP; Cather, C; Copeland, PM; Eden Evins, A; Freudenreich, O; Goff, DC; Henderson, DC; Nguyen, DD | 1 |
| Carnahan, RM; Chrischilles, EA; Lund, BC; Perry, PJ | 1 |
| Blin, P; Cialdella, P; Gérard, A; Hanssens, L; Olié, JP; Petitjean, F; Sechter, D; Westerloppe, J | 1 |
| Ballard, C; Waite, J | 1 |
| Mahadik, SP; Pillai, A; Terry, AV | 1 |
| Davis, J; Heres, S; Jetzinger, E; Kissling, W; Leucht, S; Maino, K | 1 |
| Lane, HY; Su, KP; Wu, PL | 1 |
| Herz, L; Kazis, LE; Lee, AF; Miller, DR; Qian, S; Ren, XS | 1 |
| Bitter, I; Jones, RM; Thompson, C | 1 |
| Ahl, J; Kinon, BJ; Liu-Seifert, H; Maguire, GA | 1 |
| Birkás Kováts, D; Cseh, K; Faludi, G; Palik, E | 1 |
| Abdous, B; Cooper, D; Gaudet, M; Grégoire, JP; Moisan, J | 1 |
| Reiss, JP; Sam, D; Sareen, J | 1 |
| Ascher-Svanum, H; Faries, D; Landbloom, R; Swanson, J; Swartz, M; Zhu, B | 1 |
| Snowdon, J | 1 |
| Bossie, CA; Greenspan, A; Meyer, JM; Pandina, G; Turkoz, I | 1 |
| Ekholm, J; Goldman, D; Gunduz-Bruce, H; Kane, JM; Lencz, T; Malhotra, AK; Robinson, DG; Sevy, S; Woerner, MG; Xu, K | 1 |
| Akram, A; Anders, M; Araszkiewicz, A; Dossenbach, M; Dyachkova, Y; Khalil, A; McBride, M; Pecenak, J; Pirildar, S; Shakhnovich, T; Treuer, T | 1 |
| de Haan, L; van Nimwegen, L | 1 |
| Birinyi-Strachan, L; Davey, P; Kongsakon, R; Leelahanaj, T; Price, N | 1 |
| Balshaw, R; Kopala, L; Love, L; Malla, A; Smith, G; Talling, D; Williams, R | 1 |
| Mahadik, SP; Parikh, V; Pillai, A; Terry, AV | 1 |
| Gianfrancesco, FD; Rajagopalan, K; Sajatovic, M; Wang, RH | 2 |
| Chandra, PS; Chaturvedi, SK; Gupta, A; Prabhu, SC; Ranjan, S | 1 |
| Friedman, JH | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Bloch, MH; Bracken, MB; Coric, V; Kelmendi, B; Landeros-Weisenberger, A; Leckman, JF | 1 |
| Boettger, S; Breitbart, W | 1 |
| Guo, WB; Guo, XF; Liu, ZN; Tang, JS; Wu, RR; Zhai, JG; Zhao, JP | 1 |
| Burón, JA; Gómez-de-la-Cámara, A; Ledesma, F; Martínez-Junquera, G; Rodríguez-Morales, A; Rubio, G | 1 |
| Ariogul, S; Cankurtaran, ES; Cankurtaran, M; Halil, M; Ozkayar, N; Shorbagi, A; Ulger, Z; Yavuz, BB | 1 |
| Hosalli, P; Jayaram, MB; Stroup, S | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Masand, P; Nassir Ghaemi, S; Pae, CU; Patkar, A | 1 |
| Friedman, AB; Li, X; Rosborough, KM; Roth, KA; Zhu, W | 1 |
| Dyachkova, Y; Habil, H; Lee, C; Lee, P; Wu, KH | 1 |
| Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM | 1 |
| Filonov, D; Gallinat, J; Heinz, A; Juckel, G; Kienast, T; Knutson, B; Koslowski, M; Schlagenhauf, F; Villringer, A; Wrase, J; Wüstenberg, T | 1 |
| Bedi, KS; Bryan-Lluka, LJ; Catts, SV; Catts, VS; Naiker, DV | 1 |
| Bettcher, BM; Byerly, MJ; Carmody, T; Fisher, R; Nakonezny, PA; Rush, AJ | 1 |
| Fletcher, PJ; Kapur, S; Li, M | 1 |
| Higuchi, H; Ishigooka, J; Takahashi, H; Yoshida, K | 1 |
| Antoniello, N; Falvo, F; Ferrari, E; Govoni, S; Mansi, V; Rondanelli, M; Sarra, S; Solerte, SB | 1 |
| Rustembegovic, A; Sofic, E; Wichart, I | 1 |
| Borisov, A; Feldman, J; May, R; Miller, AH; Nemeroff, CB; Rosenberg, J; Savage, R; Tucker, M; Wang, X; Woolwine, B | 1 |
| Fleischhaker, C; Heiser, P; Hennighausen, K; Herpertz-Dahlmann, B; Holtkamp, K; Mehler-Wex, C; Rauh, R; Remschmidt, H; Schulz, E; Warnke, A | 3 |
| Staller, J | 1 |
| Didriksen, M; Kreilgaard, M; Olsen, CK | 1 |
| Gonen, N; Kupchik, M; Mester, R; Roitman, S; Schwartz, S; Spivak, B; Strous, RD; Weizman, A | 1 |
| Rasmussen, K | 1 |
| Crespo-Facorro, B; Martínez-García, O; Pardo-García, G; Pelayo-Terán, JM; Pérez-Iglesias, R; Ramírez-Bonilla, M; Vázquez-Barquero, JL | 1 |
| DeVane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
| Alvarez, E; Bousoño, M; Ciudad, A; Gómez, JC; Olivares, JM | 1 |
| Gibel, A; Ritsner, MS | 1 |
| Gorobets, LN | 2 |
| Cavazzoni, P; Hardy, TA; Kryzhanovskaya, L; Marquez, E; Taylor, CC | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Wheeler, A | 1 |
| Barbui, C; Lintas, C | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Koopmans, RT; Olde Rikkert, MG; van Iersel, MB; Verhey, FR; Zuidema, SU | 1 |
| Beard, SM; Clouth, J; Maciver, F; Rüther, E | 1 |
| Arranz, MJ; Carrasco-Marín, E; Crespo-Facorro, B; Leyva-Cobían, F; Mata, I; Pelayo-Terán, JM; Pérez-Iglesias, R; Vázquez-Barquero, JL | 1 |
| Antonova, E; Ffytche, D; Geyer, MA; Kumari, V; Sharma, T; Williams, SC | 1 |
| Bies, RR; Chew, ML; Gharabawi, G; Greenspan, A; Kapur, S; Kirshner, MA; Lehman, ME; Mulsant, BH; Pollock, BG | 1 |
| Cunningham, FE; Dalack, GW; Hur, K; Lambert, BL; Miller, DR | 1 |
| Ebert, T; Michal, SE; Mozes, T; Spivak, B; Weizman, A | 1 |
| Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Chen, KP; Chiu, CC; Liu, HC; Lu, ML | 1 |
| Lin, CY; Pariante, CM; Su, KP; Wu, PL | 1 |
| Arellano, A; Baptista, T; Beaulieu, S; Contreras, Q; Galeazzi, T; Hernández, L; Lacruz, A; Martinez, M; Mendoza, S; Vargas, D | 1 |
| Gulmann, NC; Lolk, A | 1 |
| Dagerman, KS; Davis, SM; Hsiao, JK; Ismail, MS; Lebowitz, BD; Lieberman, JA; Lyketsos, CG; Ryan, JM; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Weintraub, D | 1 |
| D'Amico, G; D'Arrigo, C; Micò, U; Migliardi, G; Muscatello, MR; Perucca, E; Santoro, V; Spina, E | 1 |
| Canive, JM; Edgar, JC; Hanlon, FM; Irwin, JG; Lanoue, M; Lewis, S; Mead, V; Miller, GA; Moses, SN; Sherwood, A; Thoma, RJ; Torres, F; Tuason, VB; Weisend, MP | 1 |
| Duncan, GE; Koller, BH; Lieberman, JA; Moy, SS | 1 |
| Crespo-Facorro, B; Llorca, J; Luis Vázquez-Barquero, J; Martínez-García, O; Pérez-Iglesias, R; Ramirez-Bonilla, M | 1 |
| Higuchi, H; Ishigooka, J; Kamata, M; Takahashi, H; Yoshida, K | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Adams, DH; Citrome, L; Kinon, BJ; Liu-Seifert, H | 1 |
| Ascher-Svanum, H; Faries, DE; Kinon, BJ; Nyhuis, AW; Smelson, DA; Tunis, SL | 1 |
| Addington, D; Addington, J; Patten, S; Pierson, K | 1 |
| Herz, L; Huang, YH; Kazis, LE; Lee, AF; Ren, XS; Yu, W | 1 |
| Bauer, MS; Doshi, JA; Glick, HA; Polsky, D | 1 |
| Covell, NH; Davis, SM; Essock, SM; Lieberman, JA; Rosenheck, RA; Stroup, TS | 1 |
| Gunduz-Bruce, H; Kane, JM; Khadivi, A; Lesser, ML; Lorell, BS; McCormack, J; Mendelowitz, A; Miller, R; Napolitano, B; Patel, RC; Robinson, DG; Schooler, NR; Sevy, SM; Soto-Perello, JM; Woerner, MG | 1 |
| Boshoven, W; Duncan, E; Dunlop, BW; Hamer, RM; Phillips, LS; Woolson, SL | 1 |
| Kurz, A | 1 |
| De Oliveira, IR; Juruena, MF | 1 |
| Hardy, TA; Meyers, AL; Porksen, NK; Shankar, SS; Steinberg, HO; Yu, J | 1 |
| Bogunovic, O; Madhusoodanan, S | 1 |
| Baker, RW; Brown, EB; Jamal, HH; Perlis, RH; Schuh, LM; Tohen, M; Zarate, CA | 1 |
| Caley, C; de Leon, J; Goethe, JW; Holford, TR; Kocherla, M; Ruaño, G; Windemuth, A; Woolley, S | 1 |
| De Girolamo, G; Gamberini, L; Goldoni, CA; Nonino, F | 1 |
| Barbanoj, MJ; Clos, S; Giménez, S; Grasa, E; Morte, A; Romero, S | 1 |
| Harada, M; Kubo, H; Ohmori, T; Sumitani, S | 1 |
| Allison, DB; Cope, MB; Jumbo-Lucioni, P; Kesterson, RA; Nagy, TR; Walton, RG | 1 |
| Hahn, CG; Jandacek, R; McNamara, RK; Richtand, NM; Rider, T; Stanford, KE; Tso, P | 1 |
| Ando, K; Hashimoto, K; Ishizaka, T; Nakamura, Y; Satoh, Y; Sugiyama, A; Takahara, A | 1 |
| Azzaro, AJ; Campbell, BJ; Kemper, E; VanDenBerg, C; Ziemniak, J | 1 |
| Faries, DE; Hay, DP; Kinon, BJ; Stensland, MD; Tunis, SL | 1 |
| Asai, K; Shimada, Y; Tanaka, Y; Ueda, H; Yoshida, S | 1 |
| Akhtar-Danesh, N; Archie, SM; Goldberg, JO; Landeen, J; McColl, L; McNiven, J | 1 |
| Harris, MS; Keshavan, MS; Khine, TT; Reilly, JL; Sweeney, JA | 2 |
| Helsberg, K; Kluge, M; Schacht, A; Schreiber, W; Wehmeier, PM | 1 |
| Burke, RS; Parker, JD; Reeves, RR | 1 |
| Hirano, K; Kagawa, Y; Kato, Y; Uchida, S; Yamada, S | 1 |
| Angelini, A; Bendini, C; Neri, M; Neviani, F | 1 |
| Belz, I; Capuano, GA; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Capuano, G; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; McGee, MF; Perkins, DO; Reimherr, F; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Dierks, T; Irisawa, S; Isotani, T; Kikuchi, M; Kinoshita, T; Koenig, T; Okugawa, G; Strik, W; Yagyu, T; Yamada, K; Yoshimura, M | 1 |
| Ishimoto, Y; Motoki, I; Ohmori, T; Sumitani, S; Taniguchi, T; Tomotake, M; Ueno, S; Yamauchi, K | 1 |
| Kudo, T | 1 |
| Limosin, F | 1 |
| DeVane, CL; Horner, MD; Markowitz, JS; McGurk, SR; Nahas, Z; Palecko, S; Risch, SC | 1 |
| Agid, O; Graff, A; Kapur, S; Mamo, DC; Mizrahi, R; Rusjan, P; Zipursky, RB | 1 |
| Eich, FX; Linden, M; Pyrkosch, L | 1 |
| Gianfrancesco, F; Goldberg, JF; Rajagopalan, K; Wang, RH | 1 |
| Horikawa, N; Mikami, Y; Nishimura, K; Tsuchibuchi, S | 1 |
| Britton, AM; Lonergan, E; Luxenberg, J; Wyller, T | 1 |
| Farver, D | 1 |
| Kulkarni, J; McCauley-Elsom, K | 1 |
| Ganguli, R; Keshavan, M; Miewald, J; Strassnig, M | 1 |
| Freudenreich, O; Goff, DC; Green, MF; Johnson, SA; Lamberti, JS; Leon, AC; Manschreck, T; Miller, AL; Patel, J | 1 |
| Förstl, H | 1 |
| Amitai, N; Markou, A; Semenova, S | 1 |
| Joo, YH; Kim, B; Kim, SJ; Son, JI | 1 |
| Bowie, CR; Buckley, PF; Harvey, PD; Loebel, A | 1 |
| Hsu, HB; Huang, CL; Pariante, CM; Su, KP | 1 |
| Post, DE | 1 |
| Bounthavong, M; Okamoto, MP | 1 |
| Hui, HY; Law, WL; You, JH; Young, WM | 1 |
| Alvarez, E; Bousoño, M; Carlos Gómez, J; Ciudad, A; Gurpegui, M; Olivares, JM | 1 |
| Bilder, RM; Capuano, G; Davis, CE; Davis, SM; Gold, JM; Green, MF; Harvey, PD; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Palmer, BW; Perkins, DO; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Beninger, RJ; Savina, I | 1 |
| Goodman, C; Silver, H | 1 |
| Fisher, JE; Yury, CA | 1 |
| Anjum, N; Cheetham, S; Dickinson, K; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM; Vickers, S | 1 |
| Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G | 1 |
| Jindal, RD | 1 |
| Harrison, BE; Therrien, B | 1 |
| Axelsson, S; Eriksson, AC; Hägg, S; Lindahl, TL; Whiss, PA | 1 |
| Ashton, J; Garcia-Quiroga, J; Harrison-Woolrych, M; Herbison, P | 1 |
| Kozma, CM; Nasrallah, H; Ramaswamy, K | 1 |
| Gu, H; Hamer, RM; Lazarus, A; Lieberman, JA; McEvoy, JP; Olexy, C; Perkins, DO; Strakowski, SD; Sweitzer, D; Weiden, P | 1 |
| Gu, H; Hamer, RM; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Sweeney, JA | 1 |
| Carlson, GA; Findling, RL; Flanders, SC; Jensik, SE; Pandina, GJ; Rupnow, MF; Youngstrom, EA | 1 |
| Agid, O; Arenovich, T; Kapur, S; Remington, G; Zipursky, RB | 1 |
| Choe, BM; Conley, RR; Jae, YM; Kelly, DL; Kim, HC; Kim, JG; Kim, SG; Oh, MK; Shim, JC | 1 |
| Daiello, LA | 1 |
| Amato, L; Davoli, M; Minozzi, S; Pani, PP | 1 |
| Bret, MC; Bret, P; Fourier-Réglat, A; Pariente, A | 1 |
| Akhtar, S; Ameen, S; Saddichha, S | 2 |
| Altunay, IK; Kayaoğlu, S; Mercan, S; Ogutcen, O; Taskintuna, N | 1 |
| Hemrick-Luecke, SK; Hsu, MA; Johnson, BG; Noone, S; Rasmussen, K; Thompson, LK | 1 |
| Braff, DL; Erhart, S; Green, MF; Light, GA; Marder, SR; Mintz, J; Reist, C; Sprock, J; Widmark, C; Wynn, JK | 1 |
| Ingham, M; Karcher, K; Keks, NA; Khan, A | 1 |
| Ambler, D; Anderson, R; Findling, RL; Frazier, JA; Hamer, RM; Hlastala, SA; Hunt-Harrison, T; Lieberman, JA; Maloney, AE; McCLELLAN, J; Ritz, L; Sikich, L; Vitiello, B; Williams, E | 1 |
| Alemdar, M; Cerit, C; Evren Tufan, A; Ozten, E; Yaluğ, I | 1 |
| Beach, AJ; Calamaras, MR; DeVane, CL; Donovan, J; Gibson, BB; Knight, BT; Nemeroff, CB; Newport, DJ; Owens, MJ; Stowe, ZN; Viguera, AC; Winn, S | 1 |
| Binder, CE; Fallu, A; Yatham, LN | 1 |
| Arnt, J; Bang-Andersen, B; Brennum, LT; Christoffersen, CT; Di Matteo, V; Didriksen, M; Esposito, E; Hertel, P; Larsen, AK; Marcus, MM; Pouzet, B; Ramirez, T; Svensson, TH; Søby, KK | 1 |
| Akhtar, S; Ameen, S; Sahoo, S | 1 |
| Dimpfel, W | 1 |
| Den, R; Kashima, H; Manki, H; Nio, S; Nomura, K; Suzuki, T; Takeuchi, H; Tanabe, A; Tomita, M; Tsunoda, K; Uchida, H; Watanabe, K; Yagi, G | 1 |
| Mathews, M; Muzina, DJ | 1 |
| Wooten, J | 1 |
| Bailey, PE; Crocq, MA; Guillon, MS; Provost, D | 1 |
| Bartlett, MG; Terry, AV; Zhang, G | 1 |
| Hergüner, S; Mukaddes, NM | 1 |
| Maggini, C; Marchesi, C; Tonna, M | 1 |
| Akkaya, C; Cangur, S; Kirli, S; Sarandol, A | 1 |
| Gardner, MP; Graulich, A; Lamy, C; Liégeois, JF; Moran-Gates, T; Tarazi, FI | 1 |
| Ascher-Svanum, H; Belger, M; Faries, D | 1 |
| Braff, DL; Erhart, S; Green, MF; Kee, KS; Marder, SR; Mintz, J; Reist, C; Sergi, MJ; Widmark, C | 1 |
| Bogetto, F; Fonzo, V; Montemagni, C; Pandullo, P; Rocca, P; Villari, V | 1 |
| Citrome, L | 1 |
| Burdick, KE; Goldberg, TE; Goldman, RS; Kane, JM; Lencz, T; Malhotra, AK; Patel, RC; Robinson, DG; Schooler, NR; Woerner, MG | 1 |
| Hosalli, PM; Jayaram, MB; Stroup, TS | 1 |
| Hassan, M; Islam, S; Kalsekar, ID; Kavookjian, J; Madhavan, SS; Makela, EH; Miller, LA; Rajagopalan, K | 1 |
| Castillo, D; Diamond, PM; Ereshefsky, L; Lam, YW; Li, X; Maples, N; Miller, AL; Mintz, J; Velligan, DI; Zeber, J | 1 |
| Parrinello, G; Sacchetti, E; Valsecchi, P | 1 |
| Allen, MH; Nordstrom, K | 1 |
| Jain, R; Skale, TG | 1 |
| Aichhorn, W; Hinterhuber, H; Kemmler, G; Marksteiner, J; Stuppaeck, C; Walch, T; Zernig, G | 1 |
| Bick, P; Castle, D; Knoesen, N | 1 |
| Kirchheiner, J; Mehler-Wex, C; Romanos, M; Schulze, UM | 1 |
| Barnett, MJ; Perry, PJ; Wehring, H | 1 |
| Avorn, J; Brookhart, MA; Choudhry, NK; Mogun, H; Patrick, A; Schneeweiss, S; Setoguchi, S; Wang, PS | 1 |
| Alonso, J; Bousoño, M; Ciudad, A; Gilaberte, I; Haro, JM; Novick, D; Suárez, D | 1 |
| Perlis, RH | 1 |
| Castro, CC; Coitinho, AS; Dos Reis-Lunardelli, EA; Izquierdo, I; Schmidt, WJ | 1 |
| Amado, JA; Crespo-Facorro, B; Garcia-Unzueta, MT; Gonzalez-Blanch, C; Martinez-Garcia, O; Perez-Iglesias, R; Ramirez-Bonilla, ML; Vazquez-Barquero, JL | 1 |
| Akhtar, S; Ameen, S; Manjunatha, N; Saddichha, S | 1 |
| Alvarez-Jimenez, M; Amado, JA; Crespo-Facorro, B; Garcia-Unzueta, MT; Martinez-Garcia, O; Pelayo-Teran, JM; Perez-Iglesias, R; Ramirez-Bonilla, ML; Vazquez-Barquero, JL | 1 |
| Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J | 1 |
| Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
| Inada, T; Oda, T; Yamamoto, N | 2 |
| Endo, T; Miyake, N; Miyamoto, S; Ogino, S; Yamaguchi, N | 1 |
| Brousse, G; Gavaudan, G; Jamain, S; Lancon, C; Leboyer, M; Llorca, PM; Macquin-Mavier, I; Méary, A; Schmitt, A; Schürhoff, F; Szöke, A | 1 |
| Ajwani, N; Lee, C; Lim, HK; Pae, CU; Patkar, AA; Peindl, K; Serretti, A | 1 |
| Ascher-Svanum, H; Baker, RW; Faries, DE; Kinon, BJ; Nyhuis, AW; Shekhar, A | 1 |
| Berger, W; Fontenelle, LF; Kinrys, G; Mendlowicz, MV; Portella, CM | 1 |
| Adams, DH; Baron, D; Faries, D; Houston, JP; Lipkovich, I; Mallinckrodt, C | 1 |
| Boggs, DL; Carpenter, WT; Davis, JM; Hu, Q; Kelly, DL; Li, L; McMahon, RP | 1 |
| Kaiser, RM; Ozbolt, LB; Paniagua, MA | 1 |
| Canive, JM; Davis, SM; Hsiao, JK; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Stroup, TS; Swanson, JW; Swartz, MS; Wagner, HR | 1 |
| Arkadiev, V; Diana, L; Lim, K; Rossvanes, C; Ruedrich, SL; Swales, TP | 1 |
| Crosby, RD; Gosnell, BA; Mitchell, JE; Roerig, JL; Steffen, KJ | 1 |
| Kennedy, A; Kilzieh, N; Tapp, AM; Todd-Stenberg, JA; Wood, AE | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR | 1 |
| Degmecić, D; Filaković, P; Koić, O; Laufer, D; Pozgain, I; Radanović-Grgurić, L | 1 |
| Czarnecki, K; Josephs, KA; Kumar, N | 1 |
| Aparasu, RR; Chen, H; Jano, E; Johnson, M | 1 |
| Carrasco-Marín, E; Crespo-Facorro, B; Fernandez-Prieto, L; Leyva-Cobián, F; Pelayo-Terán, JM; Pérez-Iglesias, R; Vázquez-Barquero, JL | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 1 |
| Chiang, HL; Liu, CC; Wu, SY | 1 |
| Albert, U; Bogetto, F; Maina, G; Pessina, E | 1 |
| Borras, L; Constant, EL; de Timary, P; Eytan, A; Hermans, C; Huguelet, P | 1 |
| Ader, M; Bergman, RN; Berry, SA; Garvey, WT; Gharabawi, G; Greenspan, A; Mahmoud, R; Mao, L; Morein, J; Musselman, DL; Nemeroff, CB; Phillips, LS; Zhu, Y | 1 |
| Aarsland, D; Nygaard, HA; Ruths, S; Straand, J | 1 |
| Anjum, N; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM | 1 |
| Gu, H; Hamer, RM; Lieberman, JA; McEvoy, JP; Perkins, DO; Weiden, PJ | 1 |
| Brennum, LT; Kreilgaard, M; Olsen, CK | 1 |
| Chen, CH; Lin, SK; Pan, CH | 1 |
| de Haan, L; Laan, W; Linszen, D; van Beveren, N; van den Brink, W; van Nimwegen, L | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Corey-Lisle, PK; Crosby, RD; Kan, HJ; Kolotkin, RL; McQuade, RD | 1 |
| Melamed, Y; Tadger, S | 1 |
| Danilov, DS; Tiul'pin, IuG | 1 |
| Barzman, DH; Findling, RL | 1 |
| Ascher-Svanum, H; Correll, CU; Faries, DE; Kane, JM; Zhu, B | 1 |
| Ascher-Svanum, H; Faries, DE; Kinon, BJ; Nyhuis, AW | 1 |
| Agoston, T; István, S; Tamás, T; Zoltán, J | 1 |
| Palencia-Herrejón, E; Romera, MA; Silva, JA | 1 |
| Sutton, BJ | 1 |
| Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D | 1 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Engedal, K; Selbaek, G | 1 |
| Washburn, CF | 1 |
| Amado, JA; Berja, A; Carrasco-Marín, E; Crespo-Facorro, B; Garcia-Unzueta, MT; Mata, I; Pelayo-Terán, JM; Perez-Iglesias, R; Vazquez-Barquero, JL | 1 |
| Athey, R; Forlano, R; Singh, D | 1 |
| Fiedler, T; Gutmann, P; Wustmann, T | 1 |
| Dagerman, KS; Davis, SM; Hsiao, JK; Lebowitz, BD; Lieberman, JA; Lyketsos, CG; Rosenheck, RA; Schneider, LS; Sultzer, DL; Tariot, PN | 1 |
| Findling, RL | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Daumit, GL; Davis, SM; Davis, VG; Goff, DC; Hsiao, J; Lieberman, JA; McEvoy, JP; Meyer, JM; Nasrallah, HA; Stroup, TS; Swartz, MS | 1 |
| Kashima, H; Nakajima, S; Nomura, K; Suzuki, T; Takeuchi, H; Tanabe, A; Uchida, H; Watanabe, K; Yagi, G | 1 |
| Romeo, F; Rossi, A; Tiradritti, P; Vita, A | 1 |
| Hempel, RJ; Hengeveld, MW; Röder, CH; Tulen, JH; van Beveren, NJ | 1 |
| Fusar-Poli, RR | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Arango, C; Cifuentes, A; Fraguas, D; Giráldez, M; Laita, P; Merchán-Naranjo, J; Moreno, D; Parellada, M; Ruiz-Sancho, A | 1 |
| Berry, SA; Brar, JS; Ganguli, R; Mahmoud, R; Pandina, GJ | 1 |
| Aouizerate, B; Rotgé, JY; Tignol, J | 1 |
| Weber, K | 1 |
| Bahk, WM; Cho, HS; Chung, SK; Ha, K; Jon, DI; Kim, W; Lee, E; Min, KJ; Seo, JS; Shin, YC; Yoon, BH | 1 |
| de Haan, L; Linszen, D; van Beveren, NJ; van den Brink, W; van der Helm, M; van Nimwegen, LJ | 1 |
| Dickerson, F; Leister, F; Origoni, A; Rubalcaba, E; Stallings, C; Sullens, A; Viscidi, R; Yang, S; Yolken, R | 1 |
| Haro, JM; Novick, D; Roca, M; Suarez, D | 1 |
| Darby, JK; Herbert, J; Pasta, DJ; Wilson, MG | 1 |
| Jerrell, JM; Ramirez, PM | 1 |
| Gagnon, PR | 1 |
| Crabbe, JC; Philibin, SD; Porter, JH; Vunck, SA; Walentiny, DM | 1 |
| Bogeski, M; Gogos, A; van den Buuse, M | 1 |
| Ayache, L; Buysschaert, M; Fagnart, O; Feys, JL; Gruson, D; Hermans, MP; Jamart, J; Luts, A; Mertens de Wilmars, S; Misson, A; Oriot, P | 1 |
| Bilusic, H; Bozina, N; Hotujac, L; Kuzman, MR; Medved, V; Sain, I | 1 |
| Anjum, A; Jensen, JB; Kumra, S; Lee, SS; Leitten, W; Oberstar, J; Schulz, SC; White, T; Wozniak, J | 1 |
| Arango, C; Baeza, I; Castro-Fornieles, J; de la Serna, E; Gonzalez-Pinto, A; Graell, M; Moreno, D; Parellada, M; Paya, B; Soutullo, CA | 1 |
| Alvarez, M; Arango, C; de Castro, MJ; Fraguas, D; Giráldez, M; Laita, P; Leiva, M; Merchán-Naranjo, J; Moreno, D; Parellada, M; Pascual, D; Rapado, M | 1 |
| Endo, S; Hamamura, T; Ishihara, T; Kuroda, S; Miyata, S; Taoka, H; Toma, K | 1 |
| Brunovsky, M; Horacek, J; Kopecek, M; Krajca, V; Mohr, P; Novak, T; Tislerova, B | 1 |
| Ambler, D; Anderson, R; De Jong, S; Delporto-Bedoya, D; Findling, RL; Frazier, JA; Hamer, RM; Hlastala, S; Lieberman, JA; Maloney, AE; McClellan, J; McNamara, NK; Michael, E; Noyes, N; Pierson, L; Puglia, M; Ritz, L; Sikich, L; Slifka, K; Vitiello, B | 1 |
| Freudenmann, RW; Lepping, P | 1 |
| Marshall, TS; McCombs, JS; Stafkey-Mailey, D | 1 |
| Chan, HY; Chang, CJ; Chen, CH; Chen, JJ; Chiang, SC; Hwu, HG; Lai, MS; Sun, HJ | 1 |
| Preuss, UW; Wustmann, T | 1 |
| Haug, HJ; Kolb, SA; Koponen, H; Lublin, H; Sigmundsson, T | 1 |
| Cretaz, E; Diniz, BS; Forlenza, OV | 1 |
| Galińska, B; Konarzewska, B; Popławska, R; Szulc, A; Waszkiewicz, N; Wołczyński, S | 1 |
| Harris, MS; Keshavan, MS; Lencer, R; Reilly, JL; Sprenger, A; Sweeney, JA | 1 |
| Crespo-Facorro, B; de Lucas, EM; Gutiérrez, A; Martínez, O; Pelayo-Terán, JM; Pérez-Iglesias, R; Ramírez, M; Rodríguez-Sánchez, JM; Roiz-Santiáñez, R; Tordesillas-Gutiérrez, D; Vázquez-Barquero, JL | 1 |
| Abdous, B; Cooper, D; Grégoire, JP; Moisan, J | 1 |
| Covell, N; Davis, S; Essock, S; Lieberman, J; McEvoy, J; Rosenheck, RA; Stroup, S; Swartz, M | 1 |
| Amado, JA; Berja, A; Crespo-Facorro, B; Garcia-Unzueta, MT; Martinez-Garcia, O; Mata, I; Pelayo-Teran, JM; Perez-Iglesias, R; Vazquez-Barquero, JL | 1 |
| Lee, E; Leung, CM | 1 |
| Anders, M; Dossenbach, M; Irimia, V; Kotler, M; Logozar-Perkovic, D; Lowry, AJ; Pecenak, J; Peciukaitiene, D; Smulevich, AB; Szulc, A; Treuer, T; West, TM | 1 |
| Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Sato, Y; Yasui-Furukori, N | 2 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Baker, RA; Byerly, MJ; Eudicone, JM; Marcus, RN; Tran, QV; Whitehead, R | 1 |
| Burdick, KE; Goldberg, TE; Goldman, R; Kane, JM; Lencz, T; Malhotra, AK; McCormack, J; Napolitano, B; Patel, RC; Robinson, DG; Sevy, SM | 1 |
| Abi-Saab, W; Baker, J; Casey, DE; Daniel, DG; Greco, N; Kane, JM; Redden, L; Saltarelli, M; Tamminga, C; Tran-Johnson, T; Wozniak, P | 1 |
| Alvarez-Jiménez, M; Crespo-Facorro, B; González-Blanch, C; Martínez-García, O; Pelayo-Terán, JM; Pérez-Iglesias, R; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Hanssens, L; Kerselaers, W; L'Italien, G; Loze, JY; Marcus, RN; Pans, M | 1 |
| Gebhardt, N; Gebhardt, S; Haberhausen, M; Hebebrand, J; Heinzel-Gutenbrunner, M; Krieg, JC; Remschmidt, H; Theisen, FM | 1 |
| Albert, A; De Graeve, D; Gillain, B; Peuskens, J; Van Vleymen, B | 1 |
| Futamura, T; Maeda, K; Marunaka, Y; Mitsumoto, Y; Sugino, H | 1 |
| Mishra, AC; Mohanty, B | 2 |
| De Graeve, D; De Ridder, A | 1 |
| He, W; Li, M; Mead, A | 1 |
| Adanez, LD; Aguado, FJ; Agut, MM; Albarracín, JR; Alfaro, GP; Alonso, JA; Alvarado, PF; Alvarez, DF; Ambrosolio, EB; Anton, CC; Aragón, AB; Arias-Camison, JM; Arrebola, ER; Arroyo, MB; Artiles, FJ; Averbach, MC; Ballester, JA; Ballesteros, EM; Barba, JJ; Bardolet I Casas, C; Barquero, NC; Barrio, JA; Bea, ER; Benítez, AF; Benitez, MH; Bennassar, MR; Berenguer, MM; Berna, JA; Bertolin, RG; Biedma, JA; Blanco, AS; Blanco, JJ; Boada, PC; Bonaselt, IT; Bonet, AF; Bonome, LS; Borri, RC; Bravo, AP; Bros, PC; Caballero, GI; Cabornero, GL; Cala, FI; Callol, VV; Calvin, JL; Camarasa, MG; Camo, VP; Cañas de la Paz, F; Cano, DV; Cano, TR; Canseco, JM; Carazo, FJ; Carbonell, EF; Carrasco, PR; Carrillo, CS; Casado, CJ; Castillo, JJ; Castro, LM; Casula, RR; Catala, JM; Chao, MA; Chillarón, EG; Cleries, FM; Coca, AS; Contreras, MA; Corrales, EC; Cortés, SS; Criado, MD; Cuéllar, JA; Cuquerella, MA; De Arce Cordon, R; de Castro, FJ; de Dios Molina Martín, J; de Hoyos, CM; De la Varga González, M; de Pedro, RB; de Uña Mateos, MA; de Vicente Muñoz, T; del Pino Cuadrado, P; del Rosal, FM; del Rosario Santana, P; del Valle, EF; Delgado, CE; Diaz, MC; Diaz, MR; Diels, J; Díez, JM; Domingo, JP; Domínguez, P; Dorado, MS; Duaso, MA; Dumont, MV; Echevarria Martínez de Bujo, M; Enjuanes, FB; Escabias, FT; Escudero, MA; Estevez, L; Fallada, SM; Felipe, MA; Feliz, FD; Fernández, FJ; Fernández, JC; Fernández, MA; Fernández, MR; Ferrandiz, FP; Figueras, JF; Figuero, MA; Fleta, JL; Fontecilla, HB; Fortacin, MD; Fortes, FP; Forteza, AC; Gallego de Dios, MT; Garate, RC; García Campayo, J; García, AM; García, BF; García, JB; García, JV; García, MB; García, MS; García, OS; García-Castrillon Sales, JA; Garibo, MM; Gil, RS; Giribets, CA; Gómez, AC; Gómez, IL; Gómez, JL; Gómez, MA; González, AG; González, JF; González, MC; Guerras, FC; Guisasola, JE; Guitarte, GP; Herguedas, FM; Hernandez, MC; Hernández-Alvarez de Sotomayor, C; Herrero, AU; Hortelano, CM; Iglesias, ES; Iglesias, SS; Ingles, FJ; Jacobs, A; Jiménez, AR; Jiménez, JP; Joaquim, IG; Juan, JM; Kidias, MM; Lam, A; Lamela, MA; Lauffer, JC; Leal, FJ; Leon, SO; Lieb, PM; Linde, ER; Liste, JF; Llacer, JM; Llordes, IB; Lobeiras, JM; López, AG; López, CA; López, FJ; López, JA; López, MD; López, ME; López, PA; Losada, AC; Lozano, JM; Lozano, ML; Macia, JF; Madera, PM; Mahia, MC; Mallen, MJ; Mandoli, AS; Manzano, JC; Marín, CG; Marín, PB; Martel, AD; Martíin, JF; Martín, MA; Martín, MD; Martín, PF; Martínez, AR; Martínez, AV; Martínez, EP; Martínez, JM; Martínez, VB; Martorell, AL; Mateos Marcos, AM; Mazo, FJ; Medina, O; Melgarejo, CA; Mendez, GF; Méndez, MR; Mendez, RV; Menéndez, LF; Merino, MI; Merola, MC; Mesa, MY; Mestre, NP; Molina, EM; Montesinos, JS; Monzo, JL; Moreno, HD; Múgica, BD; Muñoz de Morales, A; Muñoz, JF; Muñoz, JL; Muñoz, JM; Muñoz, PG; Muñoz, RM; Nafs, AE; Navarro, CS; Navarro, JC; Navarro, PP; Navarro, VF; Nebot, FJ; Nicolau, AL; Noguera, JL; Ojeda, JL; Olivares, JM; Ortiz, JB; Ortiz, RF; Pagador, PM; Pagan, JP; Palancares, EG; Palma, MM; Palmes, JR; Pardell, LT; Parrado, EC; Paya, EF; Pellicer, AF; Pena, AT; Peña, RV; Peralvarez, MB; Perera, JL; Pérez, FJ; Pérez, LS; Pérez, MF; Pérez-Brian, JM; Pérez-Villamil, AH; Piñero, MV; Piñol, MB; Povey, M; Puigros, JS; Quiles, MD; Quintero, CM; Ramos, JM; Rebollo, FJ; Rivas, RS; Robina, FG; Roca, JM; Rodon, EP; Rodríguez de la Torre, M; Rodríguez, EN; Rodríguez, EO; Rodríguez, JA; Rodríguez, PA; Rodríguez, PG; Rodríguez, VM; Rodriguez-Morales, A; Roig, MM; Rojo, CF; Romero, JB; Romero, JJ; Romero, SA; Rubio, JP; Ruiz, O; Sacristán, MP; Saiz, CG; Sala Ayma, JM; Sampedro, JM; Sánchez, AJ; Sánchez, JJ; Sánchez, JM; Sánchez, KP; Sans, LA; Santiuste de Pablos, M; Sanz Granado, OS; Seco, RG; Serrano, GG; Serrano, PS; Sevilla, JS; Solano, FG; Solano, JJ; Soto, JV; Subirats, RC; Tavera, JA; Torres, AM; Torresano, JR; Ubago, JG; Urdaniz, AP; Valero, CP; Valladolid, GR; Valtuille, AG; Vaz, FC; Vázquez, JG; Vazquez, LS; Velasco, JL; Velazquez, SC; Vera, GS; Vergara, GN; Vidal, MM; Villalobos Vega, JC; Villanueva, AP; Yañez, PQ; Zarranz Herrera-Oria, I; Zhao, Z; Zugarramurai, AI | 1 |
| Cohen, D; Mason, JP; Moncrieff, J | 1 |
| de Haan, L; Dingemans, P; Linszen, D; van Amelsvoort, T; van Bruggen, M; Wouters, L | 1 |
| Assion, HJ; Busse, R; Gericke, CA; Juckel, G; Stargardt, T; Weinbrenner, S | 1 |
| Li, M; Mead, A | 1 |
| Carlström, EL; Jazin, E; Jiang, L; Saetre, P | 1 |
| Ascher-Svanum, H; Ball, T; Conley, R; Liu, L; Stauffer, V | 1 |
| Brecher, M; Emsley, R; Eriksson, JW; Leong, RW; Leonova-Edlund, J; Meulien, D; Miller, F; Newcomer, JW; Ratner, RE | 1 |
| Dagerman, KS; Hsiao, JK; Lebowitz, BD; Lyketsos, CG; Mack, WJ; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Vigen, C; Zheng, L | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Charach, A; Gearing, RE | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Peritogiannis, V; Tsouli, S | 2 |
| Campos, MS; Cuesta, MJ; Jalón, EG; Peralta, V | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ | 1 |
| Azar, MR; Geyer, MA; Gold, L; Marston, HM; Martin, FD; Meltzer, LT; Moore, CL; Serpa, KA; Shahid, M; Wong, EH; Young, JW | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Fukui, N; Ozdemir, V; Someya, T; Suzuki, Y; Watanabe, J | 1 |
| Barsoum, P; Graff-Guerrero, A; Houle, S; Kapur, S; Mamo, D; Marcon, H; Mizrahi, R; Rusjan, P; Shammi, CM; Wilson, AA | 1 |
| Akhras, KS; Gopal, S; Palumbo, JM; Schadrack, J; Singh, J | 1 |
| Duncan, EJ; Dunlop, BW; Hamer, RM; Woolson, SL | 1 |
| Heard, K; Hoppe, J; Tan, HH | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Ito, F; Matsumoto, K; Matsuoka, N; Miyakoshi, T; Omuro, N | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Akkaya, C; Alptekin, K; Brook, S; Danaci, AE; El Tallawy, H; Hafez, J; Karayal, ON; Lowe, W; Tzebelikos, E; Ucok, A | 1 |
| Dukić-Dejanović, S; Ignjatović, DR; Janjić, V; Jevtović, I; Jović, SD; Jurisić, V; Milovanović, DR; Pantović, MM; Ravanić, DB | 1 |
| Chandrasena, R; Davis, L; Dickson, R; Hanley, J; Karagianis, J; Monga, N; Procyshyn, R; Thakur, A; Williams, R | 1 |
| Csernansky, JG; Deberdt, W; Keefe, RS; Kollack-Walker, S; Lipkovich, IA; Sabbe, B | 1 |
| Khan, RA; Mican, LM; Suehs, BT | 1 |
| Farias, MR; Grohs, GE; Lindner, LM; Marasciulo, AC | 1 |
| Dietrich-Muszalska, A; Olas, B; Rabe-Jabłońska, J | 1 |
| Sillence, D; Tchan, MC | 1 |
| D'Arrigo, C; de Leon, J; Diaz, FJ; Gagliano, A; Germanò, E; Migliardi, G; Siracusano, R; Spina, E | 1 |
| Aberg, K; Adkins, DE; Lieberman, JA; McClay, JL; Perkins, DO; Stroup, S; Sullivan, PF; van den Oord, EJ; Vladimirov, VI | 1 |
| Gaszner, P | 1 |
| Bundzikova, J; Kiss, A; Mikkelsen, JD; Pirnik, Z | 1 |
| Barbera, T; Blázquez, A; Cervera-Casino, P; López-Valcarcel, BG; Peiró, S; Sanfélix-Gimeno, G | 1 |
| Cornwell, J; Davis, JM; Hu, Q; Kelly, E; Khan, A; Lindenmayer, JP; Smith, RC; Vaidhyanathaswamy, S; Viviano, TF | 1 |
| El-Sayeh, HG; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Cross, CL; Edlich, RF; Long, WB; Wack, CA | 1 |
| Correll, CU; Kane, JM; Malhotra, AK; Manu, P; Napolitano, B; Olshanskiy, V | 1 |
| Ascher-Svanum, H; Chen, L; Kane, JM; Kapur, S; Kinon, BJ; Kollack-Walker, S; Stauffer, VL; Zhou, W | 1 |
| Alonso, J; Brown, J; Croudace, T; Gasquet, I; Knapp, MR; Novick, D; Suárez, D | 1 |
| Barraco, A; Benazzi, F; Berk, M; Frye, MA; Tohen, M; Wang, W | 1 |
| Bond, DJ; Kauer-Sant'Anna, M; Lam, RW; Yatham, LN | 1 |
| Cabaniss, DL; Kahn, DA; Marcus, ER; Moga, DE; Walsh, BT | 1 |
| Ames, D; Cheesman, N; Harrigan, S; Macfarlane, S; Mastwyk, M; Ritchie, CW | 1 |
| Park, S | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Srisurapanont, M | 1 |
| Conley, Y; Davies, MA; Roth, BL | 1 |
| Baik, JH; Choi, SY; Noh, JS; Yoon, S | 1 |
| Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D | 1 |
| Grégoire, JP; Moisan, J | 1 |
| Artigas, F; Bortolozzi, A; Cortés, R; Díaz-Mataix, L; Gingrich, JA; Masana, M; Scorza, MC; Toth, M | 1 |
| He, W; Hu, G; Li, M; Sun, T | 1 |
| Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Sato, Y; Sugawara, N; Tsuchimine, S; Yasui-Furukori, N | 1 |
| Ahn, IL; Hong, SM; Kim, DS; Kim, SH; Park, S | 1 |
| Fujita, K; Fukuo, Y; Furukawa, O; Iwata, N; Kawashima, K; Kishi, T; Kitajima, T; Moriwaki, M; Naitoh, H; Okochi, T | 1 |
| Chatton, A; Claeys, F; Khan, R; Khazaal, Y; Ribordy, F; Zullino, D | 1 |
| Alexander, J | 1 |
| Bozina, N; Grubišin, J; Jovanovic, N; Kuzman, MR; Medved, V; Sertic, J | 1 |
| Aguera, L; De La Gándara, J; Franco, M; Llorca, G; Majadas, S; Martín-Carrasco, M; Montejo, AL; Prieto, N; Rico-Villademoros, F | 1 |
| Kastania, A; Katsafouros, K; Laskos, E; Lykouras, L; Michalopoulou, PG; Papadopoulou, A; Rizos, EN; Vasilopoulos, D | 1 |
| Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Dietrich-Muszalska, A; Kontek, B; Nowak, P; Rabe-Jablonska, J | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Cicale, M; de Bartolomeis, A; Fiore, G; Iasevoli, F; Muscettola, G | 1 |
| Hebebrand, J | 1 |
| Badr, MG; D'yachkova, Y; Dikeos, D; Fábián, Z; Harrison, G; Hudiţă, C; Okasha, T; Pesek, MB; Tapia-Paniagua, G; Treuer, T; Yang, F | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Wentzel-Larsen, T | 1 |
| Arakawa, R; Ito, H; Maeda, J; Okubo, Y; Okumura, M; Suhara, T; Takahashi, H; Takano, A; Takano, H | 1 |
| Fujii, A; Furukori, H; Inoue, Y; Kaneko, S; Sugawara, N; Tsuchimine, S; Yasui-Furukori, N | 1 |
| Bai, YM; Chen, TT; Hong, CJ; Liou, YJ; Tsai, SJ; Wang, YC | 1 |
| Alda, JA; Alvarez, M; Arango, C; Baeza, I; de la Serna, E; Giráldez, M; Martínez-Cantarero, C; Merchán-Naranjo, J; Moreno, C; Parellada, M; Sánchez, B | 1 |
| Graff-Guerrero, A; Kapur, S; McCormick, PN; Nobrega, JN; Raymond, R; Wilson, AA | 1 |
| Chan, HY; Chang, CJ; Chen, CH; Chen, JJ; Chiang, SC; Gau, SS; Hwu, HG; Lai, MS | 1 |
| Buyukoglan, H; Kaya, MG; Ulusoy, HB; Yagmur, F | 1 |
| Gebhardt, S; Haberhausen, M; Hebebrand, J; Heinzel-Gutenbrunner, M; Krieg, JC; Kühnau, W; Remschmidt, H; Schmidtke, J; Theisen, FM; Wehmeier, PM | 1 |
| Cornwell, J; Davis, JM; Hu, Q; Kelly, E; Lindenmayer, JP; Marcovina, S; Smith, RC; Vaidhyanathaswamy, S; Viviano, TF | 1 |
| Bianchi, S; Chiabrando, G; Montanaro, N; Poluzzi, E; Scanavacca, P | 1 |
| Kenchaiah, BK; Kumar, S; Tharyan, P | 1 |
| Elsom, SJ; Gurvich, C; Kulkarni, J; McCauley-Elsom, K | 1 |
| Klemperer, D | 1 |
| Gunduz-Bruce, H; Kane, J; Lorell, BS; McCormack, J; Miller, R; Napolitano, B; Patel, RC; Robinson, DG; Sevy, S | 1 |
| Blanc, O; Brousse, G; Lançon, C; Leboyer, M; Llorca, PM; Meary, A | 1 |
| Chiu, NY; Hsu, WY; Huang, SS; Lee, BS | 1 |
| Dysken, MW; Lederle, FA; Rector, TS; Rossom, RC | 1 |
| Findling, RL; Frazier, JA; Hamer, RM; Hlastala, S; Johnson, JL; Kaufman, EM; Lieberman, JA; Lingler, J; Maloney, AE; McClellan, J; McNamara, NK; Noyes, N; Pierson, L; Puglia, M; Ritz, L; Sikich, L; Vitiello, B | 1 |
| Albaugh, VL; Breazeale, S; Elich, TD; Ilkayeva, O; Joyal, JL; Lang, CH; Lynch, CJ; Maresca, KP; Vary, TC; Wenner, BR | 1 |
| Danilov, DS | 1 |
| Horn, H; Koschorke, P; Müller, TJ; Razavi, N; Strik, W; Walther, S; Wopfner, A | 1 |
| Guirguis-Blake, J | 1 |
| Aguado, J; Gonzalez-Pinto, A; Haro, JM; Novick, D; Perrin, E; Reed, C; Tohen, M | 1 |
| Ciobica, A; Dobrin, I; Padurariu, M; Stefanescu, C | 1 |
| Idris, NF; Marston, HM; McLean, SL; Neill, JC; Shahid, M; Wong, EH | 1 |
| Goldman, D; Kane, JM; Lencz, T; Malhotra, AK; Napolitano, B; Robinson, DG; Sevy, S | 1 |
| de Leon, J; Diaz, FJ; Spina, E | 1 |
| Cañas, F; Möller, HJ | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Gold, L; Marston, HM; Martin, FD; Papp, M; Shahid, M; Wong, EH | 1 |
| Akimoto, T; Matsuo, K; Ohtsuchi, H; Watanabe, Y | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| Campbell, EC; Caroff, SN; Chakos, MH; Davis, SM; Davis, VG; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, DD; Riggio, S; Rosenheck, RA; Saltz, BL; Stroup, TS; Swartz, MS | 1 |
| D'Souza, DC; Kane, JM; Keefe, RS; Patkar, AA; Tiller, JM; Yang, R; Youakim, JM | 1 |
| de Haan, L; Laan, W; Linszen, D; van Beveren, N; van den Brink, W; van Nimwegen-Campailla, L | 1 |
| D'Arrigo, C; Micò, U; Muscatello, MR; Santoro, V; Spina, E; Zoccali, R | 1 |
| Feingold, A; Kapur, S; Mann, S; Remington, G; Seeman, P; Shammi, C | 1 |
| Bai, YM; Chen, JY; Chen, TT; Hong, CJ; Lin, E; Liou, YJ; Tsai, SJ | 1 |
| Dietrich-Muszalska, A; Kontek, B | 1 |
| Ascher-Svanum, H; Case, M; Conley, R; Jacob, J; Kane, JM; Kapur, S; Kinon, BJ; Kollack-Walker, S; Stauffer, VL | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Ardizzone, I; Carratelli, TI; Ferrara, M; Marconi, A; Nardecchia, F | 1 |
| Asenjo Lobos, C; Hunger, H; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Bilder, RM; Gunduz-Bruce, H; Kane, JM; McCormack, J; Narr, KL; Phillips, OR; Robinson, DG; Sevy, S; Szeszko, PR | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Fernalld, R; Jordan, S; Kambayashi, J; Kikuchi, T; Koprivica, V; Murphy, JJ; Regardie, K; Wolff, C | 1 |
| Caseiro, O; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pardo, G; Pelayo-Terán, JM; Pérez-Iglesias, R; Ramirez-Bonilla, M; Vázquez-Barquero, JL | 1 |
| Suzuki, T; Takeuchi, H; Watanabe, K | 1 |
| Amore, M; Bertelli, M; Rossi, M; Tamborini, S; Villani, D | 1 |
| McKinney, C; Renk, K | 1 |
| Nagamine, T; Nakamura, M | 1 |
| Amminger, P; Berger, GE; Kerr, M; Kunstmann, C; Kunstmann, S; Lasch, J; Marculev, C; McGorry, PD; Milleit, B; Milleit, C; Nenadic, I; Proffitt, TM; Sauer, H; Smesny, S; Willhardt, I; Yotter, RA | 1 |
| Lee, SY; Pae, CU; Park, MH; Patkar, AA | 1 |
| Depping, AM; Kissling, W; Komossa, K; Leucht, S | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Depping, AM; Kissling, W; Komossa, K; Leucht, S; Meyer, M | 1 |
| Lee, J; Ng, KW; Swapna, V | 1 |
| Bai, YM; Chen, TT; Hong, CJ; Liou, YJ; Tsai, SJ | 2 |
| Fang, Y; Li, M; Zhang, C | 1 |
| Bak, M; de Haan, L; Delespaul, PA; Lardinois, M; Lataster, J; Lataster, T; Myin-Germeys, I; Thewissen, V; van Os, J | 1 |
| Aker, AT; Bos Gelmez, SÜ; Cerit, C; Ozten, E; Vural, M; Yıldız, M | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Araszkiewicz, A; Barbui, C; Godman, B; Haycox, A; Szabert, K; Wladysiuk, M | 1 |
| Caseiro, O; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pardo-Garcia, G; Pelayo-Terán, JM; Pérez-Iglesias, R; Ramirez-Bonilla, M; Vázquez-Barquero, JL | 1 |
| Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M | 1 |
| Friis, S; Haahr, U; Johannessen, JO; Larsen, TK; McGlashan, TH; Melle, I; Opjordsmoen, S; Rund, BR; Simonsen, E; Vaglum, P | 1 |
| Buneviciute, J; Davis, JM; Hu, Q; Janowsky, DS | 1 |
| Ashizawa, Y; Hamakawa, H; Hatta, K; Hayakawa, T; Hayashi, N; Hirata, T; Ito, S; Nakamura, H; Nakase, R; Otachi, T; Sawa, Y; Sudo, Y; Takebayashi, H; Usui, C | 1 |
| Campbell, GM; Forrester, TD; Hardy, TA; Henry, RR; Kryzhanovskaya, LA; Marks, DM; Mudaliar, S | 1 |
| Agid, O; Arenovich, T; Foussias, G; Kapur, S; Remington, G; Sajeev, G; Zipursky, RB | 1 |
| Calabrese, JR; Johnson, E; Kemp, DE; Tohen, M; Wang, WV | 1 |
| Cole-Strauss, A; Jandacek, R; Lipton, JW; McNamara, RK; Rider, T; Tso, P | 1 |
| Arango, C; Bretón, I; Camblor, M; Cuerda, C; de Castro, MJ; Desco, M; Dulín, E; García-Peris, P; Giráldez, M; Gutierrez, A; Leiva, M; Merchan-Naranjo, J; Parellada, M; Sanz, I; Velasco, C | 1 |
| Alvir, JM; Correll, CU; Delman, H; Greenwald, B; Kane, JM; Woerner, MG | 1 |
| Collette, J; De Hert, M; Hanssens, L; Heald, A; Peuskens, J; Reginster, JY; Scheen, A; van Winkel, R; Wampers, M | 1 |
| Ahn, YM; Jung, DC; Kang, UG; Kim, EY; Kim, SH; Kim, YS; Lee, NY; Sung, KH; Yu, HY | 1 |
| Baker, RA; Forbes, RA; Guo, Z; Hebden, T; Jing, Y; Kim, E; L'italien, GJ | 1 |
| Bobo, WV; Brennan, MD; Brock, GN; Jayathilake, K; Mehrotra, B; Meltzer, HY; Ramsey, TL | 1 |
| Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA | 1 |
| Dagerman, KS; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lyketsos, CG; Mack, WJ; Sano, M; Schneider, LS; Stroup, TS; Sultzer, DL; Tariot, PN; Vigen, CL; Zheng, L | 1 |
| Afful, J; Brown, CH; Dixon, LB; Ehrenreich, B; Kreyenbuhl, J; Medoff, DR; Slade, EP | 1 |
| Kaneda, A; Kaneko, S; Sugawara, N; Tomita, T; Yasui-Furukori, N | 1 |
| Kane, J; McCormack, J; Miller, R; Napolitano, B; Robinson, DG; Sevy, S; Sunday, S | 1 |
| Ashton, J; Harrison-Woolrych, M; Herbison, P; Skegg, DC; Skegg, K | 1 |
| Chojnacka-Wójtowicz, J; Jarema, M; Jernajczyk, W; Skowerska, A; Tafliński, T; Wichniak, A; Wierzbicka, A | 1 |
| Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Ortiz, V; Pelayo-Terán, JM; Pérez-Iglesias, R; Valdizan, E; Vazquez-Barquero, JL | 1 |
| Beduin, AS; Bruggeman, R; Cahn, W; de Haan, L; Dekker, N; Kahn, RS; Krabbendam, L; Linszen, DH; Machielsen, M; Myin-Germeys, I; van Os, J; Wiersma, D | 1 |
| Hamer, RH; LaVange, LM; Lieberman, JA; McEvoy, JP; Nussbaum, AM; Perkins, DO; Ring, KD; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Eberhard, J; Fors, BM; Hansen, K; Lindström, E; Sapin, C | 1 |
| Bobo, WV; Bonaccorso, S; Jayathilake, K; Meltzer, HY | 1 |
| Conley, RR; Fijal, BA; Hoffmann, VP; Houston, JP; Kinon, BJ; Stauffer, VL; Witte, MM; Zhao, F | 1 |
| Bobo, WV; Bonaccorso, S; Chen, Y; Jayathilake, K; Meltzer, HY | 1 |
| Abad-Santos, F; López-Rodríguez, R; Novalbos, J; Ochoa, D; Pelegrina, ML; Román, M | 1 |
| Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z | 1 |
| Berinder, K; Hulting, AL; Melkersson, K | 1 |
| Johnsen, E; Jørgensen, HA; Kjelby, E; Kroken, RA; Løberg, EM | 1 |
| Weiden, PJ | 1 |
| Constant, E; Jacques, D; Manceaux, P; Reynaert, C; Zdanowicz, N | 1 |
| Chakrabarti, S; Grover, S; Kumar, V | 1 |
| Carpiniello, B; Mellino, G; Pinna, F; Pintore, S; Puddu, L | 1 |
| Arndt, S; Chrischilles, EA; Coryell, WH; Ellingrod, VL; Fiedorowicz, JG; Haynes, WG; Miller, del D; Prabhakar, M; Warren, L | 1 |
| Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM | 1 |
| Dirican, E; Geyikoglu, F; Hacimuftuoglu, A; Keles, MS; Kirkpinar, I; Tatar, A; Togar, B; Turkez, H | 1 |
| Gallego, JA; Kane, JM; Lesser, ML; McCormack, J; Napolitano, B; Robinson, DG; Sevy, SM | 1 |
| Bai, YM; Hong, CJ; Liou, YJ; Tsai, A; Tsai, SJ; Wu, CL | 1 |
| Bai, YM; Hong, CJ; Huang, HH; Liou, YJ; Tsai, SJ; Wang, YC; Wu, CL | 1 |
| Iagubov, MI; Shtark, LN | 1 |
| Jardemark, K; Malmerfelt, A; Marcus, MM; Shahid, M; Svensson, TH | 1 |
| Chan, HY; Chen, CH; Chen, JJ; Gau, SS; Hwu, HG | 1 |
| Aas, E; Kim, K | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I | 1 |
| Deuschle, M; Kopf, D; Paslakis, G; Rüsse, S; Thome, J | 1 |
| Bschor, T; Erbe, S; Gutwinski, S | 1 |
| Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K | 1 |
| Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 2 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Berkowitz, RL; Docherty, JP; Ni, Q; Parks, JJ; Patel, U | 1 |
| Bies, RR; Mamo, DC; Mimura, M; Mizuno, Y; Pollock, BG; Remington, G; Suzuki, T; Tsuboi, T; Uchida, H; Watanabe, K | 1 |
| Barry, RJ; Beninger, RJ; Bradford, L; Delva, NJ; Wasserman, JI | 1 |
| Altamura, AC; Correll, CU; Csernansky, JG; Davis, JM; Glick, ID; Leucht, S; Marder, SR; Weiden, PJ | 1 |
| Barabash, R; Molina-Ruiz, AM; Molina-Ruiz, RM; Requena, L; Zulueta, T | 1 |
| Chrisphonte, P; Ostroff, RB; Rosenheck, RA | 1 |
| Anderson, GM; Fischer, H; Gill, SS; Gruneir, A; Herrmann, N; Hyson, C; Marras, C; Rochon, PA; Wang, X | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Bies, RR; Keefe, RS; Mamo, DC; Mimura, M; Pollock, BG; Rajji, TK; Sakurai, H; Stroup, ST; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML | 2 |
| Chang, CH; Kao Yang, YH; Lai, EC; Lin, CY; Lin, SJ | 1 |
| Ali, G; Essali, A | 1 |
| Rosa, F; Schreiner, A; Sherif, T; Thomas, P | 1 |
| Rogóż, Z; Skuza, G | 1 |
| Jacobson, J; Munzig, E; Tavaré, CJ; Turkel, SB | 1 |
| Han, C; Jeong, HG; Joe, SH; Ko, YH; Lee, HY; Lee, MS | 1 |
| Hata, K; Hatta, K; Hayakawa, T; Hayashi, H; Hirata, T; Ishii, R; Kasuya, M; Kuga, H; Morikawa, F; Nakamura, H; Nakamura, M; Otachi, T; Sawa, Y; Sudo, Y; Takebayashi, H; Usui, C | 1 |
| Knoepflmacher, D; Shapley, L; Turner, EH | 1 |
| Martin, M; McGuire, A; Mehnert, A; Nicholl, D; Pudas, H | 1 |
| Bhalerao, S; Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Seyfried, LS | 1 |
| Davis, JM; Dwivedi, S; Rachakonda, S; Smith, RC | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Hermes, E; Rosenheck, R | 1 |
| Bachman, P; Bearden, CE; Jalbrzikowski, M | 1 |
| Breiger, D; Findling, RL; Frazier, JA; Giuliano, AJ; Hamer, RM; Hooper, SR; Johnson, JL; Lieberman, JA; McClellan, J; Sikich, L; Vitiello, B; Yakutis, L; Youngstrom, EA | 1 |
| Becker, T; Croissant, D; Eschweiler, GW; Frasch, K; Jaeger, S; Kilian, R; Längle, G; Messer, T; Pfiffner, C; Schepp, W; Steinert, T; Weiser, P | 1 |
| Chung, TS; Lung, FW | 1 |
| Fujiki, R; Matsuoka, T; Mori, K; Morita, K; Shoji, Y; Uchimura, N | 1 |
| Ascher-Svanum, H; Fujikoshi, S; Nakahara, N; Ohmori, T; Takahashi, M; Ye, W | 1 |
| Abdallah, CG; Hong, X; Huang, H; Huang, Q; Jiang, L; Liang, C; Liu, Y; Wan, X; Wang, J; Wu, R; Xu, C; Zhang, J | 1 |
| Ferencz, C; Fullajtar, M | 1 |
| Koek, RJ; Mintz, J; Yerevanian, BI | 1 |
| Ascher-Svanum, H; Bertsch, J; Brugnoli, R; Haro, JM; Hong, J; Novick, D | 1 |
| Chaves, KM; de Araújo Júnior, RF; de Araújo, AA; de Paula Soares Rachetti, V; do Socorro Costa Feitosa Alves, M; Filgueira Júnior, A; Guerra, GC; Ribeiro, SB; Serrano-Blanco, A; Soares, LA | 1 |
| Bhutani, G; Gupta, R; Kaushal, J | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gutiérrez, A; Ortíz-García de la Foz, V; Roiz-Santiáñez, R; Tabarés-Seisdedos, R; Tordesillas-Gutiérrez, D; Vázquez-Barquero, JL | 1 |
| Den, R; Hirano, J; Kikuchi, T; Kitahata, R; Mimura, M; Nakajima, S; Nio, S; Nishimoto, M; Shibuya, Y; Shimanuki, H; Suzuki, T; Takeuchi, H; Tani, H; Tsuboi, T; Tsunoda, K; Uchida, H; Watanabe, K | 1 |
| Aguglia, E; Dipasquale, S; Minutolo, G; Petralia, A | 1 |
| Azorin, JM; Gasquet, I; Gierski, F; Leguay, D; Lemogne, C; Limosin, F; Raucher-Chéné, D; Rouillon, F; Schuster, JP | 1 |
| Alvarez, E; Arranz, B; Corripio, I; Dueñas, R; Perez, V; Ramirez, N; Safont, G; San, L | 1 |
| Bishop, JR; Conley, RR; Ellingrod, VL; Fijal, BA; Houston, JP; Kohler, J; Ostbye, KM; Poole Hoffmann, V; Zhao, F | 1 |
| Campos, MS; Cuesta, MJ; García de Jalón, E; Ibáñez, B; Peralta, V; Sánchez-Torres, AM | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Amado, JA; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez-García, O; Mata, I; Pérez-Iglesias, R; Valdizán, EM; Vázquez-Barquero, JL | 1 |
| Crespo-Facorro, B; Díaz, I; Mata, I; Pelayo-Terán, JM; Pérez-Iglesias, R; Suárez-Pinilla, P; Tabarés-Seisdedos, R; Vázquez-Barquero, JL | 1 |
| Castle, D; Deng, C; Huang, XF; Pai, N; Vella, SL | 1 |
| Raghunath, A | 1 |
| Brugnoli, R; Dossenbach, M; Haro, JM; Hong, J; Karagianis, J; Novick, D | 1 |
| Anderson, GM; Fischer, HD; Herrmann, N; Marras, C; Rochon, PA; Wang, X | 1 |
| Arndt, S; Glorioso, DK; Golshan, S; Henry, R; Jeste, DV; Jin, H; Kraemer, HC; Mudaliar, S; Shih, PA | 1 |
| Korver, N; Machielsen, M; Scheltema Beduin, AA; Swets, M | 1 |
| Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F | 1 |
| Correll, CU; De Hert, M; Kane, JM; Manu, P; Shiffeldrim, D; van Winkel, R; Wampers, M; Yu, W | 1 |
| Bouvard, S; Ciumas, C; d'Amato, T; Daléry, J; Lerond, J; Lothe, A; Poulet, E; Ryvlin, P; Saoud, M | 1 |
| Avis, K; Darvishi, F; Khazaie, H; Najafi, F; Rezaie, L | 1 |
| Ascher-Svanum, H; Case, M; Chen, J; Kane, JM; Kapur, S; Kinon, BJ; Kollack-Walker, S; Naber, D; Stauffer, VL | 1 |
| Awerbuck, J; Ganguli, R; Strassnig, M | 1 |
| Hrisko, S; Jerrell, JM | 1 |
| Bader, M; Klingerman, CM; Lynch, CJ; Stipanovic, ME | 1 |
| Carano, A; Cavuto, M; De Berardis, D; Di Giannantonio, M; Fornaro, M; Iasevoli, F; Lang, AP; Marini, S; Martinotti, G; Mazza, M; Perna, G; Piersanti, M; Valchera, A | 1 |
| Bourque, J; Champagne, J; Lakis, N; Lalonde, P; Lipp, O; Mendrek, A; Stip, E | 1 |
| Eade, A; Heilbronn, C; Lloyd, B; Lubman, DI; McElwee, P | 1 |
| Honaker, J; Lohr, WD | 1 |
| Brixner, DI; Ghate, SR; Hashibe, M; Joy, E; Porucznik, CA; Said, Q | 1 |
| Byerly, MJ; Glick, ID; Hamer, RM; Khan, AY; Lamberti, JS; McEvoy, JP; Nasrallah, HA; Ray, N; Steinbook, RM; Stroup, TS | 1 |
| Cheung, C; Chua, SE; Collier, DA; Deng, W; Gong, Q; Huang, C; Jiang, L; Li, M; Li, T; Ma, X; McAlonan, GM; Sham, PC; Wang, Q; Wang, Y | 1 |
| El-Sayeh, HG; Hunger, H; Khanna, P; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Martínez-García, O; Pérez-Iglesias, R; Rodríguez-Sánchez, JM; Roiz-Santiáñez, R; Sánchez-Moreno, J; Tabarés-Seisdedos, R; Vázquez-Barquero, JL | 1 |
| Crespo-Facorro, B; de León, J; Diaz, FJ; Pelayo-Terán, JM; Pérez-Iglesias, R; Suárez-Pinilla, P; Tabarés-Seisdedos, R | 1 |
| Bhatia, MS; Jhanjee, A; Srivastava, S | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Jennifer Njoku, I; Manu, P; Shulman, M | 1 |
| Aitchison, KJ; Almandil, NB; Besag, FM; Liu, Y; Murray, ML; Wong, IC | 1 |
| Choi, NK; Jung, SY; Kwon, JS; Lee, J; Park, BJ; Shin, JY | 1 |
| Kirk Morton, N; Zubek, D | 1 |
| Desjardins, O; Grégoire, JP; Moisan, J; Turgeon, M | 1 |
| Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Fleischhacker, WW | 1 |
| Bewley, A; Lowry, CL; Taylor, R | 1 |
| Adams, DH; Baygani, S; Kinon, BJ; Kollack-Walker, S; Millen, BA; Velona, I; Walling, DP | 1 |
| Alessi-Severini, S; Biscontri, RG; Enns, MW; Metge, CJ; Vasilyeva, I | 1 |
| Agid, O; Arenovich, T; Fervaha, G; Foussias, G; McDonald, K; Remington, G; Sajeev, G; Schulze, L | 1 |
| Bies, RR; Graff-Guerrero, A; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsuboi, T; Uchida, H | 1 |
| Jacobson, JR; Tavaré, CJ; Turkel, SB | 1 |
| Galińska, B; Konarzewska, B; Szulc, A; Waszkiewicz, N | 1 |
| Einarson, TR; Garg, M; Hemels, ME; Skoupá, J; Veselá, S; Zilbershtein, R | 1 |
| Harding, H; Mori, K; Nadanaka, S; Nagamine, T; Okada, T; Ozasa, R; Ron, D; Zyryanova, A | 1 |
| Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
| Abe, T; Bies, RR; Graff-Guerrero, A; Mimura, M; Remington, G; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K | 1 |
| Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R | 1 |
| Abad-Santos, F; Ayuso, C; Borobia, AM; Cabaleiro, T; Carcas, AJ; López-Rodríguez, R; Novalbos, J; Ochoa, D; Román, M | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Bies, RR; Mamo, DC; Mimura, M; Moriguchi, S; Pollock, BG; Remington, G; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Hatta, K; Hirata, T; Ito, S; Kasuya, M; Katayama, S; Kuga, H; Morikawa, F; Nakamura, H; Nakamura, M; Nakase, R; Ohnuma, T; Sawa, Y; Shirai, Y; Sudo, Y; Takebayashi, H; Usui, C | 1 |
| Amminger, GP; Becker, J; O'Donoghue, B; Papageorgiou, K; Schäfer, MR | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Choi, SH; Choi, WJ; Kim, JJ; Park, JY; Park, KM; Seok, JH; Yoon, HJ | 1 |
| Hugdahl, K; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM; Sinkeviciute, I | 1 |
| Ishigooka, J; Iwata, N; Nakagome, K; Ohmori, T | 1 |
| Amado, JA; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez-García, O; Pardo-Garcia, G; Pérez-Iglesias, R; Tabares-Seisdedos, R | 1 |
| Datta, SS; Furtado, VA; Kumar, A; Russell, PS; Wright, SD | 1 |
| Li, M; Qiao, J; Zhang, Q | 1 |
| Hobbs, D; Karagianis, J; Raskin, J; Treuer, T | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Jiang, KD; Shen, XL; Wang, HF; Yang, XM; Zhang, HX; Zhou, H | 1 |
| Asmal, L; Flegar, SJ; Komossa, K; Leucht, S; Rummel-Kluge, C; Wang, J | 1 |
| Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Au, RW; Chiu, HF; Dickerson, F; Kreyenbuhl, J; Lai, KY; Man, D; Shum, D; Tang, WK; Ungvari, GS; Wang, CY; Xiang, YT; Yu, X; Zhou, FC; Zhou, JJ; Zhou, Y | 1 |
| Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW | 1 |
| Abderhalden, C; Horn, H; Maier, N; Moggi, F; Moskvitin, K; Müller, TJ; Strik, W; Walther, S | 1 |
| Lin, H; Rosenheck, R | 1 |
| Fukui, N; Ono, S; Saito, M; Sawamura, K; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
| Leucht, S; Zhao, J | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Alamo, C; Huelves, L; López-Muñoz, F; Molina, Jde D; Moreno, R; Noriega, C; Pérez-Nieto, MÁ; Rubio, G; Shen, WW; Sim, K | 1 |
| Alva, G; Brams, M; Citrome, L; Glick, ID; Hochfeld, M; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Pestreich, L; Weiden, PJ; Winseck, A | 1 |
| Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K | 1 |
| Ainsworth, C; Berardo, CG; Brodtkorb, TH; Mauskopf, J; Patel, A; von Schéele, B | 1 |
| Alessi-Severini, S; Austin, PC; Blackburn, DF; Blais, L; Bresee, L; Filion, KB; Kawasumi, Y; Kurdyak, P; Lipscombe, LL; Paterson, JM; Platt, RW; Tamim, H | 1 |
| Bahn, S; de Witte, L; Guest, PC; Kahn, RS; Rahmoune, H; Schwarz, E; Tomasik, J | 1 |
| Kozumplik, O; Mihaljevic-Peles, A; Muck-Seler, D; Nedic Erjavec, G; Nikolac Perkovic, M; Pivac, N; Sagud, M; Uzun, S; Zivkovic, M | 1 |
| Blackburn, DF; Bresee, L; Champagne, A; Crawley, A; Lynds, S; Remillard, AJ; Tran, D | 1 |
| Galińska-Skok, B; Konarzewska, B; Malus, A; Simonienko, K; Szulc, A; Waszkiewicz, N; Łazarczyk-Kirejczyk, J | 1 |
| Bahramzi, M; Campillo, A; Minassian, A; Vilke, GM; Wilson, MP | 1 |
| Miki, T; Mizuki, Y; Takaki, M | 1 |
| Derbabian, B; Jacobowitz, W; Saunders, A | 1 |
| Mimura, M; Remington, G; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K | 2 |
| Chaves, KM; de Araújo Dantas, D; de Araújo, AA; de Araújo, RF; de Lima Silva, V; de Medeiros, CA; de Souza, DL; do Nascimento, GG; Ribeiro, SB | 1 |
| Barton, HA; Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Pilla Reddy, V; Proost, JH; Vermeulen, A | 1 |
| Brawman-Mintzer, O; Gros, DF; Hershenberg, R | 1 |
| Hviid, A; Melbye, M; Pasternak, B; Ranthe, MF; Svanström, H | 1 |
| Hanft, A; Turkel, SB | 1 |
| Hu, JY; Huang, A; Liu, YY; Liu, ZL; Wang, LM; Wen, XJ | 1 |
| Chen, KP; Lung, FW; Yang, MC | 1 |
| Ambaliya, A; Dosi, R; Joshi, H; Patell, R | 1 |
| Kuntz, KM; Park, T | 1 |
| Bernardo, M; Caballero, M; Corripio, I; Felipe, AE; Fernandez de Corres, B; González Piqueras, JC; Huerta, R; Ibáñez, A; Iniesta, R; López-Carrilero, R; Oliveira, C; Roca, M; Rodriguez-Jimenez, R; Sindreu, SD; Usall, J | 1 |
| Abe, T; Fujita, K; Hatta, K; Hirata, T; Ito, H; Ito, S; Katayama, S; Morikawa, F; Nakamura, H; Nakase, R; Otachi, T; Sawa, Y; Shirai, Y; Sudo, Y; Takebayashi, H; Tomiyama, H; Usui, C; Yamashita, T | 1 |
| Bies, RR; Mimura, M; Remington, G; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Dixon, SN; Gandhi, S; Garg, AX; Hwang, YJ; Nash, DM; Pannu, N; Parikh, CR; Rehman, F; Reiss, JP; Shariff, SZ; Wald, R | 1 |
| Gui, X; Hu, G; Ma, X; Maimaitirexiati, T; Xu, G; Zhang, R; Zhang, W | 1 |
| Boettger, S; Breitbart, W; Jenewein, J | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Frydecka, D; Kiejna, A; Misiak, B; Ślęzak, R; Łaczmański, Ł | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H | 1 |
| Chung, H; Cohen, N; Favis, R; Fu, DJ; Gopal, S; Jadwin, A; Li, Q; Savitz, A; Wang, D | 1 |
| Castle, DJ; Slott Jensen, JK | 1 |
| Alva, G; Citrome, L; Glick, ID; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Weiden, PJ; Winseck, A | 1 |
| Cipriani, A; Davis, JM; Furukawa, TA; Goldberg, Y; Leucht, S; Levine, SZ; Samara, M; Tanaka, S | 1 |
| Aiello, R; Citraro, R; De Sarro, G; Leo, A; Pugliese, M; Russo, E | 1 |
| Ghezai, H; Goldacre, B; Hodsoll, J; Miles, S; Smallcombe, N; Veale, D | 1 |
| Álvarez, M; Dilla, T; Happich, M; Möller, J; O'Donohoe, P; Sacristán, JA; Tockhorn, A | 1 |
| Alda, JA; Arango, C; Baeza, I; Castro-Fornieles, J; Correll, CU; Cuerda, C; de Andrés, P; de la Serna, E; Fraguas, D; Giráldez, M; Martínez-Cantarero, C; Merchán-Naranjo, J; Moreno, C; Parellada, M | 1 |
| Brennan, MD; Ramsey, TL | 1 |
| Chiu, HF; Dong, H; Han, X; Lu, Z; Ungvari, GS; Wang, CY; Wu, YF; Xiang, YT; Yang, FD; Yu, X; Yuan, YB; Zhao, JP | 1 |
| Crespo-Facorro, B; Prieto, C; Sainz, J | 1 |
| Damkier, P; Ennis, ZN | 1 |
| Goya, S; Kai, T; Kanemura, S; Kashiwagi, Y; Maeda, I; Matsuda, Y; Nakajima, S; Okamoto, Y; Taira, T; Takei, K; Tanimukai, H; Tokoro, A; Tokuyama, M; Tsujimoto, H; Tsujio, I; Watanabe, M | 1 |
| Caravaggio, F; Chung, JK; Fervaha, G; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mihashi, Y; Mulsant, B; Nakajima, S; Plitman, E; Remington, G; Takeuchi, H | 1 |
| Dixon, SN; Fraser, LA; Garg, AX; Hwang, YJ; Liu, K; Naylor, KL; Shariff, SZ | 1 |
| Agid, O; Fervaha, G; Lee, J; Remington, G; Takeuchi, H | 1 |
| Berardi, MA; Caraceni, A; Caruso, R; Grassi, L; Mitchell, AJ; Nanni, MG; Riba, M | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Chiang, C; Kales, H; Kim, HM; Schneider, LS; Weintraub, D | 1 |
| Kim, J; Shin, H; Song, JH | 1 |
| Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Maust, DT; Schneider, LS; Seyfried, LS | 1 |
| Pongpirul, K; Puangthong, U | 1 |
| Bobo, WV; Bonaccorso, S; Chen, Y; Jayathilake, K; Li, J; Meltzer, HY; Sodhi, M; Theleritis, C; Tumuklu, M | 1 |
| Brooks, KR; Kram, BL; Kram, SJ | 1 |
| Babigumira, JB; Lubinga, SJ; Mutamba, BB; Nganizi, A | 1 |
| Anilkumar, AP; Corr, PJ; Deuschl, C; Ettinger, U; Ffytche, DH; Kumari, V; Lee, SE; Schmechtig, A; Williams, SC | 1 |
| Baraniuk, A; Gavrilidis, E; Gilbert, H; Kulkarni, J; Storch, A; Worsley, R | 1 |
| DiPaula, BA; Feldman, S; Kelly, DL; Love, RC; McMahon, RP; Miller, J; Morris, AA; Raley, H; Wehring, H | 1 |
| David, AS; Flanagan, RJ; Gudbrandsen, M; Landau, S; Law, S; Magill, N; Patel, MX; Rose, D; Sweetman, I | 1 |
| Hofer, A; Wartelsteiner, F | 1 |
| Lin, H; McEvoy, J; Mohamed, S; Rosenheck, RA; Stroup, S; Swartz, M | 1 |
| Borodyuk, YN; Burdovitsina, TG; Kornetova, EG; Parshukova, DA; Semke, AV; Seregin, AA; Smirnova, LP; Tkacheva, GD | 1 |
| Ramanathan, M; Siva Selva Kumar, M | 1 |
| Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H | 2 |
| Beaune, P; Blanc, O; Fond, G; Jamain, S; Le Clerc, S; Leboyer, M; Llorca, PM; Meary, A; Rajagopal, K; Taing, L; Tamouza, R; Zagury, JF | 1 |
| de Araújo Júnior, RF; de Araújo, AA; Dos Santos, AC; Guerra, GC; Lemos, TM; Medeiros, CA; Ribeiro, SB; Rubio-Valera, M; Serrano-Blanco, A | 1 |
| Bies, RR; Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Plitman, E; Pollock, BG; Suzuki, T; Uchida, H | 1 |
| Amada, N; Deiana, S; Kikuchi, T; Riedel, G; Stott, C; Watanabe, A; Yamasaki, Y | 1 |
| Bialer, M; Finnell, RH; Lin, LY; Ogle, K; Wlodarczyk, BJ | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Bulanov, VS; Gorobets, LN; Ivanova, GP; Litvinov, AV; Polyakovskaya, TP; Tsarenko, MA; Vasilenko, LM | 1 |
| Al-Jadiri, A; Borenstein, Y; Carbon, M; Correll, CU; David, L; Gerstenberg, M; Kane, JM; Kapoor, S; Mormando, C; Saito, E; Seidman, AJ; Sheridan, EM; Singh, S; Steinhausen, HC; Vernal, DL | 1 |
| Berge, RK; Ersland, KM; Røst, TH; Skrede, S; Steen, VM | 1 |
| Bereza, BG; Einarson, TR; Goswami, P; Pudas, H; van Impe, K | 1 |
| Brandl, EJ; Chowdhury, NI; Freeman, N; Goncalves, VF; Kennedy, JL; Lieberman, JA; Meltzer, HY; Müller, DJ; Tiwari, AK; Zai, CC | 1 |
| Baruch, P; Beaulieu, S; Bond, DJ; da Cunha, A; Daigneault, A; Dias, R; Kapczinski, F; Kauer-Sant'Anna, M; Kunz, M; Lafer, B; Lam, RW; Milev, R; Parikh, SV; Qian, H; Quevedo, J; Schaffer, A; Sharma, V; Silverstone, PH; Walji, N; Wong, H; Yatham, LN; Young, LT | 1 |
| Alda, JA; Andrés Nestares, P; Arango, C; Baeza, I; Cantarero, CM; Castro-Fornieles, J; de la Serna, E; Garcia-Amador, M; Merchán-Naranjo, J; Moreno, C; Muñoz, D; Tapia, C | 1 |
| Bahn, S; Guest, PC; Lago, SG; Leweke, FM; Rahmoune, H; Rothermundt, M; Schwarz, E; Steiner, J; Tomasik, J; van Beveren, NJM | 1 |
| De Santis, M; Deng, C; Huang, XF; Lian, J | 2 |
| Auricchio, F; Baldelli, S; Bernardini, R; Bertella, S; Bravaccio, C; Capuano, A; Carnovale, C; Cattaneo, D; Clementi, E; Ferrajolo, C; Fucile, S; Guastella, G; Mani, E; Molteni, M; Pascotto, A; Pisano, S; Pozzi, M; Radice, S; Rafaniello, C; Riccio, MP; Rizzo, R; Rossi, F; Scuderi, MG; Sperandeo, S; Sportiello, L; Villa, L | 1 |
| Beillat, M; Robinson, P; Sapin, C; Tempest, M; Treur, M | 1 |
| Alda, JA; Andrés-Nestares, P; Arango, C; Baeza, I; Calvo-Escalona, R; Castro-Fornieles, J; Fernández-Avilés, F; Martínez-Cantarero, C; Merchán-Naranjo, J; Muñoz-Samons, D; Tapia-Casellas, C; Tor, J | 1 |
| Ahnaou, A; Biermans, R; Drinkenburg, WH | 1 |
| Hammarlund-Udenaes, M; Jansson, B; König, F; Loryan, I; Melander, E; Payan, M; Svensson, M | 1 |
| Khouzam, HR | 1 |
| Beszłej, JA; Bieńkowski, P; Frydecka, D; Kucharska-Mazur, J; Misiak, B; Moustafa, AA; Samochowiec, A; Samochowiec, J; Tybura, P | 1 |
| Dold, M; Gianatsi, M; Helfer, B; Leucht, S; Nikolakopoulou, A; Salanti, G; Samara, MT | 1 |
| Baymeeva, NV; Burminskiy, DS; Miroshnichenko, II; Morozova, MA; Platova, AI; Potanin, SS | 1 |
| Bieńkowski, P; Jastrzębska-Więsek, M; Kołaczkowski, M; Mierzejewski, P; Partyka, A; Wasik, A; Wesołowska, A | 1 |
| Chen, J; Li, Y; Liang, S; Shi, S; Shi, Y; Wang, Y; Xu, Y; Yang, L | 1 |
| Amato, L; Indave, BI; Minozzi, S; Pani, PP | 1 |
| Uguz, F | 1 |
| Bo, L; Saha, KB; Sampson, S; Xia, J; Zaman, RU; Zhao, S | 1 |
| Davis, JM; Furtado, VA; Hosalli, P; Sampson, S | 1 |
| Ake, T; Al-Dhaher, Z; Carbon, M; Correll, CU; David, L; Kane, JM; Kapoor, S; Krakower, S; Saito, E | 1 |
| Bereza, BG; Einarson, TR; Goswami, P; Maia-Lopes, S; Van Impe, K | 1 |
| Arango, C; Baeza, I; Calvo-Escalona, R; Castro-Fornieles, J; de la Serna, E; Merchán-Naranjo, J; Rodríguez-Latorre, P; Vigo, L | 1 |
| Charan, D; Chawla, N; Kumar, S; Pattanayak, RD | 1 |
| Barbosa, DS; Bonifácio, KL; Brinholi, FF; Casagrande, R; Farias, CC; Higachi, L; Moreira, EG | 1 |
| Brobert, G; Heintjes, EM; Herings, RM; Overbeek, JA; Penning-van Beest, FJ | 1 |
| Ariyawansa, J; De Meulder, M; Remmerie, B; Savitz, A | 1 |
| De Meulder, M; Remmerie, B; Savitz, A; Weiner, S | 1 |
| Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S | 1 |
| Blais, L; Carrier, JD; Cohen, AA; Courteau, J; Delorme, A; Demers, MF; Fleury, MJ; Grignon, S; Larouche, A; Lesage, A; Roberge, P; Roy, MA; Vanasse, A | 1 |
| Ballard, C; Cricelli, C; Ferrajolo, C; Fontana, A; Gambassi, G; Giorgianni, F; Ivanovic, J; Molokhia, M; Pasqua, A; Sharp, S; Spina, E; Sturkenboom, M; Sultana, J; Trifirò, G | 1 |
| Deng, C; Lian, J; Pan, B | 2 |
| Cocker, KE; Reese, TR; Thiel, DJ | 1 |
| Bruhn, CH; Hashemi, N; Nielsen, J; Polcwiartek, C; Rosenzweig, M; Vang, T | 1 |
| Alphs, L; Correll, CU; Kim, E; Mao, L; Starr, HL | 1 |
| Chao, YY; Du, YH; Li, WW; Lü, LX; Ma, J; Song, XQ; Yang, YF; Zhang, Y; Zhao, J; Zhao, JY | 1 |
| Bies, RR; Kapur, S; Mimura, M; Pollock, BG; Sakurai, H; Suzuki, T; Uchida, H | 1 |
| Becker, DR; Drake, RE; Glynn, SM; Marder, SR; Noordsy, DL; O'Keefe, C; Sugar, CA | 1 |
| Bergmans, P; Caspi, A; Cherubin, P; Hargarter, L; Keim, S; Lara, E; Pinchuk, I; Schreiner, A; Schuepbach, D; Suleman, S | 1 |
| Bas, A; Bas, TO; Duran, A; Emul, M; Gultekin, G; Incir, S | 1 |
| King, MB; Marston, L; Nazareth, I; Osborn, D; Petersen, I; Walters, K | 1 |
| Ioannidis, JP; Steyerberg, EW; Sullivan, PG; Trepanowski, JF; Wallach, JD | 1 |
| Bervoets, C; Cleymans, S; Morrens, M | 1 |
| Coppen, EM; Roos, RA | 1 |
| Calabrese, JR; Fang, F; Gao, K; Wang, Z; Wu, R | 1 |
| Caravaggio, F; Chung, JK; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mamo, DC; Mar, W; Mulsant, BH; Nakajima, S; Plitman, E; Pollock, BG; Rajji, TK; Suzuki, T; Uchida, H | 1 |
| Loebel, A; Meyer, N; Rajagopalan, K; Wade, S | 1 |
| Ramcharran, D; Ryan, PB; Schuemie, MJ; Stang, PE | 1 |
| Liu, YP; Tung, CS; Wan, FJ; Yang, YY | 1 |
| Abe, T; Howard, R; Lebowitz, B; Mimura, M; Reeves, S; Roberts, R; Suzuki, T; Uchida, H; Yoshida, K | 1 |
| Aoki, S; Harada, T; Kishi, Y; Nomura, A; Sato, K; Takeda, T; Washida, K; Yada, Y; Yoshimura, B; Yoshimura, Y | 1 |
| Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ | 1 |
| Arasappa, R; Chand, PK; Kulkarni, K; Muralidharan, K; Murthy, P; Philip, M; Prasad M, K; Zutshi, A | 1 |
| Bieńkowski, P; Heitzman, J; Jarema, M; Parnowski, T; Rybakowski, J | 1 |
| Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Dubin, WR; Fu, E; Kovach, JG | 1 |
| Artukoglu, BB; Bloch, MH; Gabriel, D; Jakubovski, E; Taylor, JH | 1 |
| De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J | 1 |
| Bajs Janovic, M; Božina, N; Bradaš, Z; Ganoci, L; Grubisin, J; Kudlek Mikulic, S; Kuzman Rojnic, M; Mihaljevic-Peles, A; Sagud, M; Vuksan Cusa, B | 1 |
| Cuperfain, AB; Gonçalves, VF; Harripaul, R; Kennedy, JL; Maciukiewicz, M; Mittal, K; Müller, DJ; Rollins, B; Tiwari, AK; Vawter, MP; Zai, CC | 1 |
| Fujibayashi, M; Hattori, S; Hirayasu, Y; Ishii, C; Ishii, N; Kishida, I; Miyauchi, M; Moritani, T; Shiraishi, Y; Suda, A; Taguri, M; Tsujita, N | 2 |
| Baldelli, S; Bernardi, FF; Bernardini, R; Bravaccio, C; Capuano, A; Cattaneo, D; Cheli, S; Clementi, E; Molteni, M; Pozzi, M; Radice, S; Rafaniello, C; Rossi, F; Sessa, M | 1 |
| Bereza, BG; Denee, TR; Dries, PJT; Einarson, TR; Tedouri, F; Van Impe, K | 1 |
| Mock, CK; Teslyar, P; Thom, RP | 1 |
| Castberg, I; Skogvoll, E; Spigset, O; Westin, AA | 1 |
| Chen, CC; Chen, CL; Goto, S; Hsu, LW; Huang, KT; Nakano, T | 1 |
| Emond, B; Joshi, K; Kamstra, R; Lafeuille, MH; Lefebvre, P; Pilon, D; Tandon, N | 1 |
| Glynn, SM; Marder, SR; Noordsy, DL; O'Keefe, CD; Sugar, CA | 1 |
| Bertolino, A; Dukart, J; Hawkins, PCT; Mazibuko, N; Mehta, MA; Merlo-Pich, E; Risterucci, C; Sambataro, F; Silber-Baumann, H; Vernon, AC; Walsh, E; Wood, TC; Zelaya, FO | 1 |
| Kou, C; Liu, X; Liu, Y; Ma, Y; Song, Y; Su, Y; Wang, M; Yang, G; You, Y; Zhang, L; Zhang, Y | 1 |
| Barbui, C; Chatterjee, S; Eaton, J; Hanlon, C; Jones, L; Ostuzzi, G; Silove, D; Ventevogel, P | 1 |
| Ahnaou, A; Drinkenburg, WHIM; Huysmans, H; Van de Casteele, T | 1 |
| Dietrich-Muszalska, A; Kolińska-Łukaszuk, J | 1 |
| Hikita, M; Kono, S; Miura, I; Niwa, SI; Oshima, S; Suzuki, R; Wada, A; Yabe, H | 1 |
| Andreassen, OA; Dieset, I; Engum, A; Fjukstad, KK; Lydersen, S; Spigset, O; Steen, NE | 1 |
| Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T | 1 |
| Hao, R; Li, WZ; Liu, HZ; Xia, L; Zhang, XY | 1 |
| Bramness, JG; Handal, M; Hartz, I; Hjellvik, V; Nesvåg, R; Skurtveit, S | 1 |
| Golubović, J; Maljurić, N; Otašević, B; Protić, A; Zečević, M | 1 |
| Laidler, N | 1 |
| de Leon, J; Guo, GX; Guo, W; Li, WB; Ruan, CJ; Wang, CY; Zhou, M | 1 |
| Cui, H; Li, D; Li, G; Ning, Y; Zhou, Y | 1 |
| Sakamoto, S; Sato, K; Takaki, M; Yamada, N; Yoshimura, B | 1 |
| Chan, LF; Deang, KT; Gan, LLY; Tee, CK; Woon, LS | 1 |
| Deng, C; Lian, J | 1 |
| Bak, M; Drukker, M; Schoretsanitis, G; Schruers, KRJ; Van Os, J | 1 |
| Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Lin, CM; Little, K; Reynolds, PM | 1 |
| Melkote, R; Remmerie, B; Savitz, A; Singh, A; Vermeulen, A | 1 |
| Bhargava, MS; Kataria, D; Rehan, HS | 1 |
| Cuesta-Vargas, A; Mayoral-Cleries, F; Perez-Cruzado, D; Vera-Garcia, E | 1 |
| Matsuda, H; Mori, T; Okamoto, K; Ono, S; Ozeki, Y; Sagae, T; Shimoda, K; Someya, T; Sugai, T; Sugawara, N; Suzuki, Y; Yamazaki, M; Yasui-Furukori, N | 1 |
| Flavin, KS; Newcomer, JW; Nicol, GE; Patterson, BW; Schechtman, KB; Schweiger, JA; Yingling, MD | 1 |
| Bloch, MH; Gabriel, D; Jakubovski, E; Taylor, JH | 1 |
| Bell, C; Burry, L; Fergusson, DA; Hutton, B; Luxenberg, JS; Mehta, S; Perreault, MM; Rose, L; Siddiqi, N | 1 |
| Dong, F; Ji, SM; Li, AN; Li, L; Lu, W; Wang, CY; Zhou, TY | 1 |
| Beckley, N; Hayes, J; Nazareth, I; Osborn, DP; Petersen, I; Walters, K | 1 |
| Becker, R; Gass, N; Künnecke, B; Lebhardt, P; Meyer-Lindenberg, A; Reinwald, J; Risterucci, C; Sack, M; Sartorius, A; Schwarz, AJ; Tollens, F; Weber-Fahr, W | 1 |
| Bech, P; Correll, CU; Foldager, L; Mors, O; Østergaard, SD | 1 |
| Dias Alves, M; Micoulaud-Franchi, JA; Simon, N; Vion-Dury, J | 1 |
| Araszkiewicz, AS; Szota, AM | 1 |
| Galling, B; Maciejewska, D; Marlicz, W; Misera, A; Skonieczna-Żydecka, K; Stachowska, E; Łoniewski, I | 1 |
| Balcells, I; García-González, J; Honkanen, JK; Hovatta, I; Kieseppä, T; Lindgren, M; Mantere, O; Mäntylä, T; Raij, T; Saarnio, S; Suvisaari, J; Trontti, K; Vaarala, O | 1 |
| Davis, JM; Leucht, S; Smith, RC | 1 |
| Chen, KP; Chen, YL; Chiu, CC; Lung, FW; Tai, MH | 1 |
| Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
| Bertolino, A; Dipasquale, O; Dukart, J; Hawkins, PCT; Mehta, MA; Pergola, G; Rizzo, G; Sambataro, F; Selvaggi, P; Turkheimer, F; Veronese, M; Williams, SCR; Zelaya, F | 1 |
| Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L | 1 |
| Adamopoulos, P; Budhrani, GS; Easton, GS; Gray, DW; Jabaley, CS; Lynde, GC; O'Reilly-Shah, VN | 1 |
| Garip, B; Kayir, H; Uzun, O | 1 |
| Buhagiar, K; Jabbar, F | 1 |
| Li, P; Liu, X; Wang, J; Wang, Y; Yang, L; Zheng, L; Zhou, H; Zhou, Z | 1 |
| Deckert, J; Menke, A; Scherf-Clavel, M; Unterecker, S; Weidner, A | 1 |
| Bharadwaj, B; Kuppili, PP; Menon, V; Vellekkatt, F | 1 |
| Seeman, MV | 1 |
| Cope, N; Fowler, JC; Knights, J; Makin, A; Peters-Strickland, T; Phiri, P; Rathod, S | 1 |
| Bansal, Y; Kuhad, A; Medhi, B; Saroj, P; Singh, R; Sodhi, RK | 1 |
| Huang, A; Loebel, A; Messali, A; Ng-Mak, D; Wang, L | 1 |
| Horvitz-Lennon, M; Normand, ST; Spertus, J | 1 |
| Bareis, N; Stroup, TS | 1 |
| He, S; Li, HF; Li, Y; Li, YG; Qiao, Y; Shen, YF; Wen, H; Yu, YM; Zhang, L; Zhang, Y | 1 |
| Couturier, J; Isserlin, L; Norris, M; Spettigue, W | 1 |
| Cai, S; Cheng, Z; Correll, CU; Deng, H; Han, X; Lu, Z; Wang, C; Xiang, Y; Yang, F; Yang, L; Yu, X; Yuan, Y; Zhao, J | 1 |
| Iyer, S; Joober, R; Lepage, M; Malla, A; Mustafa, S; Shah, J | 1 |
| Chen, P; Jia, H; Ning, Y; Yin, D; Zhu, H | 1 |
| Bai, Y; Chen, G; Gao, K; Yang, H | 1 |
| Contu, L; Costa, G; Morelli, M; Pinna, A | 1 |
| Bazo-Alvarez, JC; Carpenter, JR; Hayes, JF; Morris, TP; Petersen, I | 1 |
| Carson, RE; D'Souza, DC; Gaiser, E; Gallezot, JD; Henry, S; Huang, Y; Lin, SF; Matuskey, D; Nabulsi, N; Planeta, B; Radhakrishnan, R; Ropchan, J | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Barlow, D; Beauchemin, M; Geguchadze, R; Guntur, AR; Houseknecht, KL; Lary, CW; Le, PT; Motyl, KJ; Nevola, K; Rue, M; Vary, CPH | 1 |
| Correll, CU | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Casu, G; Lecca, D; Marchese, G; Nicotra, EF; Palomba, M; Sil, A | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J | 1 |
| Bredicean, CA; Dehelean, L; Dumitrascu, V; Papava, I; Romosan, AM; Romosan, RS; Ursoniu, S | 1 |
| Beeker, A; Beekman, ATF; Berkhof, J; Boddaert, MSA; Neefjes, ECW; Teunissen, SCC; van der Vorst, MJDL; Verdegaal, BATT; Verheul, HMW; Wilschut, JA; Zuurmond, WWA | 1 |
| Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Hu, X; Li, K; Li, L; Li, T; Li, X; Li, Y; Lu, T; Lv, L; Ma, X; Ren, H; Reynolds, GP; Tan, L; Tan, Q; Tian, Y; Wang, C; Wang, H; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Chyou, TY; Nishtala, PS; Nishtala, R | 1 |
| Chandrasekaran, S; Dhandapani, VR; Iyer, S; Mohan, G; Mohan, M; Pattabiraman, R; Paul, V; Ramachandran, P; Rangaswamy, T; Singh, SP | 1 |
| Bijker, BJ; Bos, JHJ; Isphording, L; Luykx, JJ; Okhuijsen-Pfeifer, C; Schuiling-Veninga, CCM; Stam, N; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Hong, SC; Jeong, JH; Kim, SM; Kim, TW; Oh, JH; Seo, HJ; Um, YH | 1 |
| Barlati, S; Bonvicini, C; Gennarelli, M; Maffioletti, E; Magri, C; Minelli, A; Sacchetti, E; Valsecchi, P; Vita, A | 1 |
| Carvalho, BS; Garcia-Rosa, S; Guest, PC; Martins-de-Souza, D; Steiner, J | 1 |
| Cheng, Z; Han, X; Hou, Y; Shi, C; Xie, J; Yang, L; Yu, X; Yuan, Y | 1 |
| Bîgiu, NF; Dima, L; Ifteni, P; Moga, MA; Popa, MA; Teodorescu, A | 1 |
| Alexander-Bloch, A; Appel, S; Bloch, MH; Eli, M; Gur, RE; Maayan, L; Taylor, JH | 1 |
| Escudero, MAG; Gutiérrez-Rojas, L; Lahera, G | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Babinska, Z; Hammer, T; Horska, K; Karpisek, M; Kotolova, H; Micale, V; Prochazka, J; Ruda-Kucerova, J; Stark, T | 1 |
| Bienertova-Vasku, J; Horska, K; Hruska, P; Kucera, J; Kuruczova, D; Micale, V; Ruda-Kucerova, J | 1 |
| Soltan-Alinejad, P; Soltani, A; Turki, H; Vahedi, M | 1 |
| Anazawa, T; Imami, K; Inaba, K; Inoguchi, K; Ishihama, Y; Ishikawa, T; Kanemura, S; Kinoshita, M; Mackin, RB; Mori, K; Nagamine, T; Ninagawa, S; Okumura, M; Tada, S; Torii, S; Umezawa, H | 1 |
| Brambilla, P; Cantù, F; Ciappolino, V; Delvecchio, G; Enrico, P; Moltrasio, C | 1 |
| Kim, BH; Kim, E; Kim, S; Kuk, S; Lee, W; Park, SI | 1 |
| Bergé, D; Catalan, A; Díaz-Marsá, M; García, L; Gil, P; Labad, J; Olivares, JM; Ovejero, S; Pérez-Martín, J; Rivera-Baltanás, T; Rodríguez, A; Sanchez-Alonso, S; Torres, MÁG; Tost, M | 1 |
| Broadbent, M; Dobson, RJB; Dzahini, O; Govind, R; Ibrahim, ZM; Iqbal, E; Kim, CH; MacCabe, JH; Romero, A; Smith, T; Stewart, R; Werbeloff, N | 1 |
| Beauchemin, M; Bernier, E; Bouchard, C; Houseknecht, KL; May, M; Rostama, B; Vary, CPH | 1 |
| Basu, B; John Jayakumar, JAK; Panicker, MM | 1 |
| Acurcio, FA; Barbosa, WB; Godman, B; Gomes, RM; Guerra Júnior, AA | 1 |
| Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN | 1 |
| Atlani, MK; Chaudhary, P; Sutar, R | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
| Nagamine, T | 1 |
| Hadryś, T; Rymaszewska, J | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Aronen, ET; Mogk, H; Rättö, H; Saastamoinen, LK; Varimo, E | 1 |
| Aras, N | 1 |
| Bernardo, M; García-Rizo, C; Gómez-Huelgas, R; Rico-Villademoros, F; Rojo, R | 1 |
| Naguy, A | 1 |
| Ding, W; Hu, C; Hu, M; Li, H; Sun, X; Wang, Q; Wang, X; Wu, M; Zhang, C | 1 |
| Babiy, B; Busto, R; Canfrán-Duque, A; Cruz-Jentoft, AJ; García-Seisdedos, D; Gómez-Coronado, D; Lasunción, MA; Lerma, M; Martínez-Botas, J; Molina, YL; Pastor, Ó; Sánchez-Castellano, C | 1 |
| Arnold, AG; Birnbaum, SG; Chen, X; Jia, L; Li, L; Li, X; Liu, C; Sohn, JW; Wan, R; Wyler, SC; Yoo, ES | 1 |
| Kyriakopoulos, M; Singappuli, P; Sonuga-Barke, E | 1 |
| Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE | 1 |
| Ren, J; Zhang, C | 1 |
| Kumar, PNS; Radhika, MK; Suresh, R; Uvais, NA | 1 |
| Alisauskiene, R; Gjestad, R; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Kyziridis, TC | 1 |
| Agarwal, SM; Asgariroozbehani, R; Bowden, S; Hahn, MK; McIntyre, WB; Remington, G; Siskind, D; Smith, E; Stogios, N; Tran, V | 1 |
| Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y | 1 |
| Abler, V; Rajagopalan, K; Rashid, N; Yunusa, I | 1 |
| Daniel, V; Sanon, M; See, S | 1 |
| Bitter, I; Czobor, P; Katona, L | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| El-Mallakh, RS; Elsayed, OH; Good, ME; Pahwa, M; Sleem, A | 1 |
| Heng, W; Wu, G; Zang, X; Zhu, L | 1 |
| Bies, R; Caravaggio, F; Gerretsen, P; Graff-Guerrero, A; Ismail, M; Mamo, D; Mulsant, BH; Nakajima, S; Pollock, BG; Straubinger, T; Suzuki, T; Uchida, H | 1 |
| Alomo, M; Arce, C; Chiapella, LC; Corral, RM; Cuesta, MJ; Farinola, R; Lopredo, LS; Prokopez, CR; Sfriso, LE; Vallejos, M | 1 |
| Adams, SJ; Sprecher, A | 1 |
| Abler, VC; Demos, GN; Mahadik, BS; Rajagopalan, K; Rashid, N; Yunusa, I | 1 |
| Correll, CU; Hagi, K; Kane, JM; Kishimoto, T; Kurokawa, S | 1 |
| Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A | 1 |
| Correll, CU; Leucht, S; Luykx, JJ; Solmi, M; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Konradsson-Geuken, Å; Mazrina, J; Radhe, O; Ström, A; Svensson, TH; Titulaer, J | 1 |
| Aakjær, M; Andersen, M; Baltzer Houlind, M; Brøgger Kristiansen, S; Lange, T; Sharon, R | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Johannesen, CAB; Johnsen, E; Kroken, RA; Larsen, TK; Løberg, EM; Mørkved, N; Rettenbacher, MA; Thimm, JC; Winje, D | 1 |
| Osman, E; Yıldız, M | 1 |
| Chiappini, S; Giannantonio, MD; Martinotti, G; Miuli, A; Mosca, A; Pettorruso, M; Santovito, MC; Sensi, SL; Skryabin, V | 1 |
| Bartels-Velthuis, AA; Bruggeman, R; Burin, LM; Cahn, W; da Rocha, NS; de Haan, L; Hahn, MK; Schirmbeck, F; Simons, CJP; van Amelsvoort, T; van Os, J | 1 |
| Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
| Bessonova, L; Cichewicz, A; Doane, MJ; Harvey, PD; Hughes, R; Martin, A; O'Sullivan, AK; Snook, K; Weiden, PJ | 1 |
| Krishnegowda, S; Udaykumar, P; Yadiyal, A | 1 |
| Ikeda, M; Iwata, N; Kanazawa, T; Kishi, T; Saito, T | 1 |
| Chen, B; Ma, X; Wang, M; Yan, Y; Yang, X; Yin, L | 1 |
| Deng, C; Han, M; Hodgson, J; Lian, J; Su, Y | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J | 1 |
| Forray, C; Hertel, P; Howes, OD; Kane, JM; Kinon, BJ; Lemming, OM; Mittoux, A; Such, P | 1 |
| Cao, L; Liu, J; Wu, J | 1 |
| Brand, BA; Gangadin, S; Sommer, IE; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Nabekura, T; Uwai, Y | 1 |
| Baeza, I; Gutiérrez-Arango, F; Ilzarbe, D; Ilzarbe, L | 1 |
| Hu, J; Huang, S; Shang, D; Wen, Y; Xiao, T; Zhu, X | 1 |
| Boesen, MS; Ladefoged, MR; Marloth, PV | 1 |
| Hopkins, SC; Koblan, KS; Ogirala, A; Worden, M; Zeni, C | 1 |
| Chen, Q; Deng, W; Du, X; Hao, Q; Hu, X; Li, C; Li, K; Li, L; Li, T; Li, X; Lu, T; Lv, L; Ma, X; Ren, H; Tan, L; Tan, Q; Tang, Y; Wang, C; Wang, L; Wang, Q; Wang, Y; Wu, Y; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Cooper, J; Duffull, SB; Isbister, GK | 1 |
| Aarsland, D; Ballard, C; Creese, B; Mueller, C; Rogowska, M; Stewart, R; Thornton, M; Tsamakis, K; Velayudhan, L | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Li, K; Li, L; Li, T; Lu, T; Lv, L; Ma, X; Tan, L; Tan, Q; Tao, S; Wang, C; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Carvalho, AF; Hsu, CW; Hsu, TW; Liang, CS; Thompson, T; Tsai, TC; Tseng, PT; Yu, CL | 1 |
| Donohoe, G; McKernan, DP; Patlola, SR | 1 |
| Gupta, B; Lee, J; Pilunthanakul, T; Ting, MQJ | 1 |
| Blanchet, C; Carretier, E; Guessoum, SB; Ludot, M; Moro, MR; Thorey, S | 1 |
| Carlson, HE; Correll, CU; Kazimi, MM; Koch, MT | 1 |
| Anczewska, M; Balicki, M; Droździkowska, A; Gorczyca, P; Janus, J; Paciorek, S; Plisko, R; Zięba, M | 1 |
| Cheng, Z; Gao, T; Huang, B; Huang, Z; Pu, C; Shi, C; Yu, X; Zhang, D; Zheng, Y; Zhou, E; Zhou, T | 1 |
| Feng, X; Kang, Z; Liao, Y; Lu, T; Lu, Z; Sun, Y; Wang, L; Yan, H; Yue, W; Zhang, D; Zhang, Y | 1 |
| Breen, G; Everall, I; Guo, LK; Huang, HL; Huang, Z; Kang, ZW; Li, J; Li, M; Li, WQ; Li, Y; Liao, YD; Liu, B; Lu, TL; Lu, Z; Lv, LX; Su, Y; Tan, YL; Wang, HX; Wang, LF; Xiao, X; Yan, H; Yang, YF; Yao, Y; Yu, H; Yue, WH; Zhang, D; Zhang, YY | 1 |
| Cai, J; Chen, Y; Fang, M; Hu, J; Huang, M; Liu, F; Liu, T; Liu, Z; Long, Y; Meng, H; Song, X; Tang, Y; Wan, C; Wang, X; Wang, Z; Wu, Q; Wu, R; Wu, X; Xiao, J; Xu, X; Xu, Y; Yang, Y; Zhang, R; Zhao, J; Zheng, Y | 1 |
| Apa, H; Kutlu, A; Songür, ÇY | 1 |
| Eberhard, J; Fagerström, E; Gottfridsson, R; Konradsson-Geuken, Å; Nordling, D; Titulaer, J | 1 |
| Bateman, BT; Ely, EW; Inouye, SK; Jones, RN; Kim, DH; Lee, SB; Levin, R; Marcantonio, ER; Metzger, E; Pandharipande, PP; Park, CM; Pisani, MA | 1 |
| Prebil, K; Rus Prelog, P | 1 |
324 review(s) available for risperidone and olanzapine
| Article | Year |
|---|---|
Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence.
Topics: Animals; Antipsychotic Agents; Humans | 1998 |
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
Selective optimization of side activities: another way for drug discovery.
Topics: Animals; Biological Availability; Combinatorial Chemistry Techniques; Databases, Factual; Drug Design; Humans; Patents as Topic; Pharmaceutical Preparations; Structure-Activity Relationship | 2004 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dopamine Antagonists; Humans; Imidazoles; Indoles; Isoxazoles; Olanzapine; Piperidines; Pirenzepine; Risperidone; Schizophrenia; Serotonin Antagonists | 1995 |
Side effect profiles of new antipsychotic agents.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Seizures; Sleep; Weight Gain | 1996 |
Atypical antipsychotic drugs and long-term outcome in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
Evaluating outcomes of treatments for persons with psychotic disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Costs; Health Care Reform; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
The promise of new drugs for schizophrenia treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1997 |
[New antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Clinical Trials as Topic; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Pramipexole; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 1997 |
Managing the behavioral and psychological signs and symptoms of dementia.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dementia; Humans; Olanzapine; Pirenzepine; Risperidone | 1997 |
New antipsychotic medications: strategies for evaluation and selected findings.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Approval; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Recurrence; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States; United States Food and Drug Administration | 1997 |
Treatment of the refractory schizophrenic patient.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Diagnosis, Differential; Humans; Imidazoles; Indoles; Olanzapine; Patient Compliance; Pirenzepine; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Terminology as Topic; Treatment Failure | 1998 |
Antipsychotic agents and bipolar disorder.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome | 1998 |
Emergency treatment of acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Emergency Services, Psychiatric; Emergency Treatment; Haloperidol; History, 20th Century; Humans; Lorazepam; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone | 1998 |
Effects of antipsychotics on the clinical and psychosocial behavior of patients with schizophrenia.
Topics: Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Clozapine; Family Health; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Social Adjustment | 1997 |
New atypical antipsychotics. Experience and utility in the elderly.
Topics: Aged; Aging; Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 1998 |
Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Risperidone; Trimipramine | 1998 |
Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Cost-Benefit Analysis; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 1998 |
Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms.
Topics: Adolescent; Adolescent Psychiatry; Age Factors; Antipsychotic Agents; Benzodiazepines; Cholinergic Fibers; Clozapine; Controlled Clinical Trials as Topic; Corpus Striatum; Disease Susceptibility; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed | 1998 |
Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Cost-Benefit Analysis; Dibenzothiazepines; Drug Approval; Health Care Costs; Health Status; Hospitalization; Humans; Meta-Analysis as Topic; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States; United States Food and Drug Administration | 1998 |
Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Central Nervous System Diseases; Clozapine; Dibenzothiazepines; Drug Interactions; Dyskinesia, Drug-Induced; Health Status; Humans; Hypotension, Orthostatic; Olanzapine; Pirenzepine; Quality of Life; Quetiapine Fumarate; Receptors, Cholinergic; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Sleep Wake Disorders; Treatment Refusal; Weight Gain | 1998 |
Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Humans; Olanzapine; Parkinson Disease, Secondary; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1998 |
Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Comorbidity; Depressive Disorder; Humans; Mood Disorders; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Suicide Prevention | 1998 |
Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
Topics: Adult; Age Factors; Aged; Algorithms; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Decision Trees; Dementia; Dibenzothiazepines; Female; Humans; Male; Mood Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Treatment refractory schizophrenia: how should we proceed?
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1998 |
Common treatment goals of antipsychotics: acute treatment.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Hospitalization; Humans; Length of Stay; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology | 1998 |
Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome.
Topics: Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Electroconvulsive Therapy; Episode of Care; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1998 |
The routine use of atypical antipsychotic agents: maintenance treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Caregivers; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Risk Assessment; Risperidone; Schizophrenia | 1998 |
Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 1998 |
Conventional vs. newer antipsychotics in elderly patients.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Use of atypical neuroleptics in child and adolescent psychiatry.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Child; Child Development Disorders, Pervasive; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Remoxipride; Risperidone; Schizophrenia; Treatment Outcome | 1998 |
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 1999 |
Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Disease Progression; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Research Design; Risperidone | 1999 |
Cognitive improvement in schizophrenia with novel antipsychotic medications.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index | 1999 |
Tardive dyskinesia and atypical antipsychotic drugs.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Sex Factors | 1999 |
Antipsychotic drugs and relapse prevention.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention | 1999 |
Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Humans; Olanzapine; Pirenzepine; Research Design; Risperidone; Schizophrenia | 1999 |
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Regression Analysis; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 1999 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
Cognitive deficit in schizophrenia and its neurochemical basis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Glutamic Acid; Haloperidol; Humans; N-Methylaspartate; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 1999 |
Review of recent clinical studies with olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Depressive Disorder; Drug Resistance; Humans; Olanzapine; Pirenzepine; Prolactin; Psychotic Disorders; Quality of Life; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 1999 |
Antipsychotics from theory to practice: integrating clinical and basic data.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dose-Response Relationship, Drug; Humans; Limbic System; Models, Biological; Olanzapine; Pirenzepine; Psychotic Disorders; Receptors, Neurotransmitter; Risperidone; Schizophrenia | 1999 |
D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
Topics: Amoxapine; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; In Vitro Techniques; Loxapine; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Tomography, Emission-Computed | 1999 |
Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Humans; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Quetiapine Fumarate; Risperidone; Schizophrenia; Terminology as Topic | 1999 |
The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Loxapine; Mental Disorders; Olanzapine; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 1999 |
Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials.
Topics: Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Confidence Intervals; Dibenzothiazepines; Humans; Odds Ratio; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 1999 |
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
Topics: Antipsychotic Agents; Attention; Benzodiazepines; Clinical Trials as Topic; Clozapine; Cognition Disorders; Humans; Mental Recall; Neuropsychological Tests; Olanzapine; Pirenzepine; Risperidone; Verbal Learning | 1999 |
Drug metabolism and atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Schizophrenia treatment: the use of atypical drugs--risperdal, zyperexa, and clozaril.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Nurse Clinicians; Olanzapine; Pirenzepine; Psychiatric Nursing; Risperidone; Schizophrenia | 1998 |
[Clinical efficacy of olanzapine].
Topics: Antipsychotic Agents; Benzodiazepines; Binding Sites; Clinical Trials as Topic; Clozapine; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Serotonin | 1999 |
Pharmacologic treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quality of Life; Quetiapine Fumarate; Recurrence; Risperidone; Schizophrenia | 1999 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Risk Assessment; Risperidone; Schizophrenia | 1999 |
New antipsychotic medications: more than old wine and new bottles.
Topics: Agranulocytosis; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia | 2000 |
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Depression; Depressive Disorder; Dibenzothiazepines; Hostility; Humans; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Thiazoles; Treatment Outcome | 2000 |
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brain; Clozapine; Dibenzothiazepines; Humans; Movement Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risk Factors; Risperidone | 2000 |
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
The treatment of tardive dyskinesia and tardive dystonia.
Topics: Adult; Akathisia, Drug-Induced; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Olanzapine; Pirenzepine; Probability; Reserpine; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Tetrabenazine; Treatment Outcome; Vitamin E | 2000 |
[Atypical neuroleptics in child- and adolescent psychiatry].
Topics: Adolescent Psychiatry; Antipsychotic Agents; Benzodiazepines; Child; Child Psychiatry; Clozapine; Germany; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
Risperidone side effects.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Incidence; Movement Disorders; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology; Weight Gain | 2000 |
Adverse events related to olanzapine.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Mass Index; Clinical Trials as Topic; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Weight Gain | 2000 |
Antipsychotic drug side effect issues in bipolar manic patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2000 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Risperidone versus other atypical antipsychotic medication for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2000 |
[Atypical antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Netherlands; Olanzapine; Pirenzepine; Psychopharmacology; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Agents | 2000 |
Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia | 2000 |
The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Haloperidol; Humans; Olanzapine; Pirenzepine; Prolactin; Risperidone; Schizophrenia | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical neuroleptics in child and adolescent psychiatry.
Topics: Adolescent; Adolescent Psychiatry; Antipsychotic Agents; Benzodiazepines; Binding Sites; Brain; Clozapine; Female; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Tomography, Emission-Computed | 2000 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
Rationale and guidelines for the inpatient treatment of acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Hospitalization; Hostility; Humans; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome | 2000 |
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
Consistency of atypical antipsychotic superiority to placebo in recent clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Olanzapine: an updated review of its use in the management of schizophrenia.
Topics: Adolescent; Aged; Animals; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Cognition Disorders; Cost-Benefit Analysis; Cytochrome P-450 Enzyme System; Depression; Drug Interactions; Haloperidol; Humans; Olanzapine; Pirenzepine; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Serotonin; Risperidone; Schizophrenia | 2001 |
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
Topics: Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Risperidone; Schizophrenia; Terminology as Topic; Tomography, Emission-Computed | 2001 |
Weight change and atypical antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Dose-Response Relationship, Drug; Follow-Up Studies; Haloperidol; Health Behavior; Humans; Obesity; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Weight Gain | 2001 |
Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cognition; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 2001 |
Priapism associated with conventional and atypical antipsychotic medications: a review.
Topics: Antipsychotic Agents; Benzodiazepines; Circadian Rhythm; Clozapine; Erectile Dysfunction; Female; Forensic Psychiatry; Humans; Male; Olanzapine; Pirenzepine; Priapism; Psychotic Disorders; Risperidone | 2001 |
Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Health Care Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2001 |
Ziprasidone: a new atypical antipsychotic.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Dopamine Antagonists; Drug Interactions; Guidelines as Topic; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles; Time Factors; Tourette Syndrome | 2001 |
Atypical antipsychotics: impaired glucose metabolism.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Glucose; Humans; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Broad therapeutic uses of atypical antipsychotic medications.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child Development Disorders, Pervasive; Clozapine; Dementia; Dibenzothiazepines; Humans; Mood Disorders; Olanzapine; Personality Disorders; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
Use of atypical antipsychotics in mood disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles | 2001 |
[Efficacy of rispolept and zyprexa in the treatment of patients with schizophrenia].
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Pirenzepine; Quality of Life; Risperidone; Schizophrenia | 2001 |
[Clinical and pharmacological studies of the second generation antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Cytoskeletal Proteins; Dibenzothiazepines; Dopamine; Dopamine Antagonists; Humans; Nerve Tissue Proteins; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists | 2001 |
[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Hostility; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2002 |
The role of novel antipsychotics in bipolar disorders.
Topics: Acute Disease; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Lithium; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone | 2002 |
Movement disorders associated with atypical antipsychotic drugs.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Neuroleptic Malignant Syndrome; Neurotoxicity Syndromes; Olanzapine; Pirenzepine; Risperidone | 2002 |
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2002 |
[Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Humans; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors | 2002 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prevalence; Psychotic Disorders; Risperidone; Sulpiride | 2002 |
Economic evaluations of olanzapine and risperidone.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Humans; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Retrospective Studies; Risperidone; Schizophrenia | 2002 |
Atypical antipsychotics in Parkinson-sensitive populations.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Dementia, Vascular; Dibenzothiazepines; Hallucinations; Humans; Iatrogenic Disease; Lewy Body Disease; Olanzapine; Parkinson Disease; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2002 |
Atypical antipsychotics: experience and use in the elderly.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Dementia; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; United Kingdom | 2002 |
[Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Antagonists; Humans; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Tics; Tourette Syndrome | 2002 |
Using antipsychotics in elderly patients.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Delusions; Hallucinations; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone | 2002 |
Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Economic evaluations of novel antipsychotic medications: a literature review.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Drug Costs; Humans; Olanzapine; Pirenzepine; Research Design; Risperidone; Schizophrenia; United States | 2003 |
Clinical trial response and dropout rates with olanzapine versus risperidone.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Patient Compliance; Patient Dropouts; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Time Factors; Treatment Outcome | 2003 |
Safety in treating bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyskinesias; Haloperidol; Humans; Hyperglycemia; Hyperprolactinemia; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Thioridazine; Weight Gain | 2003 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; Bone Marrow Diseases; Child; Dibenzothiazepines; Endocrine System Diseases; Humans; Mental Disorders; Nervous System Diseases; Olanzapine; Piperazines; Pirenzepine; Primary Health Care; Quetiapine Fumarate; Risperidone; Thiazoles | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles | 2003 |
[An introduction to antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine Antagonists; Humans; Indoles; Isoindoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles | 2003 |
An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
Topics: Acute Disease; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cholinergic Antagonists; Clozapine; Double-Blind Method; Female; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risperidone; Schizophrenia | 2003 |
Antipsychotic medication and seizures: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2003 |
Diabetes mellitus associated with atypical anti-psychotic medications.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Humans; Hyperglycemia; Middle Aged; Odds Ratio; Olanzapine; Risperidone | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
New generation antipsychotics for first episode schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2003 |
Pharmacologic management of psychosis in the elderly: a critical review.
Topics: Aged; Alzheimer Disease; Benzodiazepines; Bipolar Disorder; Clozapine; Depressive Disorder; Drug Administration Schedule; Humans; Lewy Body Disease; Olanzapine; Parkinson Disease; Pirenzepine; Psychotic Disorders; Risperidone | 2003 |
[The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Clinical Trials as Topic; Clozapine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Glucose; Haloperidol; Humans; Intellectual Disability; Male; Mental Disorders; Metabolic Syndrome; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain | 2003 |
Cost comparisons of olanzapine and risperidone in treating schizophrenia.
Topics: Benzodiazepines; Fees, Pharmaceutical; Humans; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome; United States | 2004 |
Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; Schizophrenia | 2004 |
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Molecular Structure; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Piperazines; Polypharmacy; Quetiapine Fumarate; Quinolones; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
New antipsychotics and schizophrenia: a review on efficacy and side effects.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Cognition; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders | 2004 |
Novel antipsychotics in bipolar and schizoaffective mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Psychotic Disorders; Risperidone | 2004 |
Atypical antipsychotics and diabetes mellitus: an association.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Glucose; Humans; Male; Olanzapine; Risperidone; Schizophrenia | 2004 |
Atypical antipsychotics and diabetes mellitus.
Topics: Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Dibenzothiazepines; Glucose; Humans; Insulin Resistance; Islets of Langerhans; Obesity; Olanzapine; Pancreas; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
Tardive dyskinesia rates with atypical antipsychotics in older adults.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Incidence; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2004 |
Alleviating stuttering with pharmacological interventions.
Topics: Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Frontal Lobe; Humans; Interdisciplinary Communication; Olanzapine; Risperidone; Stuttering; Temporal Lobe | 2004 |
Efficacy of atypical antipsychotics in elderly patients with dementia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2004 |
Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Humans; Lewy Body Disease; Olanzapine; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine.
Topics: Benzodiazepines; Clinical Trials as Topic; Clozapine; Drug Industry; Humans; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Risperidone | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Serotonin Antagonists; Thiazoles; Treatment Outcome; United States | 2004 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Olanzapine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Schizophrenia | 2004 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2003 |
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Industry; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Support as Topic; Retrospective Studies; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
[Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Benzodiazepines; Bipolar Disorder; Cognition; Dibenzothiazepines; Drug Design; Drug Resistance; Drug Therapy, Combination; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2004 |
Do atypical antipsychotics cause stroke?
Topics: Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Dementia; Humans; MEDLINE; Olanzapine; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Stroke; Treatment Outcome | 2005 |
[Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Stroke | 2005 |
Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
Topics: Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone | 2005 |
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiazepines; Family Planning Services; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Teratogens; Triazines; Valproic Acid; Women's Health | 2005 |
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; MEDLINE; Neuropsychological Tests; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
Atypical antipsychotics for nursing home patients: a retrospective chart review.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Homes for the Aged; Humans; Medical Records; Mental Disorders; Nursing Homes; Olanzapine; Retrospective Studies; Risperidone | 2005 |
Risperidone versus olanzapine for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Male; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2005 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2004 |
Effectiveness and cost of risperidone and olanzapine for schizophrenia: a systematic review.
Topics: Antipsychotic Agents; Benzodiazepines; Costs and Cost Analysis; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2005 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Memory Disorders; Olanzapine; Retention, Psychology; Risperidone; Schizophrenia | 2006 |
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approach.
Topics: Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Computer Simulation; Decision Making; Haloperidol; Humans; Markov Chains; Models, Psychological; Monte Carlo Method; Olanzapine; Risperidone; Schizophrenia | 2006 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
Antipsychotic poisoning in young children: a systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Chlorpromazine; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Infant; Infant, Newborn; Olanzapine; Pimozide; Piperazines; Poisoning; Quetiapine Fumarate; Quinolones; Risperidone | 2005 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2005 |
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Refusal | 2005 |
Typical and atypical antipsychotics in bipolar depression.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Administration Schedule; Humans; Olanzapine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Severity of Illness Index; Treatment Outcome | 2005 |
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2006 |
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Bias; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Industry; Humans; Olanzapine; Patient Selection; Publication Bias; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Research Support as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2006 |
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comorbidity; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Haloperidol; Humans; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Tic Disorders; Treatment Outcome | 2006 |
Atypical antipsychotics in the management of delirium: a review of the empirical literature.
Topics: Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2005 |
Risperidone versus olanzapine for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2006 |
Creating more effective antidepressants: clues from the clinic.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder, Major; Dibenzothiazepines; Drug Design; Drug Synergism; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine; Receptors, Histamine; Receptors, Serotonin; Risperidone; Stress Disorders, Post-Traumatic | 2006 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Olanzapine; Psychotic Disorders; Risperidone; Treatment Outcome | 2006 |
[Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
Topics: Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Mental Disorders; Olanzapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2006 |
Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Outcome | 2006 |
Clinical trial-based cost-effectiveness analyses of antipsychotic use.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Costs; Health Care Costs; Humans; Olanzapine; Patient Dropouts; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Resource Allocation; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Treatment of psychosis: 30 years of progress.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2006 |
[Application of neuroleptics for dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Dementia; Dibenzothiazepines; Drug Approval; Humans; Mental Disorders; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; United States; United States Food and Drug Administration | 2007 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Antipsychotics for delirium.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delirium; Female; Haloperidol; Humans; Male; Olanzapine; Randomized Controlled Trials as Topic; Risperidone | 2007 |
Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Topics: Antipsychotic Agents; Benzodiazepines; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Follow-Up Studies; Humans; Mental Disorders; Olanzapine; Quetiapine Fumarate; Risperidone | 2007 |
Antipsychotic medications for cocaine dependence.
Topics: Antipsychotic Agents; Benzodiazepines; Cocaine-Related Disorders; Haloperidol; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone | 2007 |
Atypical antipsychotics: new drugs, new challenges.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Humans; Olanzapine; Psychotic Disorders; Risk Factors; Risperidone; Weight Gain | 2007 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Managing the acutely agitated and psychotic patient.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.
Topics: Adolescent; Anorexia Nervosa; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2008 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Data Interpretation, Statistical; Double-Blind Method; Humans; Olanzapine; Placebos; Randomized Controlled Trials as Topic; Risperidone; Stress Disorders, Post-Traumatic | 2008 |
[Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?].
Topics: Adrenergic Antagonists; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Humans; Lamotrigine; Olanzapine; Prazosin; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Failure; Triazines | 2007 |
Atypical antipsychotics for the treatment of delirious elders.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Delirium; Geriatrics; Haloperidol; Humans; Olanzapine; Risk Factors; Risperidone | 2008 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2008 |
Pharmacological treatment of pathologic aggression in children.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Child; Drug Prescriptions; Health Status; Humans; Lithium Carbonate; Methylphenidate; Olanzapine; Risperidone; Time Factors; Valproic Acid; Violence | 2008 |
[Delusion in the critical patient].
Topics: Antipsychotic Agents; Benzodiazepines; Critical Illness; Delusions; Diagnostic and Statistical Manual of Mental Disorders; Haloperidol; Humans; Olanzapine; Propofol; Risk Factors; Risperidone; Severity of Illness Index; Surveys and Questionnaires | 2008 |
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know.
Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials, Phase I as Topic; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Risperidone; Schizophrenia; Thiazoles | 2008 |
Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Dibenzothiazepines; Disorders of Excessive Somnolence; Headache; Humans; Methylphenidate; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2008 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
[Atypical antipsychotics in first-episode psychosis: a review].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index | 2008 |
Asperger's syndrome: from hiding to thriving.
Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Depressants; Child; Child Behavior; Diagnosis, Differential; Early Diagnosis; Fluvoxamine; Humans; Interpersonal Relations; Melatonin; Nurse Practitioners; Nursing Assessment; Olanzapine; Prevalence; Primary Health Care; Prognosis; Psychological Tests; Psychology, Child; Risperidone; Serotonin Agents; Social Behavior; United States | 2008 |
Treatment of delirium in supportive and palliative care.
Topics: Antipsychotic Agents; Benzodiazepines; Delirium; Dopamine Antagonists; Haloperidol; Humans; Olanzapine; Palliative Care; Prognosis; Risperidone; Serotonin Antagonists; Severity of Illness Index; Time Factors | 2008 |
[Turner-syndrome and psychosis: a case report and brief review of the literature].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Chromosome Aberrations; Citalopram; Combined Modality Therapy; Drug Therapy, Combination; Female; Hallucinations; Humans; Middle Aged; Olanzapine; Patient Education as Topic; Psychotherapy; Psychotic Disorders; Risperidone; Turner Syndrome | 2009 |
[The use of antipsychotics in patients with dementia].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia, Vascular; Dibenzothiazepines; Double-Blind Method; Evidence-Based Medicine; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2008 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cardiovascular System; Dibenzothiazepines; Drug Overdose; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2009 |
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Delusions of parasitosis.
Topics: Antipsychotic Agents; Benzodiazepines; Delusions; Emergency Service, Hospital; Humans; Insurance Coverage; Olanzapine; Parasitic Diseases; Referral and Consultation; Refusal to Treat; Risperidone | 2009 |
Amisulpride versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
[Neuroleptic adverse effects with emphasis on weight gain].
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Brain; Cardiomyopathies; Child; Clozapine; Dyskinesia, Drug-Induced; Energy Metabolism; Feeding Behavior; Female; Gene Expression; Genetic Association Studies; Humans; Male; Myocarditis; Olanzapine; Pericarditis; Risperidone; Tourette Syndrome; Twin Studies as Topic; Weight Gain | 2009 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes, Gestational; Dibenzothiazepines; Female; Humans; Infant, Newborn; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2010 |
Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.
Topics: Administration, Oral; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Dyslipidemias; Humans; Hyperglycemia; Hyperprolactinemia; Injections; Medication Adherence; Movement Disorders; Olanzapine; Pain; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Weight Gain | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Male; Multicenter Studies as Topic; Olanzapine; Patient Selection; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Clozapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Child; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Treatment Outcome | 2011 |
Second-generation antipsychotics for anxiety disorders.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2010 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Second-generation antipsychotics for obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Obsessive-Compulsive Disorder; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature.
Topics: Age Factors; Antipsychotic Agents; Benzodiazepines; Chemical and Drug Induced Liver Injury; Clozapine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Liver; Middle Aged; Olanzapine; Perazine; Risk Factors; Risperidone; Transaminases | 2011 |
[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium Carbonate; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone | 2012 |
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; Humans; Olanzapine; Patient Participation; Psychotherapy; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Time Factors; Treatment Outcome | 2011 |
Antipsychotic drug treatment for elderly people with late-onset schizophrenia.
Topics: Age of Onset; Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2012 |
Second-generation long-acting injectable antipsychotic agents: an overview.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Costs; Humans; Injections; Isoxazoles; Monitoring, Physiologic; Olanzapine; Paliperidone Palmitate; Practice Guidelines as Topic; Pyrimidines; Risperidone; Schizophrenia | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Are there different neural mechanisms responsible for three stages of weight gain development in anti-psychotic therapy: temporally based hypothesis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Nervous System Physiological Phenomena; Olanzapine; Psychotic Disorders; Risperidone; Time Factors; Weight Gain | 2012 |
Efficacy and safety of long acting injectable atypical antipsychotics: a review.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Delivery Systems; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Atypical antipsychotics for the treatment of disruptive behavior.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
Thrombotic complications of treatment with antipsychotic drugs.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Odds Ratio; Olanzapine; Risk Factors; Risperidone; Thrombosis; Venous Thromboembolism | 2013 |
Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Weight Gain | 2013 |
The first-episode of schizophrenia: a challenge for treatment.
Topics: Age Factors; Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Medication Adherence; Olanzapine; Patient Education as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome | 2002 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
Atypical antipsychotics for psychosis in adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Molindone; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2013 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzocycloheptenes; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Risperidone; Schizophrenia; Sensitivity and Specificity; Treatment Outcome | 2014 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
A bibliometric study of scientific research conducted on second-generation antipsychotic drugs in Singapore.
Topics: Antipsychotic Agents; Benzodiazepines; Bibliometrics; Biomedical Research; Clozapine; Humans; Journal Impact Factor; Olanzapine; Publications; Risperidone; Singapore | 2014 |
Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Humans; Models, Economic; Olanzapine; Outcome Assessment, Health Care; Risperidone; Schizophrenia | 2014 |
Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Generalization, Psychological; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Treatment Outcome | 2014 |
The pharmacologic management of delirium in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Delirium; Dexmedetomidine; Dibenzothiazepines; Humans; Melatonin; Olanzapine; Quetiapine Fumarate; Risperidone | 2014 |
Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chemotherapy, Adjuvant; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Synergism; Humans; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Risperidone; Treatment Outcome; Young Adult | 2014 |
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA Modulators; Humans; Lithium Compounds; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone; Serotonin Syndrome; Valproic Acid; Young Adult | 2014 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
Topics: Alleles; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Genetic Association Studies; Humans; Male; Metabolic Syndrome; Olanzapine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2C; Risperidone; Schizophrenia; Weight Gain | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical Marijuana; Olanzapine; Psychotherapy; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Treatment Outcome | 2015 |
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Olanzapine; Pregnancy; Pregnancy Complications; Quetiapine Fumarate; Risperidone; Schizophrenia | 2015 |
Management of delirium in palliative care: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cholinesterase Inhibitors; Delirium; Disease Management; Haloperidol; Health Personnel; Humans; Olanzapine; Palliative Care; Quetiapine Fumarate; Risperidone | 2015 |
Antipsychotic use in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Maternal-Fetal Exchange; Mental Disorders; Olanzapine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Quetiapine Fumarate; Risperidone | 2015 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Topics: Adult; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Clozapine; Double-Blind Method; Drug Resistance; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Single-Blind Method; Treatment Outcome | 2016 |
Antipsychotic medications for cocaine dependence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cocaine-Related Disorders; Haloperidol; Humans; Lamotrigine; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Reserpine; Risperidone; Triazines | 2016 |
Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Breast Feeding; Female; Humans; Infant Health; Infant, Newborn; Lactation; Olanzapine; Prospective Studies; Risperidone | 2016 |
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2016 |
Risperidone (depot) for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delayed-Action Preparations; Humans; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2016 |
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Behavioral Disorders in Dementia: Appropriate Nondrug Interventions and Antipsychotic Use.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Behavior Therapy; Benzodiazepines; Cognitive Behavioral Therapy; Dementia; Emotions; Humans; Hypotension, Orthostatic; Metabolic Syndrome; Neuroleptic Malignant Syndrome; Olanzapine; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2016 |
Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Denmark; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Olanzapine; Risk Factors; Risperidone; Young Adult | 2016 |
Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses.
Topics: Benzodiazepines; Bias; Carotid Stenosis; Endarterectomy, Carotid; Female; Humans; Hyperprolactinemia; Incidence; Lung Neoplasms; Male; Olanzapine; Outcome Assessment, Health Care; Prolactin; Randomized Controlled Trials as Topic; Risperidone; Sex Factors; Stroke | 2016 |
Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Huntington Disease; Olanzapine; Risperidone; Tetrabenazine; Tiapride Hydrochloride | 2017 |
Is there a 'weight neutral' second-generation antipsychotic for bipolar disorder?
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Risperidone | 2017 |
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea | 2017 |
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Male; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia | 2017 |
Delirium in hospitalized patients: Risks and benefits of antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Haloperidol; Hospitalization; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2017 |
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Humans; Insulin; Lurasidone Hydrochloride; Network Meta-Analysis; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles | 2017 |
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles | 2018 |
Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials.
Topics: Adolescent; Antipsychotic Agents; Child; Humans; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2018 |
Delusions of parasitosis: a brief review of the literature and pathway for diagnosis and treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Delusions; Humans; Olanzapine; Risperidone; Skin Diseases, Parasitic | 2018 |
No differences in olanzapine- and risperidone-related weight gain between women and men: a meta-analysis of short- and middle-term treatment.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Observational Studies as Topic; Olanzapine; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Weight Gain | 2018 |
Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delirium; Female; Haloperidol; Hospitalization; Humans; Male; Olanzapine; Placebo Effect; Randomized Controlled Trials as Topic; Risperidone | 2018 |
The risk factors, frequency and diagnosis of atypical antipsychotic drug-induced hypothermia: practical advice for doctors.
Topics: Antipsychotic Agents; Humans; Hypothermia; Mental Disorders; Olanzapine; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; United States; United States Food and Drug Administration | 2019 |
Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Gastrointestinal Microbiome; Humans; Hyperglycemia; Metabolic Diseases; Olanzapine; Risperidone; Weight Gain | 2019 |
Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Clozapine; Depression; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.
Topics: Antipsychotic Agents; Clozapine; Humans; Lipids; Mental Disorders; Olanzapine; Risperidone | 2019 |
Men and women respond differently to antipsychotic drugs.
Topics: Antipsychotic Agents; Clozapine; Female; Humans; Male; Olanzapine; Psychoses, Substance-Induced; Psychotic Disorders; Risperidone; Schizophrenia; Sex Factors | 2020 |
Bayesian Meta-analysis of Multiple Continuous Treatments with Individual Participant-Level Data: An Application to Antipsychotic Drugs.
Topics: Adult; Antipsychotic Agents; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Male; Markov Chains; Medication Adherence; Middle Aged; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia; Weight Gain | 2019 |
Psychotropic Medication for Children and Adolescents with Eating Disorders.
Topics: Adolescent; Anorexia Nervosa; Avoidant Restrictive Food Intake Disorder; Binge-Eating Disorder; Bulimia Nervosa; Child; Feeding and Eating Disorders; Humans; Olanzapine; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 2019 |
Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Bipolar Disorder; Female; Humans; North America; Olanzapine; Quetiapine Fumarate; Risperidone; United States; Weight Gain | 2020 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
[Pharmacotherapy of schizophrenia].
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Risperidone; Schizophrenia | 2020 |
Lights and shadows of schizophrenia therapy research: Lessons from oral risperidone and olanzapine.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Biomedical Research; Humans; Olanzapine; Patents as Topic; Risperidone; Time Factors | 2020 |
Antipsychotics in Postpartum Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Female; Humans; Olanzapine; Postpartum Period; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2020 |
Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2020 |
Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression.
Topics: Antipsychotic Agents; Benzodiazepines; Depression; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2021 |
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Citalopram; Dementia; Electroconvulsive Therapy; Haloperidol; Humans; Olanzapine; Psychopharmacology; Risperidone | 2021 |
Antipsychotics and hemodialysis: A systematic review.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Renal Dialysis; Risperidone | 2021 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Amisulpride - is it as all other medicines or is it different? An update.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Humans; Neurosecretory Systems; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology | 2020 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
Topics: Adult; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2021 |
Antipsychotic long-term treatment in children and young people: a systematic review and meta-analysis of efficacy and tolerability across mental health and neurodevelopmental conditions.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Humans; Mental Health; Olanzapine; Prolactin; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2022 |
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depression; Drug Interactions; Female; Haloperidol; Humans; Ketamine; Lithium; Male; Olanzapine; Psychotropic Drugs; Risperidone; Schizophrenia; Treatment Outcome | 2021 |
[Clinical pharmacokinetics and pharmaceutical forms of long-acting injectable antipsychotics].
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Humans; Olanzapine; Paliperidone Palmitate; Risperidone | 2022 |
Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Humans; Off-Label Use; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2022 |
Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review.
Topics: Antipsychotic Agents; Aripiprazole; Dementia; Humans; Olanzapine; Psychotic Disorders; Risperidone | 2021 |
A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
Topics: Antipsychotic Agents; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2021 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
New Antipsychotic Medications in the Last Decade.
Topics: Adult; Antipsychotic Agents; Humans; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia | 2021 |
Delirium in the Neonate.
Topics: Antipsychotic Agents; Benzodiazepines; Child; Delirium; Humans; Infant; Infant, Newborn; Olanzapine; Risperidone | 2022 |
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dementia; Humans; Network Meta-Analysis; Off-Label Use; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2022 |
Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Risperidone | 2023 |
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Female; Humans; Male; Mice; Olanzapine; Quetiapine Fumarate; Rats; Risperidone | 2022 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States.
Topics: Adult; Antipsychotic Agents; Financial Stress; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; United States | 2022 |
Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Network Meta-Analysis; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China.
Topics: Antipsychotic Agents; Aripiprazole; Cost-Benefit Analysis; Humans; Lurasidone Hydrochloride; Olanzapine; Risperidone; Schizophrenia | 2022 |
Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Female; Humans; Male; Olanzapine; Prolactin; Risperidone; Sex Characteristics | 2023 |
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2023 |
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Cytokines; Humans; Olanzapine; Risperidone; Schizophrenia | 2023 |
Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review.
Topics: Adolescent; Adult; Anorexia Nervosa; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2023 |
361 trial(s) available for risperidone and olanzapine
| Article | Year |
|---|---|
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Olanzapine; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Risperidone; Schizophrenia; Treatment Outcome | 1997 |
The effects of risperidone and olanzapine on the indications for clozapine.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 1998 |
Olanzapine-induced reversible priaprism: a case report.
Topics: Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Priapism; Risperidone; Schizophrenia; Treatment Outcome | 1998 |
Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
Topics: Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 1998 |
Atypical antipsychotics.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Clozapine; Female; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Serotonin Antagonists | 1998 |
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Regression Analysis; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 1999 |
Novel antipsychotics: comparison of weight gain liabilities.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Pirenzepine; Placebos; Retrospective Studies; Risperidone; Schizophrenia; Weight Gain | 1999 |
The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cluster Analysis; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Pirenzepine; Prognosis; Prospective Studies; Recurrence; Regression Analysis; Risperidone; Schizophrenia; Schizophrenic Psychology | 1999 |
A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Follow-Up Studies; Hospitalization; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Olanzapine; Pirenzepine; Remoxipride; Retention, Psychology; Retrospective Studies; Risperidone; Schizophrenia; Time Factors | 1999 |
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Benzodiazepines; Brain; Brain Mapping; Contrast Media; Female; Humans; Iodine Radioisotopes; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 1999 |
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Motor Skills; Neuropsychological Tests; Olanzapine; Pirenzepine; Psychomotor Performance; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2000 |
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Benzodiazepines; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain; Xerostomia | 2000 |
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2000 |
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.
Topics: Adult; Aged; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Olanzapine; Pirenzepine; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2000 |
Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Female; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2001 |
Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cognition; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 2001 |
Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
Topics: Acute Disease; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Electrocardiography; Female; Haloperidol; Humans; Incidence; Long QT Syndrome; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Risperidone; Schizophrenia | 2001 |
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain | 2001 |
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
Topics: Adult; Age Factors; Antipsychotic Agents; Appetite; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Racial Groups; Retrospective Studies; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Treatment Outcome; Weight Gain | 2001 |
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Dibenzothiazepines; Female; Humans; Male; Neuronal Ceroid-Lipofuscinoses; Olanzapine; Pilot Projects; Pirenzepine; Quetiapine Fumarate; Risperidone | 2001 |
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Emotions; Female; Haloperidol; Hostility; Humans; Linear Models; Male; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Statistics, Nonparametric; Survival Analysis | 2001 |
Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pituitary Gland; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
Topics: Aged; Algorithms; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Citalopram; Cost-Benefit Analysis; Humans; Olanzapine; Patient Compliance; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Risperidone; Treatment Outcome | 2001 |
Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Female; Humans; Iowa; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Single-Blind Method; Treatment Outcome | 2002 |
Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires | 2002 |
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Glucuronides; Glucuronosyltransferase; Humans; Male; Olanzapine; Pirenzepine; Probenecid; Renal Agents; Risperidone | 2002 |
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
Topics: Adult; Antibiotics, Antitubercular; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Cycloserine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Pirenzepine; Placebo Effect; Placebos; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Female; Humans; Longitudinal Studies; Male; Netherlands; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2002 |
Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Recurrence; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis; Time Factors; Treatment Outcome; Treatment Refusal | 2002 |
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Topics: Adolescent; Adult; Amenorrhea; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstruation Disturbances; Middle Aged; Olanzapine; Pirenzepine; Prolactin; Prospective Studies; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Treatment Outcome | 2002 |
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Double-Blind Method; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Female; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Olanzapine; Pirenzepine; Reference Values; Risperidone; Single-Blind Method; Weight Gain | 2002 |
Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Multivariate Analysis; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Single-Blind Method | 2002 |
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
Topics: Adult; Aged; Antipsychotic Agents; Benzamides; Benzodiazepines; Contrast Media; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2002 |
Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Recurrence; Risperidone; Surveys and Questionnaires | 2002 |
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Humans; Male; Middle Aged; Olanzapine; Photic Stimulation; Pirenzepine; Risperidone; Saccades; Schizophrenia | 2002 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2003 |
The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Conscious Sedation; Double-Blind Method; Heart Diseases; Heart Rate; Humans; Male; Neuropsychological Tests; Olanzapine; Pirenzepine; Predictive Value of Tests; Psychomotor Performance; Reaction Time; Risk Assessment; Risperidone; Thioridazine | 2002 |
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Clozapine; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Weight Gain | 2003 |
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.
Topics: Adolescent; Adult; Arousal; Benzodiazepines; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Movement Disorders; Olanzapine; Pirenzepine; Psychomotor Performance; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Verbal Learning | 2003 |
Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Neurologic Examination; Neuropsychological Tests; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Reaction Time; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology; Slovenia | 2003 |
Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Depression; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatigue; Female; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 2003 |
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
Topics: Adult; Antipsychotic Agents; Australia; Benzodiazepines; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Costs; Female; Humans; Male; Middle Aged; National Health Programs; New Zealand; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2003 |
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychomotor Disorders; Quality of Life; Risperidone; Schizophrenia | 2003 |
Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Risperidone | 2002 |
A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Blind Method; Drug Administration Schedule; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Skilled Nursing Facilities; Treatment Outcome | 2003 |
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Learning; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Outpatients; Pirenzepine; Risperidone; Schizophrenia; Time Factors | 2003 |
Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Comorbidity; Disabled Persons; Female; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Treatment Outcome | 2003 |
Antipsychotic-induced weight gain: bipolar disorder and leptin.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain | 2003 |
Comparison of three antipsychotics in the emergency psychiatric setting.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Emergency Services, Psychiatric; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sampling Studies; Treatment Outcome | 2003 |
Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Gonadal Steroid Hormones; Humans; Leptin; Middle Aged; Neuropeptide Y; Olanzapine; Pirenzepine; Radioimmunoassay; Risperidone; Schizophrenia; Time Factors; Weight Gain | 2003 |
Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Olanzapine; Pilot Projects; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors; Treatment Outcome | 2004 |
Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Mexico; Neurologic Examination; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment | 2003 |
Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Fasting; Fatty Acids, Nonesterified; Female; Food; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Reference Values; Risperidone | 2003 |
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
Topics: Adolescent; Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biotransformation; Clozapine; Dibenzothiazepines; Electrocardiography; Female; Haloperidol; Heart Conduction System; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Thioridazine | 2004 |
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycine; Humans; Male; Middle Aged; Multivariate Analysis; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Serine; Time Factors; Treatment Outcome | 2004 |
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Olanzapine; Prolactin; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2004 |
The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia.
Topics: Abdomen; Adipose Tissue; Adult; Antipsychotic Agents; Benzodiazepines; Body Composition; Female; Humans; Hydrocortisone; Male; Olanzapine; Risperidone; Schizophrenia; Tomography, X-Ray Computed; White People | 2004 |
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Health Services Research; Humans; Olanzapine; Placebos; Risperidone; Schizophrenia; United States; Valproic Acid | 2004 |
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Arousal; Attention; Benzodiazepines; Cognition; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles; Verbal Behavior | 2004 |
Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Smoking; Weight Gain | 2004 |
Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
Topics: Adult; Algorithms; Antipsychotic Agents; Benzamides; Benzodiazepines; Dopamine; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 2004 |
Adherence to conventional and atypical antipsychotics after hospital discharge.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Feasibility Studies; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Olanzapine; Patient Compliance; Patient Discharge; Pilot Projects; Prospective Studies; Risperidone; Schizophrenia | 2004 |
Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study.
Topics: Adiponectin; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Humans; Intercellular Signaling Peptides and Proteins; Male; Olanzapine; Pilot Projects; Proteins; Risperidone; Schizophrenia; Serum | 2004 |
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Factor Analysis, Statistical; Female; Haloperidol; Humans; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2004 |
A preliminary study of the comparative effects of olanzapine and risperidone on cognition in schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Benzodiazepines; Cognition; Cross-Over Studies; Female; Humans; Male; Mental Recall; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Verbal Behavior; Visual Perception | 2004 |
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Haloperidol; Humans; Olanzapine; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2004 |
Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Brain; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Olanzapine; Promazine; Psychomotor Disorders; Risperidone; Tomography, X-Ray Computed | 2004 |
Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia; Basal Ganglia Diseases; Benzodiazepines; Caudate Nucleus; Cross-Over Studies; Female; Follow-Up Studies; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Putamen; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2004 |
The antidepressant effects of risperidone and olanzapine in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Chemotherapy, Adjuvant; Depression; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2004 |
Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Health Status; Hospitalization; Humans; Indoles; Isoindoles; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sleep; Thiazoles | 2004 |
Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Homes for the Aged; Humans; Long-Term Care; Male; Mental Status Schedule; Nursing Homes; Olanzapine; Psychometrics; Quality of Life; Risperidone; Social Behavior Disorders | 2005 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
A comparison of two novel antipsychotics in first episode non-affective psychosis: one-year outcome on symptoms, motor side effects and cognition.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cognition Disorders; Female; Humans; Male; Olanzapine; Psychomotor Disorders; Psychotic Disorders; Risperidone; Severity of Illness Index | 2004 |
Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Community Mental Health Centers; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; North Carolina; Olanzapine; Patient Compliance; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Violence | 2004 |
Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cognition Disorders; Delusions; Dementia; Double-Blind Method; Female; Hallucinations; Humans; Male; Middle Aged; Muscarinic Antagonists; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Radioligand Assay; Receptors, Muscarinic; Risperidone; Sleep Wake Disorders; Trail Making Test; Treatment Outcome | 2004 |
Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Lipids; Longitudinal Studies; Olanzapine; Prospective Studies; Risperidone; Schizophrenia | 2004 |
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Body Mass Index; Chronic Disease; Comorbidity; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Middle Aged; Obesity; Olanzapine; Prevalence; Psychotherapy, Group; Risperidone; Schizophrenia; Treatment Outcome; Weight Loss | 2005 |
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Urea Nitrogen; Creatinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Placebos; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Serine; Time Factors; Treatment Outcome | 2005 |
The influence of olanzapine versus risperidone on facial expression of emotions in schizophrenia--preliminary results of a facial electromyogram study.
Topics: Adult; Benzodiazepines; Chi-Square Distribution; Electromyography; Emotions; Facial Expression; Facial Muscles; Female; Humans; Male; Olanzapine; Risperidone; Schizophrenia | 2005 |
Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Olanzapine; Polysomnography; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Sleep Stages; Thiazoles | 2005 |
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors | 2005 |
Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Haloperidol; Humans; Nursing Assessment; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
The effects of celecoxib augmentation on cytokine levels in schizophrenia.
Topics: Adult; Benzodiazepines; Celecoxib; Cytokines; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Pyrazoles; Risperidone; Schizophrenia; Sulfonamides | 2006 |
Atypical antipsychotic medications and risk of falls in residents of aged care facilities.
Topics: Accidental Falls; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Female; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Prospective Studies; Risperidone | 2005 |
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Female; Haloperidol; Hostility; Humans; Male; Olanzapine; Outpatients; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Comorbidity; Conduct Disorder; Dementia, Vascular; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Psychomotor Agitation; Risperidone; Treatment Outcome | 2005 |
Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Cultural Comparison; Dibenzothiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome | 2005 |
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index | 2005 |
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Risperidone; Treatment Outcome | 2005 |
A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Energy Intake; Feeding Behavior; Female; Humans; Hunger; Male; Middle Aged; Olanzapine; Risperidone; Satiety Response; Weight Gain | 2005 |
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Time Factors; Treatment Outcome | 2005 |
Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Buspirone; Denmark; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Pilot Projects; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Receptor Agonists; Weight Loss | 2005 |
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Benzodiazepines; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Reaction Time; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Female; Humans; Male; Olanzapine; Pilot Projects; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Socioeconomic Factors | 2005 |
Newer antipsychotics and glucose metabolism: a comparison between olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Olanzapine; Risk; Risperidone | 2005 |
Olanzapine versus risperidone in newly admitted acutely ill psychotic patients.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Hospitalization; Hospitals, Psychiatric; Humans; Length of Stay; Male; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Parkinsonian Disorders; Patient Dropouts; Quality of Life; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
[Neuroleptic drug utilization among schizophrenic outpatients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Drug Therapy, Combination; Drug Utilization; Female; France; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2005 |
Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; Estradiol; Female; Galactorrhea; Gynecomastia; Humans; Male; Menstrual Cycle; Olanzapine; Premenopause; Prolactin; Reproduction; Risperidone; Schizophrenia; Sex Characteristics; Sexual Dysfunction, Physiological; Testosterone | 2006 |
Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Population Surveillance; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Time Factors | 2005 |
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bias; Clozapine; Drug Administration Schedule; Episode of Care; Female; Follow-Up Studies; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Proportional Hazards Models; Research Design; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; United States | 2006 |
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
Topics: Adult; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Blood Pressure; Body Mass Index; Body Weight; Female; Humans; Male; Metabolic Syndrome; Obesity; Olanzapine; Prevalence; Psychotic Disorders; Risperidone; Schizophrenia; Systole; United States; Waist-Hip Ratio | 2005 |
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Olanzapine; Pharmacogenetics; Polymorphism, Genetic; Promoter Regions, Genetic; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome | 2006 |
Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Health Surveys; Humans; Male; Odds Ratio; Olanzapine; Outpatients; Prevalence; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological; Time; Treatment Outcome | 2006 |
Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Olanzapine; Patient Dropouts; Psychotic Disorders; Risperidone | 2006 |
Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Canada; Clozapine; Cohort Studies; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Female; Health Care Surveys; Health Resources; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia | 2006 |
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cross-Over Studies; Dibenzothiazepines; Drug Monitoring; Drug Resistance; Eosinophilia; Female; Follow-Up Studies; Humans; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2006 |
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Thiazoles; Time Factors; Treatment Outcome | 2006 |
Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Clozapine; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Metabolic Syndrome; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Sulpiride; Triglycerides; Waist-Hip Ratio | 2006 |
Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Evaluation; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2006 |
Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Data Interpretation, Statistical; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Male; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 2006 |
Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2006 |
Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics.
Topics: Adolescent; Adolescent Psychiatry; Adult; Antipsychotic Agents; Benzodiazepines; Child; Child Psychiatry; Clozapine; Drug Monitoring; Female; Humans; Male; Mental Disorders; Olanzapine; Risperidone | 2006 |
The effect of long-term antipsychotic treatment on prolactin.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Male; Mental Disorders; Olanzapine; Prolactin; Quetiapine Fumarate; Risperidone | 2006 |
Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Comorbidity; Female; Haloperidol; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Prognosis; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Schizotypal Personality Disorder; Socioeconomic Factors; Spain; Treatment Outcome | 2007 |
Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Follow-Up Studies; Humans; Middle Aged; Olanzapine; Outpatients; Patient Selection; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Behavior; Time Factors | 2006 |
The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: A 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Benzodiazepines; Confounding Factors, Epidemiologic; Follow-Up Studies; Humans; Middle Aged; Olanzapine; Outpatients; Patient Selection; Predictive Value of Tests; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2006 |
A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Attention; Benzodiazepines; Blinking; Brain; Brain Mapping; Habituation, Psychophysiologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Reaction Time; Reflex, Startle; Risperidone; Schizophrenia; Touch; Treatment Outcome | 2007 |
An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Israel; Male; Olanzapine; Patient Dropouts; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lipids; Male; Middle Aged; Olanzapine; Prospective Studies; Risperidone; Schizophrenia | 2006 |
A crossover study of prolactin changes associated with risperidone and olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Sex Distribution; Treatment Outcome | 2006 |
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain | 2007 |
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Survival Analysis; Treatment Outcome | 2006 |
Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Drug Interactions; Female; Humans; Lamotrigine; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Triazines | 2006 |
Efficacy of olanzapine and risperidone in schizophrenia: a randomized double-blind crossover design.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2006 |
A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Haloperidol; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2006 |
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Cross-Over Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Olanzapine; Prognosis; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2006 |
Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Patient Dropouts; Risperidone; Schizophrenia; Substance-Related Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 2006 |
Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Humans; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Effectiveness of switching antipsychotic medications.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Dibenzothiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Olanzapine; Patient Dropouts; Psychotherapy; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Selection Bias; Survival Analysis; Treatment Outcome | 2006 |
Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Mass Index; Female; Follow-Up Studies; Humans; Male; Obesity; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain | 2006 |
Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks.
Topics: Benzodiazepines; Blood Glucose; C-Peptide; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Olanzapine; Reference Values; Risperidone; Selective Serotonin Reuptake Inhibitors | 2007 |
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Appetite; Benzodiazepines; Bipolar Disorder; Dizziness; Double-Blind Method; Female; Headache; Humans; Least-Squares Analysis; Male; Middle Aged; Olanzapine; Risperidone; Sleep Stages; Treatment Outcome | 2006 |
Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antipsychotic Agents; Apolipoproteins; Appetite Regulation; Aryldialkylphosphatase; Benzodiazepines; Cross-Sectional Studies; Female; Genomics; Humans; Lipid Metabolism; Male; Mental Disorders; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Receptors, Leptin; Receptors, Neuropeptide Y; Risperidone; Scavenger Receptors, Class B; Weight Gain | 2007 |
Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Female; Haloperidol; Humans; Male; Olanzapine; Polysomnography; Reference Values; Risperidone; Sleep; Sleep, REM; Time Factors; Wakefulness | 2007 |
Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.
Topics: Administration, Cutaneous; Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Male; Monoamine Oxidase Inhibitors; Olanzapine; Risperidone; Selegiline | 2007 |
An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Logistic Models; Male; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Statistics, Nonparametric; Treatment Outcome | 2007 |
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Perphenazine; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
Topics: Adaptation, Psychological; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Follow-Up Studies; Health Status; Humans; National Institute of Mental Health (U.S.); Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Treatment Outcome; United States | 2007 |
A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cross-Over Studies; Dibenzothiazepines; Electroencephalography; Fourier Analysis; Haloperidol; Humans; Indoles; Isoindoles; Male; Olanzapine; Quetiapine Fumarate; Reference Values; Risperidone; Single-Blind Method; Thiazoles; Time Factors | 2007 |
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Cross-Over Studies; Donepezil; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Nootropic Agents; Olanzapine; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Corpus Striatum; Female; Humans; Male; Middle Aged; Olanzapine; Raclopride; Radionuclide Imaging; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology | 2007 |
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology | 2008 |
A pilot observational crossover study of QTc interval changes associated with switching between olanzapine and risperidone.
Topics: Adult; Benzodiazepines; Cross-Over Studies; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2007 |
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Outpatients; Pain Measurement; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Social Behavior; Spain | 2007 |
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Cohort Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2007 |
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sleep Stages; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2007 |
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Health Status; Humans; Least-Squares Analysis; Male; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Treatment Outcome | 2007 |
Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Incidence; India; Metabolic Syndrome; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Sex Factors; Treatment Outcome | 2007 |
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
Topics: Acoustic Stimulation; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Electromyography; Female; Habituation, Psychophysiologic; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Reflex, Startle; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Female; Humans; Injections; Male; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Tablets; Treatment Outcome | 2007 |
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Benzodiazepines; Child; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Molindone; Olanzapine; Risperidone; Schizophrenia; Time Factors | 2007 |
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
Topics: Administration, Oral; Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Lithium Compounds; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2007 |
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Topics: Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brief Psychiatric Rating Scale; Dibenzothiazepines; Emergency Services, Psychiatric; Female; Haloperidol; Hostility; Humans; Italy; Male; Middle Aged; Olanzapine; Prospective Studies; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Control Groups; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Practice, Psychological; Psychiatric Status Rating Scales; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.
Topics: Adaptation, Psychological; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Patient Compliance; Patient-Centered Care; Risperidone; Schizophrenia; Social Environment; Social Support; Treatment Outcome | 2008 |
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists.
Topics: Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Humans; Olanzapine; Perphenazine; Piperazines; Psychiatry; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors | 2007 |
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Topics: Adolescent; Adult; Anthropometry; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cohort Studies; Diabetes Mellitus, Type 2; Diagnostic and Statistical Manual of Mental Disorders; Dyslipidemias; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Prevalence; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Weight Gain | 2007 |
Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
Topics: Adult; Anthropometry; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Haloperidol; Humans; India; Male; Obesity; Olanzapine; Prevalence; Prospective Studies; Risperidone; Schizophrenia; Time Factors | 2007 |
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Risperidone; Spain; Treatment Outcome; Weight Gain | 2008 |
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Female; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2007 |
Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia.
Topics: Activities of Daily Living; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Treatment Failure; United States | 2008 |
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Olanzapine; Patient Dropouts; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Time Factors; Treatment Outcome; Treatment Refusal | 2008 |
A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Double-Blind Method; Feeding Behavior; Female; Ghrelin; Humans; Male; Olanzapine; Risperidone; Weight Gain | 2008 |
Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Female; Haloperidol; Humans; Male; Olanzapine; Prognosis; Prospective Studies; Risperidone; Schizophrenia; Weight Gain | 2008 |
Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Demography; Diagnostic and Statistical Manual of Mental Disorders; Female; Haloperidol; Haplotypes; Humans; Interleukin-12; Male; Olanzapine; Psychotic Disorders; Risperidone; Time Factors | 2008 |
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Prospective Studies; Risperidone; Single-Blind Method; Time Factors | 2008 |
Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia.
Topics: Absorptiometry, Photon; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Double-Blind Method; Ethnicity; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors; Tomography, X-Ray Computed | 2008 |
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Long-Term Care; Male; Neuropsychological Tests; Norway; Nursing Homes; Olanzapine; Risperidone; Withholding Treatment | 2008 |
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
Topics: Adult; Antipsychotic Agents; Attitude to Health; Benzodiazepines; Cognition Disorders; Culture; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Refusal | 2008 |
Venlafaxine for acute heroin detoxification: a double-blind, randomized, control trial.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Capsules; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome | 2008 |
Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Capsules; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome | 2008 |
Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Europe; Female; Humans; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Self Concept; Social Adjustment | 2008 |
Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Probability; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2008 |
What CATIE found: results from the schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychology; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Mass Index; Dose-Response Relationship, Drug; Energy Metabolism; Female; Ghrelin; Haloperidol; Humans; Insulin; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Olanzapine; Prospective Studies; Psychotic Disorders; Resistin; Risperidone; Schizophrenia; Weight Gain | 2008 |
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
Topics: Activities of Daily Living; Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Cognition Disorders; Dibenzothiazepines; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Psychomotor Agitation; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risperidone; Surveys and Questionnaires | 2008 |
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2008 |
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Polypharmacy; Quetiapine Fumarate; Risperidone; Schizophrenia | 2008 |
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics.
Topics: Adolescent; Benzodiazepines; Blood Glucose; Body Mass Index; Child; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Obesity; Olanzapine; Prevalence; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Substance-Related Disorders; Thyroxine; Triglycerides | 2008 |
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Single-Blind Method; Withholding Treatment | 2008 |
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Humans; Male; Marijuana Abuse; Obsessive-Compulsive Disorder; Olanzapine; Prevalence; Quality of Life; Risperidone; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires | 2008 |
Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Confidence Intervals; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Olanzapine; Outpatients; Patient Compliance; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2009 |
Changes in neuropsychological functioning following treatment with risperidone, olanzapine, and conventional antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mental Processes; Neuropsychological Tests; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Schizophrenia; Schizophrenic Psychology | 2008 |
A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Olanzapine; Pilot Projects; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome | 2008 |
Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Olanzapine; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome; Weight Gain | 2008 |
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Double-Blind Method; Female; Humans; Male; Molindone; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2008 |
A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Male; Middle Aged; Olanzapine; Parkinsonian Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Single-Blind Method | 2010 |
Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol; Chronic Disease; Dibenzothiazepines; Drug Tolerance; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Triglycerides; Young Adult | 2009 |
Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Brain; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Young Adult | 2008 |
Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Drug Monitoring; Female; Humans; Male; Olanzapine; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Treatment Outcome | 2009 |
Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Haloperidol; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Olanzapine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Spain; Triglycerides; Weight Gain; Young Adult | 2009 |
Results of phase 3 of the CATIE schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2009 |
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia; Sex Factors; Substance Withdrawal Syndrome; Young Adult | 2009 |
Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Early Diagnosis; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2009 |
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Valproic Acid; Young Adult | 2009 |
Lack of association between clinical and cognitive change in first-episode psychosis: the first 6 weeks of treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Haloperidol; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Risperidone; Schizophrenia; Statistics as Topic; Young Adult | 2008 |
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Patient Satisfaction; Piperazines; Prolactin; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior; Treatment Outcome | 2008 |
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Long-Term Care; Male; Medication Adherence; Middle Aged; Olanzapine; Patient Readmission; Prospective Studies; Psychiatric Status Rating Scales; Registries; Risperidone; Schizophrenia; Schizophrenic Psychology | 2009 |
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol, HDL; Cholesterol, LDL; Dibenzothiazepines; Female; Glucose; Humans; Insulin; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Triglycerides; Young Adult | 2009 |
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Mental Disorders; Obesity; Olanzapine; Quetiapine Fumarate; Risperidone | 2009 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Educational Status; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Statistics as Topic; Time Factors; Treatment Outcome; Young Adult | 2009 |
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2009 |
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzodiazepines; Benzothiazoles; Binding, Competitive; Carbon Radioisotopes; Caudate Nucleus; Clozapine; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Female; Globus Pallidus; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Olanzapine; Oxazines; Positron-Emission Tomography; Pramipexole; Putamen; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia | 2009 |
Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles | 2009 |
Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2009 |
Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychometrics; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2009 |
Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Linear Models; Male; Mental Disorders; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Risperidone; Time; Time Factors | 2009 |
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chromosomes, Human, Pair 4; Dibenzothiazepines; Double-Blind Method; Follow-Up Studies; Genome-Wide Association Study; Humans; Olanzapine; Perphenazine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Chronic Disease; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Longitudinal Studies; Male; Middle Aged; Olanzapine; Prolactin; Risk Factors; Risperidone; Schizophrenia | 2009 |
Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Olanzapine; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Sensitivity and Specificity; Statistics, Nonparametric; Triglycerides | 2010 |
Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3(1/2) years duration.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Olanzapine; Proportional Hazards Models; Risperidone; Schizophrenia | 2010 |
Hunger and negative alliesthesia to aspartame and sucrose in patients treated with antipsychotic drugs and controls.
Topics: Adult; Antipsychotic Agents; Aspartame; Benzodiazepines; Carbonated Beverages; Clozapine; Dibenzothiazepines; Double-Blind Method; Food Preferences; Humans; Hunger; Male; Middle Aged; Olanzapine; Pleasure; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sucrose; Surveys and Questionnaires; Sweetening Agents; Taste; Time Factors; Young Adult | 2009 |
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Galactorrhea; Hospitalization; Humans; Length of Stay; Male; Olanzapine; Patient Readmission; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Thiazoles; Treatment Outcome | 2010 |
A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Taiwan | 2010 |
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Pressure; Body Mass Index; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipid Metabolism; Lipid Metabolism Disorders; Male; Models, Statistical; Multivariate Analysis; Olanzapine; Risperidone; Schizophrenia | 2010 |
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Executive Function; Female; Humans; Male; Marijuana Abuse; Memory, Short-Term; Neuropsychological Tests; Olanzapine; Outcome Assessment, Health Care; Prospective Studies; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2010 |
Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Female; Humans; Logistic Models; Male; Olanzapine; Predictive Value of Tests; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
Topics: Acute Disease; Administration, Oral; Adult; Benzodiazepines; Disease Management; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Pharmaceutical Solutions; Prospective Studies; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Solubility; Tablets; Taiwan; Treatment Outcome | 2010 |
Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
Topics: Adolescent; Akathisia, Drug-Induced; Benzodiazepines; Child; Double-Blind Method; Female; Humans; Long-Term Care; Male; Molindone; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Weight Gain; Young Adult | 2010 |
Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2010 |
DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Promoter Regions, Genetic; Receptors, Dopamine D2; Risperidone; Schizophrenia; Weight Gain; Young Adult | 2010 |
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Movement Disorders; Olanzapine; Perphenazine; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles; Treatment Outcome | 2011 |
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Modafinil; Olanzapine; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
Topics: Affective Symptoms; Antipsychotic Agents; Benzodiazepines; Humans; Marijuana Smoking; Medication Adherence; Olanzapine; Psychotic Disorders; Risperidone | 2010 |
"Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Female; Humans; Loxapine; Male; Middle Aged; Olanzapine; Ontario; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention | 2011 |
The heterogeneity of antipsychotic response in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2011 |
Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Secondary Prevention; Treatment Outcome; Young Adult | 2011 |
Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Female; Humans; Intellectual Disability; Longitudinal Studies; Male; Middle Aged; Olanzapine; Persons with Mental Disabilities; Risperidone; Single-Blind Method; Treatment Outcome | 2011 |
Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Severity of Illness Index; Treatment Failure | 2011 |
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Olanzapine; Predictive Value of Tests; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sensitivity and Specificity | 2011 |
Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Double-Blind Method; Female; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis.
Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Remission Induction; Risperidone; ROC Curve; Time Factors; Treatment Outcome; Young Adult | 2011 |
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
Topics: Adiponectin; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Female; Humans; Insulin Resistance; Male; Middle Aged; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Waist Circumference | 2012 |
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Disease Progression; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Neuropsychological Tests; Olanzapine; Patient Dropouts; Quetiapine Fumarate; Risperidone | 2011 |
Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Olanzapine; Piperazines; Quinolones; Receptors, Dopamine D2; Risperidone; Schizophrenia | 2012 |
Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Statistics, Nonparametric; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2011 |
Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis.
Topics: Adult; Benzodiazepines; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Haloperidol; Humans; Longitudinal Studies; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Time Factors; Treatment Outcome; Young Adult | 2012 |
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dibenzothiazepines; Diet, Reducing; Drug Substitution; Exercise; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides | 2011 |
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.
Topics: Adult; Antipsychotic Agents; Apoptosis Regulatory Proteins; Benzodiazepines; Biomarkers, Pharmacological; Black or African American; Drug Resistance; Genotype; Humans; Isoxazoles; Membrane Proteins; Membrane Transport Proteins; Olanzapine; Piperidines; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, AMPA; Risperidone; Schizophrenia; White People | 2012 |
A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; GABA Agents; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Valproic Acid; Young Adult | 2011 |
DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers.
Topics: Antipsychotic Agents; Area Under Curve; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Polymorphism, Genetic; Prolactin; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D3; Regression Analysis; Risperidone; Sex Factors | 2011 |
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzodiazepines; Depression; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 2011 |
Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Delirium; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Single-Blind Method; Treatment Outcome | 2011 |
Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2011 |
TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Genotype; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Prospective Studies; Risperidone; Schizophrenia; Single-Blind Method; Tumor Necrosis Factor-alpha; Weight Gain | 2011 |
Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Trifluoperazine | 2012 |
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2013 |
The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Female; Homeostasis; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Risperidone; Schizophrenia; Young Adult | 2012 |
Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Circadian Rhythm; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted; Torsades de Pointes | 2012 |
Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study.
Topics: Adult; Aged; Benzodiazepines; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Olanzapine; Protein Binding; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome | 2012 |
Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Making; Female; Gambling; Humans; Learning; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2012 |
Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dopamine D2 Receptor Antagonists; Female; Humans; Linear Models; Male; Middle Aged; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2013 |
Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Female; Humans; Injections; Male; Middle Aged; Olanzapine; Patient Satisfaction; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2012 |
A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method | 2012 |
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Body Weight; Female; Ghrelin; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Weight Gain | 2012 |
Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Olanzapine; Patient Acceptance of Health Care; Patient Dropouts; Patient Participation; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Characteristics | 2012 |
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Molindone; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia.
Topics: Adult; Antipsychotic Agents; Aquaporin 4; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Genetic Association Studies; Humans; Isoxazoles; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Paliperidone Palmitate; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking; Young Adult | 2012 |
Comparison of fasting blood sugar and serum lipid profile changes after treatment with atypical antipsychotics olanzapine and risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Female; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metabolic Syndrome; Olanzapine; Reproducibility of Results; Risperidone; Schizophrenia; Triglycerides | 2012 |
Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia; Young Adult | 2012 |
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
Topics: Adult; Alleles; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Borderline Personality Disorder; Depressive Disorder, Treatment-Resistant; Female; Genetic Association Studies; Humans; Linkage Disequilibrium; Male; Mental Disorders; Middle Aged; Olanzapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Weight Gain | 2012 |
Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Risperidone; Statistics, Nonparametric; Young Adult | 2012 |
Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Prolactin; Prospective Studies; Psychotic Disorders; Risperidone; Time Factors; Treatment Outcome; Young Adult | 2012 |
Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Educational Status; Female; Haloperidol; Humans; Logistic Models; Longitudinal Studies; Male; Olanzapine; Prognosis; Psychotic Disorders; Remission Induction; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Time-to-Treatment; Young Adult | 2013 |
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Therapeutic Equipoise; Triglycerides; United States | 2013 |
Treatment of paradoxical insomnia with atypical antipsychotic drugs. A comparison of olanzapine and risperidone.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Risperidone; Sleep Initiation and Maintenance Disorders; Sleep, REM; Treatment Outcome | 2013 |
Predicting a 'combined treatment outcome' in chronic schizophrenia: the role of demographics, symptomatology, functioning and subjective well-being.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2013 |
A comparison of the PANSS pentagonal and Van Der Gaag 5-factor models for assessing change over time.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Theoretical; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Regression Analysis; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Time Factors; Young Adult | 2013 |
Clozapine and visuospatial processing in treatment-resistant schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Resistance; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Space Perception; Young Adult | 2013 |
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Coronary Artery Disease; Dibenzothiazepines; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Female; Follow-Up Studies; Haloperidol; Humans; Longitudinal Studies; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2013 |
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Female; Haloperidol; Humans; Male; Marijuana Smoking; Middle Aged; Models, Psychological; Olanzapine; Prognosis; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Sex Factors; Time Factors; Treatment Outcome; Young Adult | 2014 |
Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2013 |
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Amino Acids; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Standard of Care; Treatment Outcome; Young Adult | 2013 |
Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Substitution; Female; Humans; Male; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2013 |
Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Predictive Value of Tests; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sensitivity and Specificity; Thiazoles | 2013 |
Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Drug Administration Schedule; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome | 2013 |
Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Healthy Volunteers; Humans; Huntingtin Protein; Male; Nerve Tissue Proteins; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone | 2013 |
Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Nonlinear Dynamics; Olanzapine; Piperazines; Protein Binding; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Remission Induction; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States | 2013 |
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Emergency Services, Psychiatric; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2013 |
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hallucinations; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2013 |
Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Protocols; Female; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Remission Induction; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Treatment Outcome | 2013 |
Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Male; Metabolic Diseases; Middle Aged; Olanzapine; Prospective Studies; Psychotic Disorders; Risk Factors; Risperidone; Time Factors; Weight Gain; Young Adult | 2014 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
Predictive value of prospective memory for remission in first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; China; Female; Humans; Male; Memory, Episodic; Olanzapine; Piperazines; Prognosis; Quinolones; Remission Induction; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors; Switzerland; Time Factors; Treatment Outcome; Young Adult | 2014 |
Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Sample Size; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sex Characteristics; Young Adult | 2014 |
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aortic Bodies; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Administration Schedule; Drug Substitution; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Lack of effect of risperidone or olanzapine dose reduction on subjective experiences in stable patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Self Report; Treatment Outcome | 2014 |
Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Olanzapine; Psychiatric Status Rating Scales; Reboxetine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2014 |
Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Substitution; Drug Therapy, Combination; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Time Factors; Treatment Outcome | 2014 |
Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Receptors, Dopamine D2; Risperidone; Schizophrenia; Secondary Prevention | 2014 |
Management of depressive symptoms in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzocycloheptenes; Double-Blind Method; Female; Haloperidol; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2015 |
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dizziness; Female; Humans; Isoxazoles; Male; Olanzapine; Piperazines; Piperidines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People | 2014 |
The Chinese First-Episode Schizophrenia Trial: background and study design.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; China; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Quinolones; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Schizophrenia gene expression profile reverted to normal levels by antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Transcriptome; Treatment Outcome | 2014 |
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Depressive Disorder, Major; Double-Blind Method; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2015 |
Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Risperidone; Schizophrenia | 2015 |
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
Topics: Adult; Alleles; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Brain-Derived Neurotrophic Factor; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Female; Genotype; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Olanzapine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Psychotic Disorders; Risk Factors; Risperidone; Schizophrenia; Triglycerides | 2015 |
Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Brain; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Learning; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Psychomotor Performance; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2015 |
Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biological Assay; Chromatography, Liquid; Haloperidol; Humans; Male; Mass Spectrometry; Medication Adherence; Middle Aged; Olanzapine; Pilot Projects; Quetiapine Fumarate; Risperidone | 2015 |
Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Feasibility Studies; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Young Adult | 2015 |
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lithium; Male; Olanzapine; Risperidone; Time Factors; Weight Gain | 2016 |
Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Child; Child, Preschool; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Longitudinal Studies; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone | 2016 |
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Veins; Young Adult | 2016 |
Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Delayed-Action Preparations; Female; Haloperidol; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Perphenazine; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2016 |
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial.
Topics: Adult; Aged; Benzodiazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology | 2016 |
An RCT Evaluating the Effects of Skills Training and Medication Type on Work Outcomes Among Patients With Schizophrenia.
Topics: Adult; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Employment, Supported; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Professional Competence; Risperidone; Schizophrenia | 2017 |
Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Corpus Striatum; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Prolactin; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia | 2016 |
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Time Factors; Treatment Outcome | 2017 |
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2017 |
Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Early Diagnosis; Female; Humans; Olanzapine; Patient Dropouts; Predictive Value of Tests; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2017 |
Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Employment, Supported; Female; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Risperidone; Schizophrenia; Weight Gain | 2017 |
An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Brain Mapping; Cerebrovascular Circulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Olanzapine; Risperidone; Young Adult | 2018 |
Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Risperidone; Schizophrenia; Single-Blind Method; Young Adult | 2018 |
Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Humans; Male; Medication Adherence; Middle Aged; Olanzapine; Recurrence; Risperidone; Schizophrenia; Treatment Failure; Young Adult | 2018 |
Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.
Topics: Abdominal Fat; Absorptiometry, Photon; Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Insulin Resistance; Intention to Treat Analysis; Male; Mental Disorders; Olanzapine; Problem Behavior; Risperidone; Treatment Outcome | 2018 |
The validity and sensitivity of PANSS-6 in treatment-resistant schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Humans; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Quetiapine Fumarate; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity | 2018 |
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Predictive Value of Tests; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2018 |
Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles.
Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Cerebrovascular Circulation; Cross-Over Studies; Dopamine D2 Receptor Antagonists; Double-Blind Method; Fluorine Radioisotopes; Haloperidol; Healthy Volunteers; Humans; Olanzapine; Positron-Emission Tomography; Receptors, Dopamine D2; Risperidone; RNA, Messenger; Spin Labels | 2019 |
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2019 |
Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biosensing Techniques; Cloud Computing; Humans; Medical Informatics Applications; Medication Adherence; Mobile Applications; Multicenter Studies as Topic; Olanzapine; Pragmatic Clinical Trials as Topic; Psychiatry; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Tablets; United Kingdom | 2019 |
Examination of heterogeneity in treatment response to antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Deprescriptions; Female; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Mental Status and Dementia Tests; Olanzapine; Perphenazine; Proportional Hazards Models; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Risperidone; Schizophrenia; Young Adult | 2019 |
Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Humans; Male; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Time Factors; Weight Gain; Young Adult | 2019 |
Efficacy and safety of electroacupuncture on metabolic syndrome due to olanzapine and risperidone: Study protocol for a randomized controlled pilot trial.
Topics: Antipsychotic Agents; Clinical Protocols; Electroacupuncture; Humans; Metabolic Syndrome; Olanzapine; Risperidone; Schizophrenia | 2019 |
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2020 |
Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delirium; Haloperidol; Humans; Neoplasms; Olanzapine; Risperidone | 2020 |
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors | 2020 |
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2020 |
Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Risperidone; Schizophrenia | 2020 |
Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Child; Female; Humans; Male; Molindone; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; United States | 2021 |
Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial.
Topics: Adverse Childhood Experiences; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Prospective Studies; Risperidone; Schizophrenia | 2022 |
Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: A randomized, active-controlled trial with open-label extension.
Topics: Antipsychotic Agents; Dopamine; Double-Blind Method; Female; Humans; Male; Olanzapine; Prolactin; Prospective Studies; Risperidone; Schizophrenia; Schizophrenia, Treatment-Resistant; Treatment Outcome | 2022 |
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Glucose; Haloperidol; Humans; Inflammation; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2024 |
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
879 other study(ies) available for risperidone and olanzapine
| Article | Year |
|---|---|
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin | 1994 |
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Humans; Male; Molecular Structure; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Spiperone; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1996 |
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
Topics: Animals; Antipsychotic Agents; Brain; Cells, Cultured; Clozapine; Haloperidol; Humans; Male; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone | 1996 |
Iloperidone binding to human and rat dopamine and 5-HT receptors.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; CHO Cells; Cricetinae; Humans; Isoxazoles; Kinetics; Piperidines; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Receptors, Dopamine D5; Receptors, Serotonin | 1996 |
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Topics: Adenylyl Cyclases; Cell Line; Cloning, Molecular; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Piperidines; Protein Binding; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Sulfonamides | 1998 |
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Brain; Catalepsy; Dioxanes; Dopamine Antagonists; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Male; Mice; Motor Activity; Piperidines; Rats; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin Receptor Agonists; Stereoisomerism; Stereotyped Behavior; Structure-Activity Relationship; Swine | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Topics: Animals; Antipsychotic Agents; COS Cells; Dose-Response Relationship, Drug; Humans; Inositol Phosphates; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Receptor Agonists | 2000 |
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.
Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Kinetics; Olanzapine; Pirenzepine; Quetiapine Fumarate; Recombinant Proteins; Risperidone | 2002 |
A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Cation Transport Proteins; Cell Line; Clinical Trials as Topic; Cricetinae; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Trans-Activators; Transcriptional Regulator ERG | 2002 |
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Mice; Psychotropic Drugs; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship | 2005 |
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
Topics: Amino Acid Substitution; Antipsychotic Agents; Cell Line; Cyclic AMP; Humans; Mutagenesis, Site-Directed; Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.
Topics: Adenylate Kinase; Animals; Antipsychotic Agents; Enzyme Activation; Hypothalamus; Immunohistochemistry; Mice; Phosphorylation; Receptors, Histamine H1; Weight Gain | 2007 |
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzoxazines; Biogenic Monoamines; Humans; Hyperprolactinemia; Indoles; Metabolic Diseases; Phthalimides; Piperazines; Principal Component Analysis; Pyridines; Radioligand Assay; Receptors, Biogenic Amine; Weight Gain | 2007 |
BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport.
Topics: Antiviral Agents; BK Virus; Cell Line; Chloroquine; Humans; Microbial Sensitivity Tests; Molecular Structure; Nystatin; Virus Replication | 2007 |
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature.
Topics: Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Cloning, Molecular; Clozapine; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Histamine Release; Humans; Inhibitory Concentration 50; Molecular Structure; Olanzapine; Psychotropic Drugs; Radioligand Assay; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Schizophrenia; Substrate Specificity | 2009 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.
Topics: Animals; Antipsychotic Agents; Apomorphine; Azepines; Butyrophenones; Clozapine; Haloperidol; Lethal Dose 50; Male; Mice; Molecular Structure; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Structure-Activity Relationship | 2008 |
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Drug Design; Drug Evaluation, Preclinical; Humans; Ligands; Mice; Models, Molecular; Molecular Structure; Protein Binding; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Structure-Activity Relationship | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation | 2009 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.
Topics: Cell Line; HeLa Cells; Humans; Indoles; Ligands; Protein Binding; Pyrazines; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides | 2014 |
Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.
Topics: Amides; Animals; Antipsychotic Agents; Behavior, Animal; Dizocilpine Maleate; Dopamine Antagonists; Drug Evaluation, Preclinical; Female; Kinetics; Ligands; Male; Mice; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D3; Schizophrenia; Serotonin Receptor Agonists; Structure-Activity Relationship | 2014 |
Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Disease Models, Animal; Models, Molecular; Molecular Structure; Piperazine; Piperazines; Purines; Pyrimidinones; Structure-Activity Relationship | 2015 |
The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Dibenzocycloheptenes; Dibenzoxepins; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Imidazoles; Indoles; Locomotion; Male; Olanzapine; Olfactory Pathways; Pirenzepine; Rats; Rats, Wistar; Risperidone; Thiazines; Time Factors | 1995 |
Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Chlordiazepoxide; Clozapine; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Olanzapine; Piperidines; Pirenzepine; Punishment; Risperidone | 1995 |
Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Male; Mesencephalon; Neurons; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Substantia Nigra; Thiazoles | 1995 |
The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiepins; Dose-Response Relationship, Drug; Histamine Antagonists; Isotope Labeling; Male; Methylhistamines; Mice; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Receptors, Histamine H3; Remoxipride; Risperidone; Structure-Activity Relationship; Thioridazine; Tritium | 1996 |
BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; CHO Cells; Clozapine; Corpus Striatum; COS Cells; Cricetinae; Dibenzothiazepines; Dopamine; Female; Guinea Pigs; Haloperidol; Indoles; Kidney; Male; Microdialysis; Neuroblastoma; Nucleus Accumbens; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Pyridines; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Tritium; Tumor Cells, Cultured | 1997 |
Marketing of antipsychotic drugs attacked.
Topics: Advertising; Antipsychotic Agents; Benzodiazepines; Drug Industry; Federal Government; Government Regulation; Humans; Mentally Ill Persons; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 1998 |
Comments on article by Tran and colleagues, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia | 1998 |
Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders".
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia | 1998 |
The new antipsychotic compounds: is a clinical choice algorithm possible?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukocyte Count; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia, Paranoid | 1998 |
Two new atypical antipsychotics: advantages and disadvantages.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia | 1998 |
Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Hypothermia; Olanzapine; Pirenzepine; Prader-Willi Syndrome; Psychotic Disorders; Risperidone | 1998 |
Olanzapine use in women with antipsychotic-induced hyperprolactinemia.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Benzodiazepines; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Perphenazine; Pirenzepine; Risperidone; Schizophrenia | 1998 |
Quality of life and atypical antipsychotics.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology | 1998 |
Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; HIV Infections; Humans; Male; Olanzapine; Pirenzepine; Risperidone | 1998 |
Olanzapine and negative symptoms.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome | 1998 |
Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Benzodiazepines; Clozapine; Haloperidol; Imidazoles; Indoles; Injections, Intraperitoneal; Male; Neural Inhibition; Olanzapine; Pirenzepine; Prazosin; Rats; Rats, Wistar; Reflex, Startle; Remoxipride; Risperidone; Ritanserin; Serotonin Antagonists | 1997 |
Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dopamine; Dopamine Agonists; Extracellular Space; Haloperidol; Male; Norepinephrine; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Rats; Rats, Wistar; Reference Values; Risperidone; Tetrahydronaphthalenes; Thiazoles | 1998 |
Return of menstruation after switching from risperidone to olanzapine.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Benzodiazepines; Female; Humans; Menstruation; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone | 1998 |
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Clozapine; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1999 |
Use of risperidone and olanzapine in outpatient clinics at six Veterans Affairs hospitals.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Diagnosis-Related Groups; Drug Utilization Review; Health Care Costs; Hospitals, Veterans; Humans; Middle Aged; Office Visits; Olanzapine; Outpatient Clinics, Hospital; Patient Selection; Pirenzepine; Practice Patterns, Physicians'; Risperidone; United States | 1999 |
Novel antipsychotic medications in the treatment of children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child Psychiatry; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; United States | 1999 |
Hyperprolactinemia and male sexual dysfunction.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Hyperprolactinemia; Male; Olanzapine; Pirenzepine; Prolactin; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Testosterone | 1999 |
New antipsychotic drugs produce better outcomes.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Disease Management; Drug Costs; Humans; Mental Health Services; New York City; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome | 1997 |
A cost-effectiveness clinical decision analysis model for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Decision Support Systems, Clinical; Haloperidol; Humans; Markov Chains; Olanzapine; Pirenzepine; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Treatment Outcome; United States | 1998 |
Weight gain and antipsychotic medications.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Obesity; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Weight Gain | 1999 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine.
Topics: Australia; Benzodiazepines; Drug Utilization; Hospitalization; Humans; Olanzapine; Pirenzepine; Reproducibility of Results; Research Design; Risperidone; Treatment Outcome | 1999 |
Stimulation of dopamine release in the bed nucleus of stria terminalis. A trait of atypical antipsychotics?
Topics: Amygdala; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Haloperidol; Indoles; Male; Olanzapine; Pirenzepine; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Salicylamides; Thalamus | 1999 |
In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Benzodiazepines; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Olanzapine; Pirenzepine; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1999 |
Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Pirenzepine; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 1999 |
Risperidone-induced tardive dystonia and psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Dystonia; Facial Muscles; Humans; Male; Middle Aged; Neck Muscles; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence; Risperidone | 1999 |
Experience with the atypical antipsychotics--risperidone and olanzapine in the elderly.
Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Benzodiazepines; Comorbidity; Female; Geriatric Psychiatry; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Retrospective Studies; Risperidone | 1999 |
Relative weight gain among antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Obesity; Olanzapine; Pirenzepine; Risperidone; Weight Gain | 1999 |
Effects of atypical antipsychotic drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Corpus Striatum; Gene Expression Regulation; Gyrus Cinguli; Haloperidol; HSP70 Heat-Shock Proteins; Male; Nucleus Accumbens; Olanzapine; Phencyclidine; Pirenzepine; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; RNA, Messenger | 1999 |
Tardive dyskinesia from risperidone and olanzapine in an alcoholic man.
Topics: Alcoholism; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 1; Dyskinesia, Drug-Induced; Hallucinations; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone | 1999 |
Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Community Mental Health Services; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Utilization; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Urban Population | 1999 |
Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Topics: Animals; Antipsychotic Agents; Benzazepines; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Fever; Hypothermia; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Risperidone; Time Factors | 2000 |
Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Kinetics; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Septal Nuclei | 2000 |
Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; Clozapine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Imidazoles; Indoles; Ketanserin; Male; Mice; Mice, Inbred BALB C; Olanzapine; Pirenzepine; Quinpirole; Random Allocation; Rats; Rats, Wistar; Risperidone; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Species Specificity | 1999 |
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Patient Satisfaction; Piperazines; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 1999 |
Olanzapine. Keep an eye on this neuroleptic.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clinical Trials as Topic; Dopamine Antagonists; Double-Blind Method; Haloperidol; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cytoskeletal Proteins; Gene Expression; Haloperidol; Male; Nerve Tissue Proteins; Olanzapine; Phencyclidine; Pirenzepine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Tissue Distribution | 2000 |
Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain; Brain Chemistry; Clozapine; Deoxyglucose; Excitatory Amino Acid Antagonists; Ketamine; Male; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone | 2000 |
Tardive dyskinesia in older patients.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone | 2000 |
The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Discrimination Learning; Generalization, Psychological; Haloperidol; Male; Olanzapine; Pirenzepine; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Ritanserin; Scopolamine | 2000 |
[Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors | 2000 |
Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Auditory Perception; Benzodiazepines; Clozapine; Cognition Disorders; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 2000 |
Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Discrimination Learning; Imidazoles; Indoles; Male; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone | 2000 |
Side Effects of Antipsychotic Medications: Physician's Choice of Medication and Patient Compliance. Dallas, Texas, California. January 22, 1999. Proceedings of a roundtable.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Pirenzepine; Practice Patterns, Physicians'; Quality of Life; Quetiapine Fumarate; Risperidone | 2000 |
Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain Chemistry; Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Indoles; Isoindoles; Male; Olanzapine; Pirenzepine; Protein Binding; Quinolines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2000 |
Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Behavior; Benzodiazepines; Benztropine; Bipolar Disorder; Drug Interactions; Humans; Male; Muscarinic Antagonists; Olanzapine; Pirenzepine; Risperidone | 2000 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Methamphetamine; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risperidone | 2000 |
Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Benzodiazepines; Corpus Striatum; Female; Health Status; Humans; Iodine Radioisotopes; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon | 2000 |
Novel antipsychotic use in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Drug Administration Schedule; Humans; Olanzapine; Piperazines; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2000 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics for treatment of mixed depression and anxiety.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Comorbidity; Depressive Disorder; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2000 |
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Carrier Proteins; Caudate Nucleus; Cocaine; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Olanzapine; Paroxetine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tritium | 2000 |
Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Haloperidol; Immunohistochemistry; In Situ Hybridization; Limbic System; Nervous System; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger | 2000 |
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Drug Utilization; Female; Haloperidol; Humans; Male; Olanzapine; Pharmacoepidemiology; Pirenzepine; Practice Patterns, Physicians'; Prospective Studies; Risperidone; Schizophrenia | 2000 |
Use of the atypical antipsychotics Olanzapine and Risperidone in adults with intellectual disability.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Intellectual Disability; Male; Middle Aged; Mood Disorders; Olanzapine; Pirenzepine; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2000 |
Cost analysis of the treatment of schizophrenia in the UK. A simulation model comparing olanzapine, risperidone and haloperidol.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Costs and Cost Analysis; Haloperidol; Health Care Costs; Humans; Markov Chains; Models, Economic; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; United Kingdom | 2000 |
St. John's wort and schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hypericum; Male; Olanzapine; Pirenzepine; Plants, Medicinal; Recurrence; Risperidone; Schizophrenia | 2000 |
Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Monitoring; Humans; Leukopenia; Male; Neutropenia; Olanzapine; Pirenzepine; Risk Factors; Risperidone; Schizophrenia, Paranoid | 2000 |
Possible risperidone-induced visual hallucinations.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Hallucinations; Humans; Olanzapine; Pirenzepine; Risperidone; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2000 |
Risperidone and tardive dyskinesia: a case of blepharospasm.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blepharospasm; Dyskinesia, Drug-Induced; Humans; Male; Olanzapine; Pirenzepine; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome | 2000 |
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study.
Topics: Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Haloperidol; Humans; Olanzapine; Pirenzepine; Risperidone | 2000 |
Comparison of cost, dosage and clinical preference for risperidone and olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Utilization; Humans; Israel; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Psychiatry; Psychotic Disorders; Risperidone; Surveys and Questionnaires | 2000 |
Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Dopamine Antagonists; Female; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Female; Hospitalization; Humans; Israel; Male; Olanzapine; Patient Discharge; Patient Readmission; Pirenzepine; Registries; Risperidone; Schizophrenia; Time Factors | 2001 |
Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.
Topics: Adult; Benzodiazepines; Brain Mapping; Carrier Proteins; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neural Pathways; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Substantia Nigra; Tomography, Emission-Computed, Single-Photon; Tropanes | 2001 |
Epidemic of schizophrenia in children or inappropriate prescribing?
Topics: Antipsychotic Agents; Australia; Benzodiazepines; Child; Child, Preschool; Disease Outbreaks; Drug Utilization; Health Services Misuse; Humans; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Risperidone; Schizophrenia | 2000 |
Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Cardiovascular Diseases; Cross-Sectional Studies; Humans; Male; Olanzapine; Pirenzepine; Risk Factors; Risperidone; Schizophrenia | 2001 |
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Dopamine D2 Receptor Antagonists; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sulpiride | 2001 |
Priapism associated with polypharmacy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Polypharmacy; Priapism; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan).
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antipsychotic Agents; Benzodiazepines; Biphenyl Compounds; Dose-Response Relationship, Drug; Humans; Irbesartan; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenic Psychology; Tetrazoles; Water Intoxication | 2001 |
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain Chemistry; Dibenzothiazepines; Dopamine Antagonists; Image Processing, Computer-Assisted; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone | 2001 |
Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Cost of Illness; Drug Costs; Hospitals, Psychiatric; Hospitals, State; Humans; Maryland; Olanzapine; Patient Discharge; Pirenzepine; Prospective Studies; Risperidone; Schizophrenia; Time Factors | 2001 |
Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Female; Follow-Up Studies; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Weight Gain | 2001 |
Hypothesis and hypothesis testing in the clinical trial.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Humans; Olanzapine; Periodicals as Topic; Pirenzepine; Psychotic Disorders; Publishing; Quetiapine Fumarate; Reproducibility of Results; Research Design; Risperidone; Schizophrenia; Terminology as Topic | 2001 |
Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Treatment Outcome | 2001 |
Antiaggressive action of atypical antipsychotics in patients with schizophrenia.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2001 |
Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine.
Topics: Adult; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Male; Neurologic Examination; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2001 |
The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Budgets; Clozapine; Comorbidity; Depressive Disorder; Drug Costs; Female; Health Care Costs; Health Facilities; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Regression Analysis; Risperidone; Schizophrenia; Treatment Outcome; United States; United States Department of Veterans Affairs | 2001 |
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Cohort Studies; Death, Sudden; Electrocardiography; European Union; Female; Humans; Imidazoles; Indoles; Long QT Syndrome; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Risperidone; Sex Factors | 2001 |
Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Benzodiazepines; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Europe; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study.
Topics: Adult; Benzodiazepines; Cost-Benefit Analysis; Cross-Cultural Comparison; Drug Costs; Europe; Female; Humans; Male; Middle Aged; National Health Programs; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Brain; Female; Humans; Iodine Radioisotopes; Male; Olanzapine; Pirenzepine; Receptors, Muscarinic; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon | 2001 |
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding Sites; Binding, Competitive; Cell Line; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; Neurons; Norepinephrine; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Thiazoles | 2001 |
Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antipsychotic Agents; Astrocytes; Benzodiazepines; Calcium; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Clozapine; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Down-Regulation; Haloperidol; Intracellular Fluid; Neostriatum; Olanzapine; Pirenzepine; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Serotonin Antagonists; Sulpiride | 2001 |
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database.
Topics: Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Databases as Topic; Dibenzothiazepines; Drug Approval; Humans; Incidence; Olanzapine; Pirenzepine; Placebos; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Suicide; Suicide, Attempted; Treatment Outcome; United States; United States Food and Drug Administration | 2001 |
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Conditioning, Psychological; Handling, Psychological; Male; Models, Psychological; Motor Activity; Olanzapine; Pirenzepine; Rats; Reflex, Startle; Risperidone; Social Isolation; Socialization | 2001 |
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; Muscle, Skeletal; Myotonic Disorders; Olanzapine; Pirenzepine; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2001 |
Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Leukocyte Count; Neutropenia; Olanzapine; Perphenazine; Pirenzepine; Risperidone; Schizophrenia | 2001 |
Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Female; Muscle Contraction; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Urethra; Urinary Bladder | 2001 |
Global index of safety (GIS): a new instrument to assess drug safety.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Benzodiazepines; Consumer Product Safety; Drug Monitoring; Haloperidol; Humans; Olanzapine; Pharmacoepidemiology; Pirenzepine; Risperidone; Schizophrenia | 2001 |
Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Obesity; Olanzapine; Pirenzepine; Psychotic Disorders; Regression Analysis; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Weight Gain | 2001 |
Conclusions about risperidone.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Humans; Olanzapine; Pirenzepine; Risperidone | 2001 |
Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Intellectual Disability; Male; Movement Disorders; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Sex Factors | 2001 |
Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.
Topics: Animals; Benzodiazepines; Binding, Competitive; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Haloperidol; HeLa Cells; Humans; Ileum; In Vitro Techniques; Indoles; Lysergic Acid; Muscle Contraction; Olanzapine; Ondansetron; Pirenzepine; Quetiapine Fumarate; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfur Radioisotopes; Tritium; Tropisetron | 2001 |
Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Hepatolenticular Degeneration; Humans; Male; Muscle Rigidity; Olanzapine; Parkinsonian Disorders; Pirenzepine; Psychotic Disorders; Risperidone | 2001 |
Elevation of prolactin levels by atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Prolactin; Risperidone; Schizophrenia | 2002 |
Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Topics: Acute Disease; Adult; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Neurologic Examination; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome | 2001 |
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
Topics: Adolescent; Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Netherlands; Olanzapine; Pirenzepine; Risk Factors; Risperidone | 2001 |
Are the atypical antipsychotic drugs antidepressants?
Topics: Affect; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome | 2002 |
Service use and costs of treating schizophrenia with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cost-Benefit Analysis; Dose-Response Relationship, Drug; England; Female; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Patient Readmission; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2001 |
Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Olanzapine; Patient Satisfaction; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2001 |
Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).
Topics: Adult; Antipsychotic Agents; Attitude to Health; Basal Ganglia Diseases; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Patient Compliance; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Cholinesterase Inhibitors; Clozapine; Corpus Striatum; Haloperidol; Male; Nucleus Accumbens; Olanzapine; Oxotremorine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Scopolamine; Sulpiride; Thiazoles; Thioridazine | 2002 |
Effects of antipsychotic drugs on operant responding after acute and repeated administration.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Conditioning, Operant; Dibenzothiazepines; Dose-Response Relationship, Drug; Haloperidol; Imidazoles; Indoles; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Remoxipride; Risperidone; Thioridazine; Time Factors | 2002 |
A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Cost of Illness; Drug Costs; Female; Health Care Costs; Humans; Male; Middle Aged; New England; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2002 |
Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Mental Disorders; Olanzapine; Pirenzepine; Prospective Studies; Risperidone; Weight Gain | 2002 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Schizophrenia | 2002 |
Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Dialysis Solutions; Dopamine Antagonists; Extracellular Space; Haloperidol; Hippocampus; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Rats; Rats, Wistar; Risperidone; Serotonin Antagonists; Thiazoles; Thioridazine | 2002 |
Clinical and neuropsychological correlates of the P300 in schizophrenia.
Topics: Adult; Benzodiazepines; Depression; Event-Related Potentials, P300; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Parietal Lobe; Pirenzepine; Psychiatric Status Rating Scales; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Effects of atypical antipsychotics on vertebrate neuromuscular transmission.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Fluphenazine; In Vitro Techniques; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Olanzapine; Pirenzepine; Rana pipiens; Rana temporaria; Risperidone; Sulpiride; Synaptic Transmission | 2002 |
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Glucose Tolerance Test; Hospitalization; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lithium; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Valproic Acid | 2002 |
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Cerebellar Cortex; Dibenzothiazepines; Dose-Response Relationship, Drug; Entorhinal Cortex; Hippocampus; Infusion Pumps; Male; Nucleus Accumbens; Olanzapine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors | 2002 |
Atypical antipsychotics and cognition in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Female; Hospitals, Psychiatric; Hospitals, State; Humans; Long-Term Care; Male; Middle Aged; New York; Olanzapine; Patient Discharge; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Hospitals, Veterans; Humans; Male; Middle Aged; New York City; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Urban Population; Veterans | 2002 |
Olanzapine-induced mania in bipolar disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone | 2002 |
Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Follow-Up Studies; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Weight Gain | 2002 |
Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine.
Topics: Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Hospitals, Veterans; Humans; Male; Mental Health Services; Middle Aged; Olanzapine; Pirenzepine; Prescription Fees; Retrospective Studies; Risperidone; Schizophrenia; United States; United States Department of Veterans Affairs; Veterans | 2002 |
One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Humans; Middle Aged; Olanzapine; Patient Readmission; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Time Factors | 2002 |
A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Benzodiazepines; Chi-Square Distribution; Electromagnetic Fields; Evoked Potentials, Motor; Female; Humans; Male; Motor Cortex; Olanzapine; Patients; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Atypical neuroleptics stimulate neurogenesis in adult rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Brain Chemistry; Cell Differentiation; Haloperidol; Immunohistochemistry; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Risperidone | 2002 |
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Estradiol; Female; Humans; Hyperprolactinemia; Menstrual Cycle; Menstruation Disturbances; Olanzapine; Pirenzepine; Progesterone; Prolactin; Prospective Studies; Risperidone; Schizophrenia | 2002 |
Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Olanzapine; Pirenzepine; Regression Analysis; Risk Factors; Risperidone; Schizophrenia | 2002 |
Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dibenzothiazepines; Drinking; Female; Haloperidol; Learning; Male; Olanzapine; Pirenzepine; Pregnancy; Prenatal Exposure Delayed Effects; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Retention, Psychology; Risperidone; Spatial Behavior | 2002 |
The value of atypical antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Drug Labeling; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Safety; Schizophrenia; Thiazoles; United States | 2002 |
Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Electroconvulsive Therapy; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome | 2002 |
Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.
Topics: Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiepins; Hostility; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2002 |
The effects of novel antipsychotics on glucose and lipid levels.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Haloperidol; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Triglycerides; Weight Gain | 2002 |
Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Comorbidity; Confidence Intervals; Databases as Topic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Insurance Claim Review; Logistic Models; Male; Middle Aged; Odds Ratio; Olanzapine; Pirenzepine; Psychotic Disorders; Risk Factors; Risperidone; United States | 2002 |
An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; England; Female; Humans; Hyperlipidemias; Male; Middle Aged; Odds Ratio; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Risperidone; Schizophrenia; Schizophrenic Psychology; Wales | 2002 |
Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain; Dibenzothiazepines; Infusions, Intravenous; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors; Tritium | 2002 |
Comparable dopamine 2 receptor occupancy.
Topics: Benzodiazepines; Cognition Disorders; Dopamine Antagonists; Haloperidol; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2002 |
Use of atypical antipsychotics in a Veterans Affairs hospital.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, Drug-Induced; Female; Hospitals, Veterans; Humans; Male; Middle Aged; Olanzapine; Outpatients; Pirenzepine; Retrospective Studies; Risperidone; United States; United States Department of Veterans Affairs | 2002 |
Glucose intolerance with atypical antipsychotics.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Chlorpromazine; Clozapine; Diabetes Mellitus; Glucose Intolerance; Haloperidol; Humans; Hyperglycemia; Olanzapine; Pirenzepine; Risk Factors; Risperidone; World Health Organization | 2002 |
The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression.
Topics: Animals; Benzodiazepines; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Hippocampus; Kainic Acid; Male; Motor Activity; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone | 2002 |
Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Utilization; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Registries; Risperidone; Schizophrenia; Sex Distribution; Socioeconomic Factors; United States; United States Department of Veterans Affairs | 2002 |
Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Care Surveys; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Taiwan; Treatment Outcome | 2003 |
Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.
Topics: Adrenalectomy; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Clozapine; Corticosterone; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Haloperidol; Male; Olanzapine; Pirenzepine; Pregnanolone; Progesterone; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Risperidone | 2003 |
Valproic Acid and risperidone.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Child; Drug Interactions; Humans; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Valproic Acid | 2003 |
Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Cognition Disorders; Female; Haloperidol; Humans; Male; Olanzapine; Patient Compliance; Pirenzepine; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2002 |
Prescribing second-generation antipsychotics and the evolving standard of care in Italy.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Benzodiazepines; Brief Psychiatric Rating Scale; Clozapine; Community Mental Health Services; Dibenzothiazepines; Drug Therapy, Combination; Drug Utilization; Female; Humans; Italy; Male; Middle Aged; Olanzapine; Outpatients; Pharmacoepidemiology; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2002 |
The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Retrospective Studies; Risk Factors; Risperidone | 2002 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome | 2003 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
Comparative effectiveness of antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Pirenzepine; Psychotic Disorders; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Comparative effectiveness of antipsychotic drugs.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Comparative effectiveness of antipsychotic drugs.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Pirenzepine; Research Design; Research Support as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
Olanzapine and risperidone.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Humans; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2003 |
Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Estrogens; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Pirenzepine; Prolactin; Risk Factors; Risperidone; Schizophrenia; Sex Characteristics | 2003 |
Role of ethnicity in predicting antipsychotic medication adherence.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Ethnicity; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Pirenzepine; Risperidone; Schizophrenia | 2003 |
Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Dose-Response Relationship, Drug; Food Deprivation; Haloperidol; Male; Maze Learning; Memory; Olanzapine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Thiazoles | 2003 |
Cost evaluation of risperidone compared with olanzapine.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Costs and Cost Analysis; Hospitalization; Humans; Olanzapine; Pirenzepine; Prescription Fees; Retrospective Studies; Risperidone; Schizophrenia; Statistics, Nonparametric | 2003 |
Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Time Factors; Treatment Outcome | 2003 |
Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Drug Utilization; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dibenzothiazepines; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Leptin; Male; Obesity; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain | 2003 |
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Spain; Weight Gain | 2003 |
Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cost Savings; Dibenzothiazepines; Drug Costs; Drug Utilization Review; Female; Geriatric Assessment; Health Services Research; Humans; Length of Stay; Male; Mental Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; United States | 2003 |
Use of atypical antipsychotic drugs in patients with dementia.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Comorbidity; Dementia; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone | 2003 |
Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Data Collection; Diabetes Mellitus, Type 2; Female; Humans; Insurance Claim Review; Logistic Models; Male; Mood Disorders; Odds Ratio; Olanzapine; Pirenzepine; Risk Factors; Risperidone; United States | 2003 |
Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cost of Illness; Drug Costs; Female; Health Care Costs; Humans; Male; Medicaid; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Texas | 2003 |
Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Male; Olanzapine; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Risperidone | 2003 |
Rehospitalization risk with second-generation and depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome | 2003 |
The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Clozapine; Conscious Sedation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Fourier Analysis; Hypnotics and Sedatives; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Risperidone; Stereotyped Behavior; Time Factors | 2003 |
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Italy; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors | 2003 |
Antipsychotic drugs differentially modulate apolipoprotein D in rat brain.
Topics: Animals; Antipsychotic Agents; Apolipoproteins; Apolipoproteins D; Benzodiazepines; Brain; Haloperidol; Male; Neuronal Plasticity; Neurons; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Risperidone | 2003 |
Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Black People; Diabetes Mellitus; Humans; Male; Mood Disorders; Olanzapine; Pirenzepine; Retrospective Studies; Risperidone; United States; White People | 2003 |
Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Benzodiazepines; Bone Density; Female; Humans; Middle Aged; Olanzapine; Osteoporosis; Pirenzepine; Premenopause; Prolactin; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2003 |
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Valproic Acid | 2003 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
[Neuroleptics and cognition].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Risperidone; Schizophrenia; Schizophrenic Psychology | 2003 |
Schizophrenia, VI: Treatments.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Perphenazine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2003 |
Racial disparity in the use of atypical antipsychotic medications among veterans.
Topics: Antipsychotic Agents; Benzodiazepines; Black or African American; Clozapine; Dibenzothiazepines; Drug Prescriptions; Ethnicity; Hispanic or Latino; Humans; Multivariate Analysis; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; United States; Veterans; White People | 2003 |
Weight change after an atypical antipsychotic switch.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Humans; Middle Aged; Obesity; Olanzapine; Pilot Projects; Retrospective Studies; Risperidone; Schizophrenia | 2003 |
Serum ghrelin concentrations in patients receiving olanzapine or risperidone.
Topics: Adult; Analysis of Variance; Benzodiazepines; Ghrelin; Humans; Male; Middle Aged; Olanzapine; Peptide Hormones; Risperidone; Schizophrenia; Statistics, Nonparametric | 2004 |
[Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Fever; Humans; Male; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Pneumonia, Bacterial; Rhabdomyolysis; Risperidone; Schizophrenia | 2003 |
Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Olanzapine; Pirenzepine; Prevalence; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological | 2003 |
Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cholesterol; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Triglycerides; Weight Gain | 2003 |
Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Pirenzepine; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Schizophrenia; Triglycerides; Weight Gain | 2003 |
Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Haloperidol; Hippocampus; Immunohistochemistry; Male; Nerve Growth Factor; Olanzapine; Rats; Rats, Wistar; Risperidone; Septum of Brain | 2004 |
Similarities and differences among antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2003 |
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.
Topics: Adult; Alleles; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Minisatellite Repeats; Nerve Tissue Proteins; Olanzapine; Polymorphism, Genetic; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia | 2004 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Dropout rates with olanzapine or risperidone: a multi-centre observational study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Meta-Analysis as Topic; Multicenter Studies as Topic; Olanzapine; Patient Dropouts; Pharmacoepidemiology; Psychotic Disorders; Retrospective Studies; Risperidone | 2004 |
Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Catchment Area, Health; Female; Humans; Israel; Male; Olanzapine; Retrospective Studies; Risperidone; Schizophrenia; Suicide, Attempted | 2004 |
Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Black or African American; Drug Utilization; Haloperidol; Hispanic or Latino; Humans; Logistic Models; Medicaid; Middle Aged; Minority Groups; Multivariate Analysis; Olanzapine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Schizophrenia; Texas; United States; White People | 2004 |
Economic outcomes associated with switching individuals with schizophrenia between risperidone and olanzapine: findings from a large US claims database.
Topics: Adult; Aged; Benzodiazepines; Cost-Benefit Analysis; Databases, Factual; Female; Health Care Costs; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Statistics, Nonparametric; United States | 2004 |
Potential for detection bias in the association between olanzapine and diabetes.
Topics: Antipsychotic Agents; Benzodiazepines; Bias; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Olanzapine; Prediabetic State; Proportional Hazards Models; Retrospective Studies; Risk; Risperidone; Schizophrenia | 2004 |
Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.
Topics: Antipsychotic Agents; Benzodiazepines; Calibration; Chromatography, High Pressure Liquid; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Reference Standards; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2004 |
Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Chlorpromazine; Clozapine; Gene Expression Regulation; Haloperidol; Hippocampus; In Situ Hybridization; Male; Microfilament Proteins; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurites; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger; Tissue Distribution | 2004 |
Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Hospitals, State; Humans; Length of Stay; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2004 |
Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Hyperprolactinemia; International Classification of Diseases; Male; Observation; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Weight Gain | 2004 |
Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Haloperidol; Injections, Intraventricular; Male; Motor Activity; Neurotransmitter Agents; Olanzapine; Pregnanolone; Rats; Rats, Sprague-Dawley; Risperidone; Social Isolation | 2004 |
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome | 2004 |
COMT158 polymorphism and hostility.
Topics: Antipsychotic Agents; Benzodiazepines; Catechol O-Methyltransferase; Clozapine; Genotype; Haloperidol; Hostility; Humans; Methionine; Olanzapine; Polymorphism, Genetic; Risperidone; Schizophrenia; Schizophrenic Psychology; Valine | 2004 |
A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2004 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome | 2004 |
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Carrier State; Cholesterol, HDL; Coronary Artery Disease; Cross-Sectional Studies; Factor Analysis, Statistical; Fasting; Health Surveys; Humans; Hypertriglyceridemia; Insulin; Male; Metabolic Syndrome; Obesity; Olanzapine; Prevalence; Psychotic Disorders; Risk Factors; Risperidone; Weight Gain | 2004 |
CSM warning on atypical psychotics and stroke may be detrimental for dementia.
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Risk Factors; Risperidone; Stroke | 2004 |
Atypical antipsychotics and risk of cerebrovascular accidents.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Dementia; Female; Geriatric Assessment; Humans; Male; Olanzapine; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Risperidone; Stroke | 2004 |
The management of psychogeriatric patient.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cognition Disorders; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone | 2004 |
Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Incidence; Male; Managed Care Programs; Olanzapine; Patient Selection; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2004 |
Antipsychotic prescribing in older people. Which drug?
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Retrospective Studies; Risperidone | 2004 |
Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate.
Topics: Adolescent; Adult; Age Factors; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survival Analysis; Time Factors; Treatment Outcome; Valproic Acid | 2004 |
Clinical effectiveness of atypical antipsychotics in dementia.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dementia; Humans; Olanzapine; Risperidone; Stroke; Treatment Outcome; United Kingdom; United States | 2004 |
Economic outcomes associated with olanzapine versus risperidone in the treatment of uncontrolled schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases as Topic; Female; Health Care Costs; Humans; Male; Middle Aged; Olanzapine; Recurrence; Risperidone; Schizophrenia; Time Factors | 2004 |
Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Antagonists; Female; Genotype; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sex Factors | 2004 |
Atypical antipsychotics and weight gain in Chinese patients: a comparison of olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Asian People; Benzodiazepines; Female; Hong Kong; Humans; Male; Obesity; Olanzapine; Risperidone; Schizophrenia; Weight Gain | 2004 |
Comments on cost analysis of risperidone versus olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Costs and Cost Analysis; Cross-Cultural Comparison; Drug Costs; Drug Therapy, Combination; Hospital Costs; Hospitalization; Humans; Olanzapine; Research Design; Retrospective Studies; Risperidone; Schizophrenia; United Kingdom; United States | 2004 |
The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2004 |
All drugs can have serious side effects.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Randomized Controlled Trials as Topic; Risperidone | 2004 |
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzazepines; Benzodiazepines; Carbon Radioisotopes; Clozapine; Corpus Striatum; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Diabetic Ketoacidosis; Dibenzothiazepines; Hospitalization; Humans; Incidence; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; United States | 2004 |
Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Case-Control Studies; Clozapine; Demography; Diabetes Mellitus; Dibenzothiazepines; Female; Humans; Hypoglycemic Agents; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sex Factors | 2004 |
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blepharoptosis; Catalepsy; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Head Movements; Male; Methoxydimethyltryptamines; Mice; Mice, Inbred ICR; Olanzapine; Piperazines; Prosencephalon; Quinolones; Rats; Rats, Wistar; Risperidone; Serotonin; Stereotyped Behavior | 2004 |
Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic study.
Topics: Aged; Antipsychotic Agents; Attitude to Health; Basal Ganglia Diseases; Benzodiazepines; Drug Tolerance; Drug Utilization; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Quality of Life; Risperidone; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires | 2004 |
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dibenzothiazepines; Drug Prescriptions; Female; Humans; Incidence; Insurance Claim Reporting; Male; Middle Aged; Multivariate Analysis; Olanzapine; Outpatients; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; Thioridazine; Time Factors; United States | 2005 |
Effects of typical and atypical antipsychotics on human glycine transporters.
Topics: Amino Acid Transport Systems, Neutral; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chloride Channels; Choriocarcinoma; Clozapine; Female; Glycine; Glycine Plasma Membrane Transport Proteins; Haloperidol; Humans; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Olanzapine; Rats; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenia; Sodium Channels; Synapses; Uterine Neoplasms | 2004 |
Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Auditory Perception; Benzodiazepines; Clozapine; Conditioning, Psychological; Dibenzothiazepines; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Reaction Time; Reflex, Startle; Risperidone; Schizophrenia | 2004 |
Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Cognition; Dibenzothiazepines; Dose-Response Relationship, Drug; Histamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2004 |
Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Health Status; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Veterans | 2004 |
On the simulation of the time-course of dopamine D2 receptor occupancy from the pharmacokinetics of antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Brain; Dibenzothiazepines; Dose-Response Relationship, Drug; Half-Life; Humans; Metabolic Clearance Rate; Models, Statistical; Olanzapine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone | 2005 |
Antipsychotic drug prescribing in the elderly is cause for concern.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Data Collection; Drug Prescriptions; Drug Utilization; Female; Humans; Italy; Male; Olanzapine; Psychotic Disorders; Risperidone; Thioridazine | 2004 |
Selective prescribing of atypical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cholinergic Antagonists; Clozapine; Delayed-Action Preparations; Disease Susceptibility; Drug Administration Schedule; Drug Monitoring; Drug Utilization Review; Female; Humans; Male; Medical Records, Problem-Oriented; Middle Aged; Netherlands; Olanzapine; Patient Selection; Pharmacoepidemiology; Risperidone; Treatment Outcome | 2005 |
[Intoxications with atypical antipsychotic drugs--data of the Acute Intoxication Unit in Wrocław].
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Middle Aged; Olanzapine; Poland; Psychotic Disorders; Risperidone | 2004 |
Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.
Topics: Adult; Ambulatory Care; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2004 |
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Germany; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Patient Readmission; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Treatment Refusal | 2004 |
[Management of the atypical antipsychotic olanzapine in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State hospital].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Treatment Outcome | 2004 |
Weight gain and new onset diabetes associated with olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Diabetes Mellitus; Female; Humans; Male; Olanzapine; Phenothiazines; Retrospective Studies; Risperidone; Schizophrenia; Weight Gain | 2004 |
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Clozapine; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Metabolic Syndrome; Obesity; Olanzapine; Risperidone; Schizophrenia | 2005 |
The use of atypical antipsychotics in the treatment of schizophrenia in North Staffordshire.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Olanzapine; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; Survival Analysis; Time Factors; Treatment Outcome; United Kingdom | 2005 |
Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cholinergic Antagonists; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitals, Veterans; Humans; Male; Olanzapine; Outpatients; Patient Selection; Retrospective Studies; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; United States | 2005 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Bias; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Fasting; Humans; Metabolic Syndrome; Olanzapine; Research Design; Risk Factors; Risperidone | 2005 |
Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Ejaculation; Female; Humans; Hyperprolactinemia; Male; Olanzapine; Prolactin; Psychotic Disorders; Risperidone; Sex Characteristics; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2004 |
[Treatment of "the premonitory state of schizophrenia" with atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Thiazoles | 2004 |
Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
Topics: Adolescent; Age Factors; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Child; Child, Preschool; Humans; Infant; Obesity; Olanzapine; Prospective Studies; Psychotic Disorders; Risperidone; Weight Gain | 2005 |
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amenorrhea; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dibenzothiazepines; Drug Tolerance; Female; Galactorrhea; Gynecomastia; Humans; Male; Observation; Olanzapine; Outcome Assessment, Health Care; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Costs and Cost Analysis; Dibenzothiazepines; Drug Costs; Female; Humans; Inpatients; Male; Mental Health Services; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2004 |
[Cerebral infarct and atypical antipsychotic agents].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cerebral Infarction; Dementia, Vascular; Humans; Olanzapine; Psychotic Disorders; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Treatment Outcome | 2004 |
Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Dietary Fats; Dogs; Insulin Resistance; Islets of Langerhans; Male; Olanzapine; Risperidone | 2005 |
Comparison of clozapine use in Maryland and in Victoria, Australia.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Australia; Benzodiazepines; Catchment Area, Health; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Maryland; Medical Records; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Health care costs for schizophrenia patients started on olanzapine versus risperidone.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Female; Health Care Costs; Humans; Male; Middle Aged; Olanzapine; Retrospective Studies; Risperidone; Schizophrenia | 2005 |
Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Long-Term Care; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2005 |
Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapine.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Diabetes Mellitus; Drug Utilization; Female; Humans; Hyperlipidemias; Incidence; Insurance, Pharmaceutical Services; Male; Middle Aged; Olanzapine; Quebec; Risk Assessment; Risk Factors; Risperidone; Survival Analysis | 2005 |
Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; California; Case-Control Studies; Clozapine; Databases, Factual; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Incidence; Logistic Models; Male; Medicaid; Middle Aged; Odds Ratio; Olanzapine; Quetiapine Fumarate; Risk Assessment; Risperidone; Schizophrenia; Time Factors | 2005 |
[Effect of atypical antipsychotics on metabolism].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol, HDL; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Prospective Studies; Risperidone; Serotonin Agents; Triglycerides; Weight Gain | 2004 |
Antipsychotic drug-induced weight gain: development of an animal model.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Constitution; Body Weight; Dibenzothiazepines; Eating; Male; Mice; Mice, Inbred C57BL; Models, Animal; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Utilization; Female; Health Care Costs; Humans; Male; Mental Health Services; Multivariate Analysis; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone | 2005 |
Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antipsychotic Agents; Aspartate Aminotransferases; Benzodiazepines; Female; Humans; Inpatients; Liver; Liver Function Tests; Male; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia | 2005 |
[Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Risk Factors; Risperidone; Stroke | 2005 |
[Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Humans; Olanzapine; Risk Factors; Risperidone; Stroke | 2005 |
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiepins; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Olanzapine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Muscarinic; Reflex, Startle; Risperidone | 2005 |
Internet in clinical research based on a pilot experience.
Topics: Antipsychotic Agents; Benzodiazepines; Database Management Systems; Humans; Information Storage and Retrieval; Interdisciplinary Communication; Internet; Multicenter Studies as Topic; Olanzapine; Pilot Projects; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Time and Motion Studies | 2005 |
Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Olanzapine; Oxcarbazepine; Risperidone | 2005 |
Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Comorbidity; Female; Humans; Likelihood Functions; Logistic Models; Male; Mental Health Services; Middle Aged; Multivariate Analysis; Olanzapine; Patient Selection; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia; Socioeconomic Factors; United States | 2005 |
FDA warns antipsychotic drugs may be risky for elderly.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Drug Approval; Drug Labeling; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2005 |
Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Incidence; Insurance Coverage; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Sex Factors; United States | 2005 |
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Demography; Depression; Female; Health Status; Hostility; Humans; Male; Middle Aged; Olanzapine; Prognosis; Prospective Studies; Quality of Life; Risperidone; Schizophrenia; Substance-Related Disorders; Treatment Outcome; Weight Gain | 2005 |
Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument.
Topics: Accidental Falls; Aged; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cognition; Dementia; Humans; Mental Disorders; Olanzapine; Quality of Life; Risperidone | 2005 |
A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Geriatric Psychiatry; Humans; Ischemic Attack, Transient; Mental Disorders; Olanzapine; Risperidone; Stroke; United States | 2005 |
Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Cross-Sectional Studies; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prevalence; Prolactin; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Temperature; Child; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Impulsive Behavior; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid; Violence | 2005 |
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Thiazoles | 2005 |
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Australia; Benzodiazepines; Cohort Studies; Disease Progression; Female; Humans; Male; Olanzapine; Prevalence; Psychoses, Substance-Induced; Remission Induction; Retrospective Studies; Risperidone; Severity of Illness Index; Substance-Related Disorders; Treatment Outcome | 2005 |
The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Leukoencephalopathy, Progressive Multifocal; Olanzapine; Piperazines; Risperidone; Thiazoles | 2005 |
Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Haloperidol; Humans; Male; Nervous System Diseases; Neuropsychological Tests; Olanzapine; Risperidone; Schizophrenia; Severity of Illness Index | 2005 |
Patients' opinions of olanzapine and risperidone following long-term treatment: results from a cross-sectional survey.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Attitude; Benzodiazepines; Cross-Sectional Studies; Family Relations; Female; Humans; Interpersonal Relations; Male; Middle Aged; Olanzapine; Patient Satisfaction; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Sexual Behavior | 2005 |
Antipsychotic use in the elderly: shifting trends and increasing costs.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Drug Costs; Humans; Mental Disorders; Olanzapine; Ontario; Population Surveillance; Quetiapine Fumarate; Risperidone | 2005 |
Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Cost Savings; Costs and Cost Analysis; Decision Trees; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Hospitalization; Humans; Long-Term Care; Male; Mental Health; Models, Economic; Olanzapine; Patient Compliance; Public Health; Risperidone; Schizophrenia; Schizophrenic Psychology; Taiwan; Treatment Outcome | 2005 |
Gonadotrophin-releasing hormone agonist treatment of aggression in Alzheimer's disease: a case report.
Topics: Aged; Aggression; Alzheimer Disease; Amines; Antipsychotic Agents; Benzodiazepines; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Olanzapine; Propranolol; Quetiapine Fumarate; Risperidone; Testosterone; Trazodone; Treatment Outcome; Valproic Acid | 2005 |
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study.
Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Chlorpromazine; Dopamine Antagonists; Drug Administration Schedule; Family Practice; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sex Factors | 2005 |
[Obsessive-compulsive symptoms treatment in: schizophrenia].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Obsessive-Compulsive Disorder; Olanzapine; Risperidone; Schizophrenia; Severity of Illness Index | 2005 |
Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Odds Ratio; Olanzapine; Risperidone; Stroke | 2005 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Data Interpretation, Statistical; Dementia; Dibenzothiazepines; England; Family Practice; Female; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Stroke; Survival Analysis; Time Factors; Treatment Outcome | 2005 |
[Prescription of psychotropic drugs for schizophrenic outpatients in Hungary].
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Cross-Sectional Studies; Drug Prescriptions; Female; Flupenthixol; Humans; Hungary; Male; Middle Aged; Olanzapine; Outpatients; Risperidone; Schizophrenia; Serotonin Antagonists; Surveys and Questionnaires | 2005 |
Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cholesterol; Comorbidity; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Intellectual Disability; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone | 2005 |
Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Demography; Drug Tolerance; Female; Humans; Male; Medical Records; Mood Disorders; Olanzapine; Psychiatric Status Rating Scales; Reproducibility of Results; Retrospective Studies; Risperidone; Treatment Outcome | 2005 |
Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
Topics: Adult; Anti-Obesity Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Child, Preschool; Clozapine; Dibenzothiazepines; Female; Fructose; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Taiwan; Topiramate; Weight Gain | 2005 |
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Thiazoles | 2005 |
An economic comparison of risperidone and olanzapine use within an integrated managed mental health program.
Topics: Antipsychotic Agents; Benzodiazepines; Delivery of Health Care, Integrated; Drug Costs; Mental Health Services; Olanzapine; Retrospective Studies; Risperidone; Schizophrenia; Texas | 2006 |
A crossover study on lipid and weight changes associated with olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Cross-Over Studies; Female; Humans; Lipids; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Triglycerides | 2005 |
Bipolar depression: the role of atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Tolerance; Follow-Up Studies; Humans; Olanzapine; Psychotic Disorders; Risperidone; Time Factors | 2004 |
Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Female; Haloperidol; Humans; Linear Models; Male; Meta-Analysis as Topic; Middle Aged; Olanzapine; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Weight Gain | 2005 |
The CATIE schizophrenia effectiveness trial.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Drug Tolerance; Humans; Olanzapine; Perphenazine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2005 |
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Female; Humans; Male; Olanzapine; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon | 2006 |
Atypical antipsychotics: special formulations for acute agitation.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles | 2005 |
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Interview, Psychological; Male; Middle Aged; Olanzapine; Psychometrics; Psychotic Disorders; Quetiapine Fumarate; Reproducibility of Results; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2006 |
[Utilization study of clozapine, olanzapine and risperidone in Hungary].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Humans; Hungary; Olanzapine; Retrospective Studies; Risperidone | 2004 |
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, High Pressure Liquid; Drug Administration Schedule; Male; Olanzapine; Prolactin; Rats; Risperidone; Time Factors; Tissue Distribution | 2006 |
[Brief case report. Duloxetine in Cotard syndrome].
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depersonalization; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Long-Term Care; Olanzapine; Risperidone; Syndrome; Thiophenes | 2005 |
Rates and predictors of adherence with atypical antipsychotic medication: a follow-up study of adolescent inpatients.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mental Disorders; Olanzapine; Patient Compliance; Patient Discharge; Risk Factors; Risperidone; Treatment Outcome | 2005 |
Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Cell Proliferation; Cerebral Ventricles; Cognition; Dentate Gyrus; Discrimination, Psychological; Drug Administration Schedule; Immunologic Techniques; Ki-67 Antigen; Memory; Olanzapine; Prefrontal Cortex; Rats; Risperidone; Staining and Labeling | 2006 |
Can risperidone and olanzapine in elderly patients with dementia and other mental disorders be discontinued?
Topics: Administration, Oral; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Cerebrovascular Disorders; Dementia; Drug Administration Schedule; Female; Humans; Male; Medical Audit; Olanzapine; Practice Guidelines as Topic; Risk Factors; Risperidone; Treatment Outcome; Withholding Treatment | 2006 |
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis.
Topics: Antipsychotic Agents; Belgium; Benzodiazepines; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Delayed-Action Preparations; Economics, Pharmaceutical; Haloperidol; Humans; Olanzapine; Risperidone; Schizophrenia | 2005 |
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.
Topics: Administration, Oral; Antipsychotic Agents; Benzodiazepines; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Economics, Pharmaceutical; Germany; Haloperidol; Humans; Models, Economic; Olanzapine; Quality-Adjusted Life Years; Risperidone; Schizophrenia | 2005 |
Antipsychotic drugs and schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Developing Countries; Health Policy; Humans; Olanzapine; Perphenazine; Risperidone; Schizophrenia | 2006 |
Antipsychotic drugs and schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2006 |
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Blood Pressure; Chronic Disease; Clozapine; Community Mental Health Centers; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Nutrition Assessment; Olanzapine; Prediabetic State; Psychotic Disorders; Reference Values; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Statistics as Topic; Waist-Hip Ratio | 2006 |
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Iowa; Male; Mathematical Computing; Medicaid; Middle Aged; Models, Statistical; Olanzapine; Product Surveillance, Postmarketing; Psychotic Disorders; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Statistics as Topic | 2006 |
Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Chlorpromazine; Corpus Striatum; Haloperidol; Hippocampus; Male; Nerve Growth Factor; Olanzapine; Rats; Rats, Wistar; Risperidone; Time | 2006 |
Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hyperglycemia; Hyperlipidemias; Male; Olanzapine; Risperidone; Schizophrenia, Paranoid | 2006 |
Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Treatment Outcome; Veterans | 2006 |
[Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics].
Topics: Antipsychotic Agents; Benzodiazepines; Carbohydrate Metabolism; Case-Control Studies; Clozapine; Dibenzothiazepines; Female; Ghrelin; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Olanzapine; Overweight; Peptide Hormones; Quetiapine Fumarate; Resistin; Risperidone; Tumor Necrosis Factor-alpha; Weight Gain | 2005 |
Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delusions; Excitatory Amino Acid Antagonists; Female; Hallucinations; Humans; Lamotrigine; Magnetic Resonance Imaging; Multiple Sclerosis; Olanzapine; Pain; Psychotic Disorders; Risperidone; Temporal Lobe; Triazines; Weight Gain | 2006 |
Psychosis of Alzheimer disease.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cause of Death; Controlled Clinical Trials as Topic; Dementia, Vascular; Humans; Olanzapine; Psychotic Disorders; Risk; Risperidone; Statistics as Topic; Stroke; Survival Analysis | 2006 |
Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Topics: Antipsychotic Agents; Benzodiazepines; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Haloperidol; Health Care Costs; Humans; Models, Econometric; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thailand; Thiazoles; Treatment Outcome | 2005 |
Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chlorpromazine; Clozapine; Cross-Over Studies; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Haloperidol; Lipid Peroxidation; Male; Membrane Lipids; Olanzapine; Rats; Rats, Wistar; Risperidone; Schizophrenia; Superoxide Dismutase | 2007 |
Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Costs; Drug Prescriptions; Drug Utilization Review; Episode of Care; Follow-Up Studies; Humans; Insurance Claim Review; International Classification of Diseases; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2006 |
Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Risperidone; Serotonin Antagonists; Treatment Outcome | 2006 |
Anticholinergics in dementia and other confounding problems.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Benztropine; Dementia; Drug Resistance; Humans; Muscarinic Antagonists; Olanzapine; Psychotic Disorders; Risperidone | 2006 |
[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Diabetes Mellitus; Female; Humans; Hyperglycemia; Hyperlipidemias; Male; Middle Aged; Olanzapine; Risk Factors; Risperidone; Schizophrenia | 2006 |
Elderly patient with delirium after myocardial infarction.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Delirium; Humans; Hypotension; Male; Myocardial Infarction; Olanzapine; Risperidone | 2006 |
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Male; Mice; Mice, Inbred C57BL; Olanzapine; Phosphorylation; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serine; Thiazoles; Time Factors | 2007 |
Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Asian People; Basal Ganglia Diseases; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Korea; Malaysia; Male; Obesity; Olanzapine; Risperidone; Schizophrenia; Severity of Illness Index; Taiwan | 2006 |
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Piperazines; Pituitary Neoplasms; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; United States; United States Food and Drug Administration | 2006 |
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Basal Ganglia; Benzodiazepines; Cues; Dominance, Cerebral; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Motivation; Olanzapine; Oxygen; Reference Values; Reward; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2006 |
Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.
Topics: Algorithms; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Risperidone; Tritium | 2006 |
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Outpatients; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Sexual Dysfunction, Physiological | 2006 |
Time course of the antipsychotic effect and the underlying behavioral mechanisms.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Brain; Brain Chemistry; Chlordiazepoxide; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Resistance; Drug Tolerance; Haloperidol; Male; Models, Animal; Olanzapine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Risperidone; Time Factors | 2007 |
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Dibenzothiazepines; Female; Humans; Lipids; Male; Mental Disorders; Nursing Homes; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2006 |
Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Humans; Leptin; Lipids; Lipoproteins; Olanzapine; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2006 |
Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Psychological; Dioxoles; Drug Synergism; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Serine; Stereoisomerism | 2006 |
Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.
Topics: Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Clozapine; Creatine Kinase; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Sex Factors; Triglycerides | 2006 |
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Chlorpromazine; Clozapine; Cyclosporins; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Flow Cytometry; Fluorescent Dyes; Haloperidol; Isoxazoles; Kidney; Liver; LLC-PK1 Cells; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rhodamine 123; Risperidone; Swine; Transfection | 2006 |
Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Immunoenzyme Techniques; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sex Factors | 2005 |
Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Drug Therapy, Combination; Fasting; Female; Humans; Lipids; Lipoproteins, VLDL; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Triglycerides; Waist-Hip Ratio; Weight Gain | 2006 |
Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Humans; Male; Mental Disorders; Middle Aged; New Zealand; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2006 |
Decision models in the evaluation of psychotropic drugs : useful tool or useless toy?
Topics: Antipsychotic Agents; Benzodiazepines; Decision Support Techniques; Health Care Costs; Humans; Olanzapine; Research Design; Risperidone; Schizophrenia | 2006 |
A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany.
Topics: Antipsychotic Agents; Benzodiazepines; Decision Support Techniques; Germany; Health Care Costs; Hospitalization; Humans; Olanzapine; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia; Suicide Prevention; Treatment Outcome | 2006 |
Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Genotype; Haloperidol; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Olanzapine; Polymorphism, Genetic; Risperidone; Schizophrenia; Spain; Tandem Repeat Sequences; Treatment Outcome; White People | 2006 |
A model of anticholinergic activity of atypical antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Clozapine; Cognition Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Cholinergic; Risperidone; Schizophrenia; Thiazoles | 2006 |
Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Regression Analysis; Risk Factors; Risperidone; Schizophrenia; United States; Veterans | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Female; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Time Factors | 2006 |
Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Excitatory Amino Acid Antagonists; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Animal; Motor Activity; Olanzapine; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Risperidone | 2006 |
Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Clozapine; Female; Humans; Male; Mental Disorders; Olanzapine; Risperidone; Weight Gain | 2007 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Cost Savings; Databases, Factual; Health Care Costs; Olanzapine; Retrospective Studies; Risperidone; Schizophrenia; United States; United States Department of Veterans Affairs | 2006 |
Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Chlorpromazine; Cohort Studies; Female; Fluphenazine; Haloperidol; Hospitals, Veterans; Humans; Hyperglycemia; Incidence; Male; Middle Aged; Olanzapine; Perphenazine; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Southeastern United States; Time Factors; Veterans | 2007 |
[Study questions the benefit of the treatment. Aggressive Alzheimer patient -- a (not a) case for atypical neuroleptics?].
Topics: Aggression; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Controlled Clinical Trials as Topic; Dopamine Antagonists; Humans; Olanzapine; Placebos; Risk Assessment; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2006 |
The switching of risperidone to olanzapine in elderly nursing-home patients with dementia: a retrospective study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Benzodiazepines; Comorbidity; Dementia, Vascular; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Psychotic Disorders; Retrospective Studies; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome | 2007 |
Survival among elderly Italian patients with dementia treated with atypical antipsychotics: observational study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dementia; Female; Humans; Italy; Male; Multivariate Analysis; Olanzapine; Risk Factors; Risperidone; Survival Analysis | 2006 |
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs.
Topics: Adipose Tissue; Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Bone Density; Dibenzothiazepines; Dietary Fats; Drug Administration Schedule; Eating; Energy Intake; Female; Lipids; Mice; Mice, Inbred C57BL; Olanzapine; Quetiapine Fumarate; Risperidone; Weight Gain | 2007 |
Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.
Topics: Adult; Aged; Antipsychotic Agents; Arachidonic Acid; Benzodiazepines; Brain; Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Docosahexaenoic Acids; Fatty Acid Desaturases; Fatty Acids; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Olanzapine; Prefrontal Cortex; Risperidone; Schizophrenia; Sex Factors | 2007 |
Analysis of proarrhythmic potential of antipsychotics risperidone and olanzapine in anesthetized dogs.
Topics: Action Potentials; Anesthesia; Animals; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Blood Pressure; Bundle of His; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Heart Rate; Male; Olanzapine; Risperidone; Vascular Resistance; Ventricular Function, Left | 2007 |
Alteration in serum neural cell adhesion molecule in patients of schizophrenia.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Chronic Disease; Dibenzothiazepines; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Molecular Weight; Neural Cell Adhesion Molecules; Olanzapine; Protein Isoforms; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2007 |
Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes?
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise; Feeding Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Life Style; Male; Middle Aged; Nutrition Surveys; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Weight Gain | 2007 |
Atypical antipsychotic agents ineffective for AD.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Psychomotor Agitation; Quetiapine Fumarate; Risperidone | 2007 |
Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Attention; Benzodiazepines; Cues; Eye Movements; Female; Humans; Male; Memory, Short-Term; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Schizophrenia; Schizophrenic Psychology | 2007 |
Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Olanzapine; Patients; Physicians; Prospective Studies; Quality of Life; Risperidone; Schizophrenia; Self Concept; Surveys and Questionnaires | 2007 |
Characteristics of psychotic patients with foreign accent syndrome.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Humans; Language; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Valproic Acid; Verbal Behavior | 2007 |
Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dose-Response Relationship, Drug; Haloperidol; Ketanserin; Male; Olanzapine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Catecholamine; Receptors, Neurotransmitter; Receptors, Serotonin, 5-HT2; Risperidone | 2007 |
Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Topics: Activities of Daily Living; Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Female; Follow-Up Studies; Humans; Institutionalization; Male; Olanzapine; Psychomotor Agitation; Retrospective Studies; Risperidone; Severity of Illness Index | 2007 |
[Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Retrospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2006 |
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.
Topics: AMP-Activated Protein Kinase Kinases; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Hypothalamus; Olanzapine; Protein Kinases; Quetiapine Fumarate; Risperidone; Schizophrenia; Weight Gain | 2007 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, Drug-Induced; Female; Germany; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Structure-Activity Relationship; Sulpiride; Weight Gain | 2007 |
Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy; Female; Hospitalization; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles | 2007 |
Pisa syndrome resolved after switching to olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Humans; Male; Olanzapine; Posture; Risperidone; Schizophrenia; Self-Injurious Behavior; Syndrome | 2007 |
The outpatient use of atypical antipsychotics with Alzheimer's disease.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Data Interpretation, Statistical; Dibenzothiazepines; Dopamine Antagonists; Double-Blind Method; Follow-Up Studies; Humans; Multicenter Studies as Topic; Olanzapine; Outpatients; Placebos; Quetiapine Fumarate; Risk Assessment; Risperidone; Serotonin Antagonists; Time Factors; Treatment Outcome | 2007 |
Managing psychosis in pregnancy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case Management; Child Custody; Cooperative Behavior; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperbilirubinemia, Neonatal; Infant, Newborn; Infant, Small for Gestational Age; Interprofessional Relations; Olanzapine; Pregnancy; Pregnancy Complications; Psychotic Disorders; Puerperal Disorders; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Perphenazine; Psychiatric Status Rating Scales; Reference Values; Risperidone; Schizophrenia; Weight Gain | 2007 |
[Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Mental Disorders; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Survival Analysis; Treatment Outcome | 2007 |
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Topics: Animals; Antipsychotic Agents; Attention; Benzodiazepines; Clozapine; Cognition Disorders; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Hallucinogens; Haloperidol; Impulsive Behavior; Male; Olanzapine; Phencyclidine; Quetiapine Fumarate; Rats; Rats, Wistar; Reaction Time; Risperidone; Schizophrenia | 2007 |
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Male; Obesity; Olanzapine; Risperidone; Smoking; Valproic Acid | 2008 |
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Humans; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Remission Induction; Risperidone; Schizophrenia; Thiazoles | 2007 |
Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Humans; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Violence | 2007 |
Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Haloperidol; Humans; Models, Theoretical; Olanzapine; Risperidone; Schizophrenia; United States | 2007 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Analysis; Databases, Factual; Delayed-Action Preparations; Dibenzothiazepines; Female; Health Care Costs; Hong Kong; Hospitalization; Humans; Male; Medical Records; Middle Aged; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; Substance-Related Disorders; Sulpiride | 2007 |
Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Clozapine; Cognition; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Drug Prescriptions; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Risperidone; Schizophrenia; Severity of Illness Index | 2007 |
Impairment in error monitoring predicts poor executive function in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Olanzapine; Piperazines; Reaction Time; Risperidone; Schizophrenia; Self Efficacy; Severity of Illness Index; Thiazoles | 2007 |
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Topics: Adiposity; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Composition; Body Weight; Cholesterol; Drinking; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Food Preferences; Glycerol; Insulin; Leptin; Motor Activity; Olanzapine; Piperazines; Prolactin; Rats; Risperidone; Thiazoles; Triglycerides | 2007 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome | 2008 |
Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks: response to Hardy et al.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dogs; Dose-Response Relationship, Drug; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Olanzapine; Risperidone | 2007 |
Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: Assessing the potential risk for accelerated recent autobiographical memory loss.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Autobiographies as Topic; Benzodiazepines; Dibenzothiazepines; Drug Monitoring; Female; Geriatric Assessment; Haloperidol; Humans; Male; Memory; Mental Status Schedule; Neuropsychological Tests; Nursing Assessment; Olanzapine; Pilot Projects; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2007 |
In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Coagulation; Blood Platelets; Clozapine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; In Vitro Techniques; Male; Middle Aged; Olanzapine; Partial Thromboplastin Time; Platelet Adhesiveness; Platelet Aggregation; Prothrombin Time; Risperidone; Thromboembolism; Venous Thrombosis | 2007 |
Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Utilization; Female; Humans; Male; New Zealand; Olanzapine; Quetiapine Fumarate; Risperidone | 2007 |
Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; California; Diabetic Ketoacidosis; Female; Humans; Incidence; Insurance Claim Review; Male; Medicaid; Middle Aged; Olanzapine; Risperidone; Time Factors | 2007 |
Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Child; Child, Preschool; Dibenzothiazepines; Female; Humans; Length of Stay; Male; Mental Disorders; Olanzapine; Outcome and Process Assessment, Health Care; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2007 |
Early use of clozapine for poorly responding first-episode psychosis.
Topics: Adolescent; Adult; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; Female; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2007 |
Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Risperidone | 2007 |
Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Dementia; Dibenzothiazepines; Evidence-Based Medicine; Humans; Olanzapine; Psychomotor Agitation; Quetiapine Fumarate; Retrospective Studies; Risperidone; Treatment Outcome | 2007 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Sex Factors; Sulpiride | 2007 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Olanzapine; Parasitic Diseases; Paresthesia; Patient Compliance; Risperidone; Schizophrenia, Paranoid; Somatoform Disorders; Sulpiride; Treatment Outcome | 2007 |
The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Benzodiazepines; Benzoxazoles; Catalepsy; Haloperidol; Intracellular Signaling Peptides and Proteins; Locomotion; Male; Naphthyridines; Neuropeptides; Olanzapine; Orexins; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Urea | 2007 |
Bilateral pedal edema associated with olanzapine use in manic episode of bipolar disorder: report of two cases.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Edema; Electrolytes; Female; Foot Diseases; Humans; Olanzapine; Risperidone | 2007 |
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Fetal Blood; Haloperidol; Humans; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Maternal-Fetal Exchange; Olanzapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2007 |
Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsych
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Animals, Outbred Strains; Benzodiazepines; Cebus; Citalopram; Clozapine; Cognition; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Haloperidol; Haplorhini; Humans; Indoles; Male; Mice; Molecular Structure; Motor Activity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Dopamine D4; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulfonamides | 2007 |
Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Follow-Up Studies; Humans; Metabolic Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Triglycerides; Waist-Hip Ratio | 2007 |
Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Corpus Striatum; Dibenzothiazepines; Dose-Response Relationship, Drug; Electroencephalography; Female; Hippocampus; Injections, Intraperitoneal; Male; Motor Activity; Movement; Olanzapine; Piperazines; Prefrontal Cortex; Quetiapine Fumarate; Rats; Rats, Inbred F344; Reticular Formation; Risperidone; Thiazoles; Time Factors | 2007 |
Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.
Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Drug Administration Routes; Female; Humans; Male; Olanzapine; Risperidone; Schizophrenia; Tablets; Weight Gain | 2007 |
Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, Liquid; Clozapine; Haloperidol; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Rats; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry; Thiazoles | 2007 |
Risperidone-induced enuresis in two children with autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Child; Diurnal Enuresis; Humans; Intellectual Disability; Male; Nocturnal Enuresis; Olanzapine; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Muscarinic; Risperidone | 2007 |
Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Brain; Clomipramine; Comorbidity; Depressive Disorder, Major; Dopamine; Female; Genetic Predisposition to Disease; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Obsessive-Compulsive Disorder; Olanzapine; Psychoses, Substance-Induced; Risk Factors; Risperidone; Serotonin; Substance Withdrawal Syndrome; Young Adult | 2009 |
Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Female; Haloperidol; Hospitals, University; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Outpatient Clinics, Hospital; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Treatment Refusal; Turkey | 2007 |
Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Autoradiography; Benzodiazepines; Brain; Caudate Nucleus; Cerebral Cortex; Clozapine; Haloperidol; Hippocampus; Male; Olanzapine; Oxazepines; Piperazines; Putamen; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Risperidone; Tritium | 2007 |
Analysis of treatment effectiveness in longitudinal observational data.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Data Interpretation, Statistical; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology | 2007 |
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Emotions; Facial Expression; Female; Haloperidol; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Perception; Treatment Outcome | 2007 |
Evidence-based psychiatry: outcomes and decisions.
Topics: Antipsychotic Agents; Benzodiazepines; Decision Making; Evidence-Based Medicine; Humans; Olanzapine; Psychiatry; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Treatment Outcome | 2007 |
Show me the evidence: using number needed to treat.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Confidence Intervals; Data Interpretation, Statistical; Decision Making; Evidence-Based Medicine; Humans; Likelihood Functions; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Risperidone versus olanzapine for treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Risperidone; Schizophrenia | 2007 |
Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Follow-Up Studies; Haloperidol; Humans; Male; Medicaid; Middle Aged; Olanzapine; Patient Compliance; Phenothiazines; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2007 |
Practical strategies for assessing and stabilizing bipolar patients in urgent situations.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors | 2007 |
Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
Topics: Adolescent; Adult; Aging; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone; Sex Characteristics; Smoking; Tandem Mass Spectrometry; Valproic Acid | 2007 |
Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Dementia, Vascular; Dibenzothiazepines; Female; Haloperidol; Humans; Kaplan-Meier Estimate; Male; Medicare Part A; Multivariate Analysis; Olanzapine; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans | 2007 |
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Clozapine; Databases, Factual; Dementia; Dibenzothiazepines; Drug Utilization Review; Health Services for the Aged; Humans; Olanzapine; Pharmaceutical Services; Piperazines; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Stroke; Thiazoles; Treatment Outcome | 2007 |
The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.
Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Clozapine; Delayed-Action Preparations; Dibenzothiazepines; Drug Administration Schedule; Female; Follow-Up Studies; Health Care Surveys; Humans; Longitudinal Studies; Male; Olanzapine; Outcome Assessment, Health Care; Patient Dropouts; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Spain; Survival Analysis; Time Factors; Treatment Outcome | 2008 |
Clozapine and olanzapine but not risperidone impair the pre-frontal striatal system in relation to egocentric spatial orientation in a Y-maze.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Choice Behavior; Clozapine; Cues; Dopamine Antagonists; Male; Neostriatum; Olanzapine; Orientation; Prefrontal Cortex; Psychomotor Performance; Rats; Rats, Long-Evans; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Space Perception | 2007 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Fluvoxamine; Humans; Male; Meige Syndrome; Olanzapine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2007 |
Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Genotype; Humans; Male; Norepinephrine Plasma Membrane Transport Proteins; Olanzapine; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2008 |
Evaluating dose response from flexible dose clinical trials.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Olanzapine; Probability; Psychotic Disorders; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Selection Bias; Treatment Outcome | 2008 |
Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.
Topics: Benzodiazepines; Case-Control Studies; Ethics, Clinical; Feasibility Studies; Haloperidol; Humans; Olanzapine; Patient Dropouts; Pilot Projects; Randomized Controlled Trials as Topic; Registries; Risperidone; Schizophrenia; Time Factors | 2008 |
Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Benzodiazepines; Electrooculography; Female; Fixation, Ocular; Humans; Male; Neural Inhibition; Olanzapine; Orientation; Pattern Recognition, Visual; Prefrontal Cortex; Psychotic Disorders; Reaction Time; Risperidone; Saccades; Schizophrenia; Signal Processing, Computer-Assisted | 2008 |
Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Intellectual Disability; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Self-Injurious Behavior; Treatment Outcome | 2008 |
Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Outpatients; Patient Dropouts; Retrospective Studies; Risperidone; Schizophrenia; Time Factors | 2008 |
Second generation antipsychotics and risk of diabetes type II--comparison between olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Insulin Resistance; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2007 |
Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?
Topics: Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Dystonia; Humans; Male; Middle Aged; Neck Muscles; Olanzapine; Parkinsonian Disorders; Quetiapine Fumarate; Risperidone | 2008 |
Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Anxiety; Benzodiazepines; Cross-Sectional Studies; Dementia; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Residence Characteristics; Risperidone; Schizophrenia; Serotonin Antagonists; United States | 2008 |
Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neuroprotective Agents; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors | 2008 |
Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intramuscular; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Treatment Outcome | 2008 |
Pulmonary thromboembolism associated with olanzapine and risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Male; Olanzapine; Pulmonary Embolism; Risperidone | 2008 |
Three cases of schizophrenia for which olanzapine was effective after early acute phase.
Topics: Acute Disease; Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Haloperidol; Humans; Japan; Male; Mental Disorders; Middle Aged; Olanzapine; Patient Admission; Patient Compliance; Risperidone; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Treatment Outcome | 2008 |
Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Dietary Fats; Drinking Behavior; Feeding Behavior; Female; Injections, Intraperitoneal; Olanzapine; Piperazines; Rats; Risperidone; Thiazoles; Weight Gain | 2008 |
Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Benzodiazepines; Binding, Competitive; Clozapine; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Imidazoles; Indoles; Injections, Subcutaneous; Male; Models, Biological; Olanzapine; Protein Binding; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Reproducibility of Results; Risperidone | 2008 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Weight gain due to long term antipsychotic treatment of persistent mental disorders.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Female; Follow-Up Studies; Humans; Israel; Long-Term Care; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Weight Gain | 2008 |
[Prescription of traditional neuroleptics in the remission period for schizophrenic patients with excess of body mass caused by atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Drug Prescriptions; Female; Follow-Up Studies; Haloperidol; Humans; Male; Mental Status Schedule; Olanzapine; Overweight; Risperidone; Schizophrenia; Treatment Outcome; Trifluoperazine | 2007 |
Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Mental Health Services; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; United States | 2008 |
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
Topics: Adult; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Erectile Dysfunction; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hungary; International Cooperation; Libido; Male; Menstruation Disturbances; Middle Aged; Olanzapine; Outpatients; Patient Admission; Patient Compliance; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 2007 |
Lessons to be learned from CATIE and CUtLASS.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Health Care Costs; Humans; Informed Consent; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2008 |
Did CATIE influence antipsychotic use?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
[Atypical antipsychotics in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Methotrimeprazine; Middle Aged; Olanzapine; Risk Factors; Risperidone; Stroke | 2008 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone | 2008 |
[Edema related to treatment with olanzapine].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Therapy, Combination; Edema; Female; Humans; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2009 |
Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2008 |
Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Electrocardiography; Female; Haloperidol; Heart Rate; Hemodynamics; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sex Characteristics; Smoking; Young Adult | 2009 |
Clinical experiences and clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Olanzapine; Perphenazine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2008 |
Revised Korean medication algorithm for bipolar disorder.
Topics: Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Health Personnel; Humans; Korea; Olanzapine; Psychiatry; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Valproic Acid | 2009 |
Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.
Topics: 3' Untranslated Regions; Antigens, CD; Antipsychotic Agents; Benzodiazepines; CD48 Antigen; Chromosomes, Human, Pair 1; Clozapine; Diabetes Mellitus, Type 2; Diagnostic and Statistical Manual of Mental Disorders; Endogenous Retroviruses; Female; Haplotypes; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Olanzapine; Polymorphism, Genetic; Risk Factors; Risperidone; Schizophrenia; Signaling Lymphocytic Activation Molecule Associated Protein | 2008 |
Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antipsychotic Agents; Benzodiazepines; Biotransformation; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Humans; Inpatients; Isoxazoles; Male; Mental Disorders; Middle Aged; Olanzapine; Paliperidone Palmitate; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult | 2008 |
A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Discrimination Learning; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Olanzapine; Risperidone | 2008 |
Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Inhibition, Psychological; Male; Mice; Mice, Inbred Strains; Olanzapine; Piperazines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Reflex, Startle; Risperidone; Serotonin Receptor Agonists; Species Specificity | 2008 |
Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.
Topics: Adiponectin; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2008 |
The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Drug Resistance, Multiple; Exons; Female; Gene Frequency; Genes, MDR; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Obesity; Olanzapine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptor, Serotonin, 5-HT2C; Risperidone; Schizophrenia; Weight Gain | 2008 |
QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2008 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus Striatum; Depressive Disorder; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits; Haloperidol; Injections, Intraperitoneal; Male; Olanzapine; Rats; Rats, Wistar; Risperidone; Sulpiride; Time Factors | 2008 |
Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Child; Clozapine; Female; Hospitals, Psychiatric; Humans; Inpatients; Male; Olanzapine; Patch-Clamp Techniques; Risk Factors; Risperidone; Weight Gain; Young Adult | 2008 |
LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Brain Mapping; Clozapine; Electroencephalography; Female; Humans; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Signal Processing, Computer-Assisted; Young Adult | 2008 |
Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Delusions; Dose-Response Relationship, Drug; Ectoparasitic Infestations; Female; Humans; Male; Middle Aged; Olanzapine; Publication Bias; Remission Induction; Retrospective Studies; Risperidone; Time Factors; Treatment Outcome | 2008 |
Impact of patient selection criteria and treatment history on comparisons of alternative therapies: a case study of atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; California; Databases, Factual; Decision Making; Dibenzothiazepines; Female; Humans; Male; Medicaid; Middle Aged; Olanzapine; Patient Selection; Psychotic Disorders; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; United States; Young Adult | 2009 |
Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Estradiol; Gonadotropins, Pituitary; Hormones; Humans; Hyperprolactinemia; Inhibins; Male; Olanzapine; Patient Compliance; Prolactin; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Testosterone | 2009 |
Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Pursuit, Smooth; Reaction Time; Risperidone; Saccades; Schizophrenia | 2008 |
A population-based cost-effectiveness analysis of olanzapine and risperidone among ambulatory patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Cohort Studies; Cost-Benefit Analysis; Databases, Factual; Drug Costs; Female; Hospitalization; Humans; Infant; Male; Middle Aged; Olanzapine; Outpatients; Quebec; Risperidone; Schizophrenia; Statistics, Nonparametric; Young Adult | 2008 |
Atypical antipsychotics and metabolic outcomes in Chinese patients: a comparison of olanzapine and risperidone.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; China; Cross-Sectional Studies; Dose-Response Relationship, Drug; Dyslipidemias; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Pilot Projects; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2008 |
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Cost of Illness; Dibenzothiazepines; Female; Follow-Up Studies; Haloperidol; Humans; Kaplan-Meier Estimate; Long-Term Care; Male; Middle Aged; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2008 |
Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Japan; Male; Matched-Pair Analysis; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2009 |
Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Clozapine; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Olanzapine; Parents; Retrospective Studies; Risk Factors; Risperidone; Sex Factors; Smoking; Time Factors; Weight Gain; Young Adult | 2009 |
Belgian Schizophrenia Outcome Survey - results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Belgium; Benzodiazepines; Brief Psychiatric Rating Scale; Dyskinesia, Drug-Induced; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain | 2009 |
Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Cytokines; Haloperidol; Interleukin-10; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Olanzapine; Poly I-C; Risperidone; Serotonin Antagonists; Tumor Necrosis Factor-alpha | 2009 |
Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development.
Topics: Animals; Animals, Newborn; Animals, Suckling; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Lactation; Male; Mice; Milk; Olanzapine; Prolactin; Risperidone; Sex Characteristics; Waist-Hip Ratio; Weight Gain | 2010 |
Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Female; Humans; Male; Olanzapine; Prospective Studies; Regression Analysis; Risperidone; Schizophrenia | 2009 |
Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Dextroamphetamine; Disease Models, Animal; Drug Interactions; Motivation; Motor Activity; Olanzapine; Phencyclidine; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Schizophrenic Psychology | 2009 |
The subjective experience of taking antipsychotic medication: a content analysis of Internet data.
Topics: Adult; Affect; Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety Disorders; Attitude to Health; Benzodiazepines; Bipolar Disorder; Cognition Disorders; Female; Health Behavior; Humans; Internet; Male; Middle Aged; Olanzapine; Parkinsonian Disorders; Psychotic Disorders; Risperidone; Sexual Dysfunction, Physiological | 2009 |
Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Leptin; Male; Obesity; Olanzapine; Risperidone; Schizophrenia, Paranoid; Sex Factors; Young Adult | 2008 |
Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.
Topics: Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cross-Sectional Studies; Estradiol; Female; Humans; Male; Olanzapine; Prolactin; Psychotic Disorders; Risperidone; Sexual Dysfunction, Physiological; Young Adult | 2009 |
Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Humans; Insurance, Health; Male; Middle Aged; Olanzapine; Outpatients; Practice Patterns, Physicians'; Prescription Drugs; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Sex Factors; Young Adult | 2009 |
Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Injections, Subcutaneous; Male; Memory; Olanzapine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Risperidone | 2010 |
Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.
Topics: Alternative Splicing; Antipsychotic Agents; Aripiprazole; Astrocytoma; Benzodiazepines; Cell Line, Tumor; Clozapine; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; Risperidone; RNA-Binding Proteins; RNA, Messenger; Time Factors | 2009 |
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Medication adherence for children and adolescents with first-episode psychosis following hospitalization.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Cohort Studies; Dibenzothiazepines; Epidemiologic Studies; Female; Humans; Length of Stay; Male; Olanzapine; Patient Compliance; Patient Discharge; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Treatment Outcome; United States | 2009 |
Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia, Paranoid | 2010 |
Asenapine effects in animal models of psychosis and cognitive function.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Attention; Benzodiazepines; Cognition; Dibenzocycloheptenes; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Male; Olanzapine; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Risperidone | 2009 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Hypoglycemia; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2009 |
Comparison of treatment completion rates for olanzapine pamoate and risperidone microspheres.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Humans; Microspheres; Olanzapine; Research Design; Review Literature as Topic; Risperidone; Schizophrenia | 2009 |
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population.
Topics: Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dibenzothiazepines; Dyslipidemias; Female; Haloperidol; Humans; Hypertriglyceridemia; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risperidone; Time Factors; United States; United States Department of Veterans Affairs | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
[Therapeutic intervention for group with risk of psychosis--Sendai At-risk Mental State And First Episode].
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Early Diagnosis; Female; Humans; Male; Olanzapine; Outpatients; Psychotic Disorders; Randomized Controlled Trials as Topic; Risk; Risperidone; Time Factors; Young Adult | 2009 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Withholding Treatment | 2009 |
Effects of olanzapine and risperidone on metabolic factors in children and adolescents: a retrospective evaluation.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Child; Diabetes Mellitus, Type 2; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Metabolic Syndrome; Olanzapine; Psychotic Disorders; Retrospective Studies; Risperidone | 2009 |
Economic evaluation of antipsychotic drugs for schizophrenia treatment within the Brazilian Healthcare System.
Topics: Antipsychotic Agents; Benzodiazepines; Brazil; Cost-Benefit Analysis; Drug Costs; Haloperidol; Humans; Markov Chains; Medication Adherence; Olanzapine; Quality of Life; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia | 2009 |
The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Collagen; Female; Haloperidol; Humans; In Vitro Techniques; Male; Olanzapine; Platelet Activation; Platelet Aggregation; Risperidone | 2010 |
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Lamotrigine; Male; Mental Disorders; Mucopolysaccharidosis III; Olanzapine; Risperidone; Triazines; Young Adult | 2009 |
[Complex therapy of schizophrenia].
Topics: Adolescent; Adult; Antipsychotic Agents; Art Therapy; Benzodiazepines; Clinical Trials as Topic; Clozapine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dance Therapy; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Music Therapy; Occupational Therapy; Olanzapine; Psychotherapy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Single-Blind Method; Suicide; Treatment Outcome; Young Adult | 2009 |
Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Haloperidol; Hypothalamus; Immunohistochemistry; Male; Neurons; Olanzapine; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Risperidone; Supraoptic Nucleus; Vasopressins | 2010 |
Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Dose-Response Relationship, Drug; Drug and Narcotic Control; Humans; Information Dissemination; Olanzapine; Practice Patterns, Physicians'; Risperidone; Spain | 2009 |
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Lipid Metabolism; Lipids; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Weight Gain | 2009 |
Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Confidence Intervals; Female; Health Status Indicators; Humans; Longitudinal Studies; Male; Models, Economic; Multivariate Analysis; Olanzapine; Outpatients; Quality of Life; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Spain; Time Factors | 2009 |
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Placebos; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2009 |
Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Insulin; Lithium Carbonate; Male; Obesity; Olanzapine; Overweight; Prospective Studies; Quetiapine Fumarate; Risperidone; Triglycerides; Valproic Acid; Weight Gain; Young Adult | 2010 |
Religious delusions in an evangelical Christian woman with anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Female; Hospitalization; Humans; Olanzapine; Religion and Psychology; Risperidone; Schizophrenia, Paranoid | 2009 |
Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Cell Separation; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Estradiol; Estrogen Replacement Therapy; Female; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Insulin-Secreting Cells; Olanzapine; Ovariectomy; Pancreatectomy; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Weight Gain | 2010 |
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles | 2011 |
Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Eating; Male; Mice; Mice, Knockout; Motor Activity; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Thiazoles; Weight Gain | 2010 |
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2010 |
Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Topics: Adult; Age Distribution; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Databases, Factual; Dibenzothiazepines; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Female; Humans; Kaplan-Meier Estimate; Male; Mental Disorders; Middle Aged; Olanzapine; Patient Compliance; Quebec; Quetiapine Fumarate; Registries; Retrospective Studies; Risperidone; Sex Distribution; Young Adult | 2010 |
Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Dopamine Antagonists; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Models, Animal; Olanzapine; Prefrontal Cortex; Quinolines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, G-Protein-Coupled; Risperidone; Schizophrenia | 2010 |
Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepines; Fear; Male; Maze Learning; Models, Animal; Olanzapine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone; Vocalization, Animal | 2010 |
Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Sex Characteristics; Statistics as Topic; Time Factors | 2010 |
Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Eating; Estradiol; Estrogen Replacement Therapy; Female; Glucose; Insulin Resistance; Liver; Olanzapine; Ovariectomy; Pancreatectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Risperidone; Weight Gain | 2010 |
Effects of lactational exposure of olanzapine and risperidone on hematology and lymphoid organs histopathology: a comparative study in mice neonates.
Topics: Animals; Animals, Newborn; Benzodiazepines; Female; Hematologic Diseases; Hyperprolactinemia; Lactation; Male; Mice; Olanzapine; Risperidone; Spleen; Thymus Gland | 2010 |
Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.
Topics: Acoustic Stimulation; Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Benzodiazepines; Blinking; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Reflex, Startle; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
SSRIs as a treatment alternative for monosymptomatic delusional disorders.
Topics: Adult; Benzodiazepines; Cognitive Behavioral Therapy; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2010 |
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Blood Glucose; Cohort Studies; Female; Humans; Middle Aged; Olanzapine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2C; Risperidone; Schizophrenia; Waist Circumference; Young Adult | 2011 |
Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Confidence Intervals; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Logistic Models; Male; Odds Ratio; Olanzapine; Psychotic Disorders; Risk Factors; Risperidone; Schizophrenia; Severity of Illness Index; Sex Factors; Sexual Dysfunction, Physiological | 2010 |
Second-generation antipsychotics cause weight gain in youths.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Humans; Olanzapine; Overweight; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Weight Gain | 2010 |
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sulpiride; Treatment Failure | 2010 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |
The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Haloperidol; Humans; Male; Olanzapine; Platelet Activation; Platelet Aggregation; Risperidone | 2010 |
Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain Mapping; Carrier Proteins; Corpus Striatum; Gene Expression Regulation; Haloperidol; Homer Scaffolding Proteins; Male; Olanzapine; Random Allocation; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger; Sulpiride | 2010 |
Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Ethnicity; Female; Humans; Lithium Carbonate; Male; Observation; Olanzapine; Personality Disorders; Prospective Studies; Quetiapine Fumarate; Remission Induction; Risperidone; Severity of Illness Index; Substance-Related Disorders; Valproic Acid | 2010 |
Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Cerebellar Cortex; Cerebral Cortex; Computer Graphics; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Hyperprolactinemia; Male; Mathematical Computing; Middle Aged; Olanzapine; Pituitary Gland; Positron-Emission Tomography; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Salicylamides; Schizophrenia; Statistics as Topic; Sulpiride; Temporal Lobe; Young Adult | 2010 |
Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Circadian Rhythm; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hyperprolactinemia; Isoindoles; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2010 |
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Clozapine; Female; Genes; Genotype; Haplotypes; Humans; Long-Term Care; Male; Middle Aged; Odds Ratio; Olanzapine; Receptors, Dopamine D2; Risperidone; Schizophrenia; Weight Gain | 2010 |
Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Biomarkers; Bipolar Disorder; Body Mass Index; Child; Cholesterol, LDL; Chromatography, High Pressure Liquid; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Obesity; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thyroxine; Treatment Outcome; Weight Gain | 2010 |
The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Humans; In Vitro Techniques; Male; Olanzapine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone; Tritium; Vitamin K 1 | 2010 |
Academy of Medicine Singapore-Ministry of Health clinical practice guidelines: Autism Spectrum Disorders in pre-school children.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Benzodiazepines; Central Nervous System Stimulants; Child Development Disorders, Pervasive; Child, Preschool; Dopamine Antagonists; Humans; Mass Screening; Methylphenidate; Olanzapine; Prognosis; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Singapore | 2010 |
Acute respiratory distress due to antipsychotic drugs.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Drug Therapy, Combination; Dystonia; Fatal Outcome; Haloperidol; Humans; Larynx; Male; Olanzapine; Respiratory Distress Syndrome; Respiratory Insufficiency; Risperidone; Schizophrenia | 2010 |
Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Olanzapine; Retrospective Studies; Risperidone; Siblings; Twins, Monozygotic; Weight Gain; Young Adult | 2010 |
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
Topics: Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Cholinesterase Inhibitors; Dementia; Dibenzothiazepines; Drug Prescriptions; Female; Hospitals, University; Humans; Italy; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone | 2010 |
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline | 2010 |
Drug research: marketing before evidence, sales before safety.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Conflict of Interest; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Ethics, Pharmacy; Evidence-Based Medicine; Fraud; Germany; Humans; Information Dissemination; Marketing; Olanzapine; Publication Bias; Research Support as Topic; Risperidone | 2010 |
Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Sex Factors; Veterans | 2010 |
Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Carnitine; Clozapine; Energy Metabolism; Fatty Acids, Nonesterified; Female; Haloperidol; Insulin Resistance; Lipolysis; Male; Malonyl Coenzyme A; Mice; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Risperidone; Thiazoles; Vitamin B Complex | 2012 |
[Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Higher motor activity in schizophrenia patients treated with olanzapine versus risperidone.
Topics: Adult; Ambulatory Care; Benzodiazepines; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Motor Activity; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome | 2010 |
Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia | 2010 |
Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Topics: Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Glutathione Peroxidase; Haloperidol; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Olanzapine; Oxidative Stress; Quetiapine Fumarate; Risperidone; Schizophrenia; Superoxide Dismutase | 2010 |
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dextroamphetamine; Dibenzocycloheptenes; Drug Administration Schedule; Female; Hallucinogens; Heterocyclic Compounds, 4 or More Rings; Olanzapine; Phencyclidine; Rats; Rats, Inbred Strains; Reversal Learning; Risperidone | 2010 |
Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Metabolic Clearance Rate; Olanzapine; Risperidone; Valproic Acid | 2010 |
Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation.
Topics: Anhedonia; Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chronic Disease; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Imipramine; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Risperidone; Self Stimulation; Stress, Psychological | 2011 |
Fronto-limbic abnormalities in a patient with compulsive hoarding: a 99mTc-ECD SPECT study.
Topics: Antipsychotic Agents; Benzodiazepines; Cerebrovascular Circulation; Compulsive Behavior; Cysteine; Diagnostic and Statistical Manual of Mental Disorders; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Limbic System; Obsessive-Compulsive Disorder; Olanzapine; Organotechnetium Compounds; Radiopharmaceuticals; Recovery of Function; Risperidone; Tomography, Emission-Computed, Single-Photon; Young Adult | 2010 |
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.
Topics: Adult; Benzodiazepines; Clozapine; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Thiophenes; Young Adult | 2010 |
Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cross-Sectional Studies; Epistasis, Genetic; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Treatment Outcome | 2012 |
Lipid peroxidation in patients with schizophrenia.
Topics: Adolescent; Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Biomarkers; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Lipid Peroxidation; Male; Olanzapine; Oxidative Stress; Risperidone; Schizophrenia; Sulfonic Acids; Thiobarbituric Acid Reactive Substances; Young Adult | 2010 |
A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Female; Glucose; Glucose Tolerance Test; Homeostasis; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Olanzapine; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2012 |
Aripiprazole protects cortical neurons from glutamate toxicity.
Topics: Animals; Aripiprazole; Benzodiazepines; Cell Nucleus; Cerebral Cortex; Cytoprotection; Dopamine D2 Receptor Antagonists; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Molecular Imaging; Neurons; Neuroprotective Agents; Olanzapine; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Risperidone; Serotonin 5-HT1 Receptor Antagonists; Signal Transduction; Tetrazolium Salts; Thiazoles | 2011 |
Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Movement Disorders; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Severity of Illness Index | 2010 |
Severe hyperglycemia induced by olanzapine was improved with a recovery of insulin secretion after switching to risperidone and introducing insulin therapy.
Topics: Adult; Benzodiazepines; Drug Substitution; Female; Humans; Hyperglycemia; Insulin; Insulin Secretion; Olanzapine; Recovery of Function; Risperidone; Severity of Illness Index | 2010 |
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Phospholipases A2; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Treatment Outcome; Young Adult | 2011 |
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Topics: Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Female; Humans; Inpatients; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain | 2011 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
Topics: Adult; Alleles; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Gene Frequency; Genetic Linkage; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Genotype; Haplotypes; Homozygote; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Risk Factors; Risperidone; Schizophrenia; Sex Factors | 2011 |
Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Conditioning, Psychological; Male; Models, Animal; Motivation; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone | 2011 |
Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Receptors, Dopamine D2; Risperidone; Schizophrenia; Self Report; Severity of Illness Index; Young Adult | 2011 |
Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chi-Square Distribution; Clopenthixol; Clozapine; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Turkey; Young Adult | 2010 |
Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Choice Behavior; Cost Sharing; Drug Prescriptions; Drugs, Generic; Economic Competition; Health Expenditures; Humans; Insurance, Health, Reimbursement; Olanzapine; Poland; Practice Patterns, Physicians'; Risperidone | 2011 |
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Clopenthixol; Clozapine; Female; Humans; Imidazoles; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Olanzapine; Perphenazine; Psychotic Disorders; Risperidone; Statistics, Nonparametric; Time Factors; Young Adult | 2009 |
Minimum effective and relapse-associated doses of risperidone and olanzapine in aggressive, intellectually disabled adults.
Topics: Adult; Age Factors; Aggression; Benzodiazepines; Dose-Response Relationship, Drug; Female; Humans; Intellectual Disability; Male; Middle Aged; Olanzapine; Recurrence; Risperidone; Treatment Outcome | 2011 |
Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Apolipoprotein A-V; Apolipoproteins A; Benzodiazepines; Clozapine; Female; Haplotypes; Humans; Hypertriglyceridemia; Male; Middle Aged; Olanzapine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Taiwan; Triglycerides | 2012 |
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drinking Water; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Haloperidol; Isoxazoles; Linoleoyl-CoA Desaturase; Liver; Male; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rats; Rats, Long-Evans; Risperidone; RNA, Messenger | 2011 |
Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
Topics: Adiponectin; Adolescent; Adolescent Development; Antipsychotic Agents; Basal Metabolism; Benzodiazepines; Biomarkers; Body Composition; Child; Cohort Studies; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Waist Circumference; Weight Gain | 2011 |
Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Male; Olanzapine; Prospective Studies; Risperidone | 2011 |
The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Asian People; Benzodiazepines; Cohort Studies; Databases, Factual; Female; Hospitals, University; Humans; Male; Medical Records; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Quinolones; Republic of Korea; Retrospective Studies; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2011 |
A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Diabetes Mellitus, Type 2; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypoglycemic Agents; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; United States | 2011 |
Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Clinical Trials, Phase I as Topic; Drug Resistance; Female; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulfotransferases | 2011 |
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult | 2011 |
Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Olanzapine; Patient Compliance; Proportional Hazards Models; Retrospective Studies; Risperidone; Schizophrenia; Veterans | 2011 |
Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Child; Clozapine; Cohort Studies; Dibenzothiazepines; Female; Humans; Incidence; Male; Middle Aged; New Zealand; Nocturnal Enuresis; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Risperidone; Urban Population; Young Adult | 2011 |
Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.
Topics: Actigraphy; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Motor Activity; Olanzapine; Psychiatric Status Rating Scales; Rest; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep; Young Adult | 2011 |
Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cannabis; Clozapine; Cohort Studies; Dopamine; Female; Humans; Longitudinal Studies; Male; Marijuana Abuse; Olanzapine; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia | 2012 |
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Models, Economic; National Health Programs; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sweden | 2011 |
Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder.
Topics: Adolescent; Adult; Anthropometry; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Blood Glucose; Body Mass Index; Fasting; Female; Humans; Lipid Metabolism; Longitudinal Studies; Male; Middle Aged; Olanzapine; Predictive Value of Tests; Retrospective Studies; Risperidone; Schizophrenia; Time Factors; Young Adult | 2011 |
The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Brain; Drug Substitution; Dyskinesia, Drug-Induced; Humans; Olanzapine; Receptors, Dopamine; Risperidone; Schizophrenia; Treatment Outcome | 2011 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology | 2011 |
Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Topics: Adult; Anthropometry; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Clozapine; Female; Glucose Intolerance; Humans; Hyperprolactinemia; Insulin Resistance; Lipids; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Young Adult | 2011 |
Switching antipsychotic medications: not enough, too often, or just right?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia | 2011 |
[Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Butyrophenones; Clozapine; Delayed-Action Preparations; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Young Adult | 2011 |
Adjunctive antipsychotics for major depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Approval; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration | 2011 |
Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.
Topics: Academic Medical Centers; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Weight Gain | 2011 |
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors | 2011 |
The genotoxic potentials of some atypical antipsychotic drugs on human lymphocytes.
Topics: Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Cell Survival; Dibenzothiazepines; DNA Damage; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Mutagens; Olanzapine; Quetiapine Fumarate; Risperidone | 2012 |
Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Clozapine; Female; Genetic Association Studies; Haplotypes; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Weight Gain; Young Adult | 2011 |
[Sexual disturbances during the treatment with neuroleptics in patients with schizophrenia and schizophrenia spectrum disorders].
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunctions, Psychological; Young Adult | 2011 |
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Drug Synergism; Glutamic Acid; Glycine Plasma Membrane Transport Proteins; Haloperidol; Male; Membrane Potentials; Olanzapine; Oxadiazoles; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Synaptic Transmission; Tetrahydronaphthalenes | 2012 |
Cost-effectiveness analysis of olanzapine and risperidone in Norway.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Health Services; Humans; Models, Economic; Norway; Olanzapine; Risperidone; Schizophrenia | 2011 |
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome | 2011 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid | 2012 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chi-Square Distribution; Clozapine; Dibenzothiazepines; Humans; Missouri; Olanzapine; Piperazines; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Olanzapine-induced eccrine squamous syringometaplasia.
Topics: Antipsychotic Agents; Benzodiazepines; Biopsy; Dermatologic Agents; Drug Substitution; Eccrine Glands; Humans; Male; Metaplasia; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sweat Gland Neoplasms; Treatment Outcome | 2012 |
Perphenazine suspension: a new, old treatment, side effects and continuous use.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinergic Antagonists; Clinical Trials as Topic; Drug Compounding; Drug Delivery Systems; Female; Fluphenazine; Haloperidol; Hospitals, Psychiatric; Humans; Male; Movement Disorders; Olanzapine; Patient Discharge; Perphenazine; Risperidone; Suspensions; Treatment Outcome | 2012 |
Antipsychotics and mortality in Parkinsonism.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cohort Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Ontario; Parkinsonian Disorders; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
Topics: Accidental Falls; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Propensity Score; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2012 |
Effectiveness of sulpiride in adult patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome; Young Adult | 2013 |
Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Male; Maze Learning; Olanzapine; Rats; Rats, Wistar; Risperidone; Treatment Outcome | 2011 |
Atypical antipsychotic medications to control symptoms of delirium in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Delirium; Dibenzothiazepines; Female; Hospitals, Pediatric; Humans; Infant; Los Angeles; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Severity of Illness Index; Treatment Outcome | 2012 |
Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Quinolones; Retreatment; Risperidone; Schizophrenia; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulpiride; Testosterone | 2012 |
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration | 2012 |
Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Drug Substitution; Female; Health Resources; Humans; Injections; Isoxazoles; Male; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia; Sweden | 2012 |
Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone; Valproic Acid | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
The voices go, but the song remains the same: how can we rescue cognition in early-onset schizophrenia?
Topics: Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Humans; Male; Molindone; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hospital Administration; Humans; Longitudinal Studies; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Selection Bias; Survival Analysis; Time Factors; Treatment Outcome | 2012 |
Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Down-Regulation; Female; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Up-Regulation; Young Adult | 2012 |
State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Emotions; Event-Related Potentials, P300; Evoked Potentials, Visual; Facial Expression; Female; Humans; Isoindoles; Male; Olanzapine; Photic Stimulation; Psychomotor Performance; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2012 |
Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Female; Humans; Income; Japan; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Retreatment; Risperidone; Schizophrenia; Schizophrenic Psychology; Weight Gain | 2012 |
Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Auditory Cortex; Benzodiazepines; Dibenzothiazepines; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Reaction Time; Receptor, Adenosine A2A; Risperidone; Schizophrenia; Sensory Gating; Up-Regulation | 2012 |
[Designer drug induced psychosis].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Benzodioxoles; Clonazepam; Designer Drugs; Drug Therapy, Combination; Humans; Hungary; Male; Olanzapine; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrrolidines; Risperidone; Substance Abuse Detection; Synthetic Cathinone | 2012 |
Subtypes of antipsychotics and suicidal behavior in bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Suicidal Ideation; Suicide; Suicide Prevention; Suicide, Attempted; Veterans | 2012 |
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Europe; Female; Humans; Logistic Models; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2012 |
Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia.
Topics: Activities of Daily Living; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Brazil; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Employment; Female; Humans; Interpersonal Relations; Male; Olanzapine; Quality of Life; Risperidone; Schizophrenia; Social Participation | 2013 |
Neuroleptics: bedwetting.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Nocturnal Enuresis; Olanzapine; Quetiapine Fumarate; Risperidone | 2012 |
Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dental Caries; Dietary Sucrose; DMF Index; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sex Factors; Smoking; Tokyo; Toothbrushing; Tremor; Xerostomia | 2012 |
Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Female; Haloperidol; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Severity of Illness Index; Young Adult | 2012 |
Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Clozapine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Quinolones; Risperidone; Schizophrenia; Weight Loss | 2012 |
Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Vessels; Brain; Cohort Studies; Dibenzothiazepines; Emergency Medical Services; Female; Hospitalization; Housing; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Residence Characteristics; Retrospective Studies; Risk; Risperidone | 2012 |
Repeated activation of mania by atypical antipsychotics in a patient.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Medication Adherence; Middle Aged; Olanzapine; Recurrence; Risperidone; Schizophrenia | 2012 |
Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Humans; Middle Aged; Olanzapine; Outpatients; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Young Adult | 2012 |
Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Incidence; Male; Olanzapine; Parkinson Disease, Secondary; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Sex Factors | 2012 |
Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Causality; Clozapine; Cross-Sectional Studies; Female; Humans; Male; Netherlands; Obsessive-Compulsive Disorder; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Young Adult | 2012 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic | 2013 |
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Olanzapine; Predictive Value of Tests; Quetiapine Fumarate; Regression Analysis; Risperidone | 2013 |
Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Case-Control Studies; Cerebral Cortex; Drug Partial Agonism; Female; Humans; Magnetic Resonance Imaging; Male; Olanzapine; Piperazines; Positron-Emission Tomography; Pyridines; Quinolones; Radiopharmaceuticals; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2013 |
Diabetes resolution following discontinuation of a second-generation antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Withholding Treatment | 2013 |
Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Astemizole; Behavior, Animal; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Epoxy Compounds; Fatty Acids; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Olanzapine; Oxygen Consumption; Piperazines; Quinolones; Receptors, Histamine H1; Respiration; Risperidone; Terfenadine; Time Factors | 2014 |
Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Topics: Adult; Ambulances; Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Victoria | 2013 |
Association between second-generation antipsychotics and changes in body mass index in adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Confidence Intervals; Dibenzothiazepines; Female; Humans; Male; Medical Audit; Olanzapine; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; United States; Weight Gain | 2013 |
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
Topics: Adolescent; Adult; Anisotropy; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Brain Mapping; Case-Control Studies; Dibenzothiazepines; Diffusion Tensor Imaging; Female; Frontal Lobe; Gyrus Cinguli; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult | 2013 |
Delusional infestation: a clinical profile.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Delusions; Ectoparasitic Infestations; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Sulpiride; Treatment Outcome | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.
Topics: Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Confidence Intervals; Cross-Over Studies; Dibenzothiazepines; Humans; Middle Aged; Odds Ratio; Olanzapine; Quetiapine Fumarate; Risk; Risperidone; Stroke | 2013 |
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Comparative safety of antipsychotics: another look at the risk of diabetes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Diabetes Mellitus, Type 2; Dibenzothiazepines; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Young Adult | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Facial ulcer treated with olanzapine.
Topics: Aged; Benzodiazepines; Dopamine Antagonists; Drug Substitution; Facial Dermatoses; Female; Histamine Antagonists; Humans; Olanzapine; Risperidone; Skin Ulcer; Treatment Outcome | 2013 |
Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Canada; Dementia; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Phenothiazines; Proportional Hazards Models; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2013 |
The diagnosis and management of delirium in infancy.
Topics: Antipsychotic Agents; Benzodiazepines; Child, Preschool; Delirium; Female; Humans; Infant; Male; Olanzapine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Humans; Insulin; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Treatment Outcome; Young Adult | 2013 |
Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Czech Republic; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult | 2013 |
The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic β cells by blocking PERK-mediated translational attenuation.
Topics: Animals; Antipsychotic Agents; Apoptosis; Benzodiazepines; Cell Line; Cricetinae; Diabetes Mellitus; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; HEK293 Cells; Hep G2 Cells; Humans; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Olanzapine; Phosphorylation; Proinsulin; Protein Biosynthesis; Risperidone; RNA, Messenger; Schizophrenia; Unfolded Protein Response | 2013 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Finland; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult | 2013 |
Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cholesterol; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Triglycerides; Victoria | 2014 |
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Quetiapine Fumarate; Risperidone; Treatment Outcome | 2013 |
Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Topics: Age Factors; Animals; Animals, Newborn; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Inhibition, Psychological; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Reflex, Acoustic; Risperidone; Time; Time Factors | 2014 |
An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drugs, Generic; Excipients; Humans; In Vitro Techniques; Olanzapine; Particle Size; Risperidone; Saliva, Artificial; Solubility; Tablets; Time Factors; Video Recording | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Predictors of response to second generation antipsychotics in drug naïve patients with schizophrenia: a 1 year follow-up study in Shanghai.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; China; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2014 |
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden | 2014 |
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines | 2014 |
Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Diabetes Complications; Female; Humans; Hyperglycemia; Male; Meta-Analysis as Topic; Middle Aged; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risperidone; Schizophrenia; Young Adult | 2014 |
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cytokines; Female; Humans; Immunoassay; Interleukin 1 Receptor Antagonist Protein; Interleukin-10; Interleukins; Male; Meta-Analysis as Topic; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2014 |
Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Clozapine; Female; Genetic Association Studies; Genotype; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Predictive Value of Tests; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Dibenzothiazepines; Female; Humans; Insurance, Health, Reimbursement; Male; Olanzapine; Patient Discharge; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; Saskatchewan; Schizophrenia | 2014 |
Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Estradiol; Humans; Insulin; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Testosterone; Time Factors | 2014 |
Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2014 |
Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dystonia; Female; Humans; Olanzapine; Piperazines; Piperidines; Risperidone; Schizophrenia; Young Adult | 2014 |
The effect of a calorie-restricted diet on weight gain in short-term psychiatric inpatients receiving atypical antipsychotic medications.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Caloric Restriction; Education, Nursing, Continuing; Female; Humans; Male; Mental Disorders; Obesity; Olanzapine; Risperidone; Sex Factors; Time Factors; Weight Gain | 2014 |
Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brazil; Female; Humans; Male; Middle Aged; Olanzapine; Quality of Life; Risperidone; Schizophrenia; Social Class | 2014 |
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Catalepsy; Computer Simulation; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoxazoles; Markov Chains; Models, Biological; Olanzapine; Paliperidone Palmitate; Pyrimidines; Rats; Receptors, Dopamine D2; Risperidone; Severity of Illness Index | 2014 |
Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Cohort Studies; Denmark; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quetiapine Fumarate; Registries; Risk; Risperidone; Sensitivity and Specificity; Young Adult | 2014 |
Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors.
Topics: 1-Methyl-4-phenylpyridinium; Amyloid beta-Peptides; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Glutathione; Haloperidol; Humans; Hydrogen Peroxide; Models, Biological; Neuroprotective Agents; Olanzapine; Oxidative Stress; Paliperidone Palmitate; Peptide Fragments; Protein Carbonylation; Risperidone | 2014 |
Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2014 |
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cause of Death; Creatinine; Dibenzothiazepines; Female; Hospitalization; Humans; Hypotension; Male; Olanzapine; Ontario; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Urinary Retention | 2014 |
Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Dementia; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone | 2015 |
Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Carbon; Cholesterol; Female; Folic Acid; Homocysteine; Humans; Lipid Metabolism; Male; Metabolic Syndrome; Olanzapine; Risperidone; Schizophrenia; Sex Factors; Triglycerides; Vitamin B 12; Young Adult | 2014 |
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.
Topics: Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Bipolar Disorder; Genetic Association Studies; Genotype; Haplotypes; Humans; Olanzapine; Risperidone; Schizophrenia; Sulfotransferases; Treatment Outcome | 2014 |
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Disease Models, Animal; Epilepsy; Haloperidol; Mental Disorders; Olanzapine; Quetiapine Fumarate; Rats; Risperidone; Seizures | 2015 |
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Health Care Costs; Hospitalization; Humans; Male; Olanzapine; Risperidone; Schizophrenia; Spain | 2014 |
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Male; Mental Disorders; Olanzapine; Prognosis; Prospective Studies; Quetiapine Fumarate; Risk Factors; Risperidone | 2014 |
Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Delirium; Female; Half-Life; Haloperidol; Humans; Male; Middle Aged; Neoplasms; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index | 2016 |
Falls and fractures with atypical antipsychotic medication use: a population-based cohort study.
Topics: Accidental Falls; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Female; Fractures, Bone; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2015 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Treatment changes among older patients with dementia treated with antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Follow-Up Studies; Humans; Male; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Retrospective Studies; Risperidone; United States | 2015 |
Clozapine and olanzapine inhibit proton currents in BV2 microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Mice; Microglia; Olanzapine; Protons; Risperidone | 2015 |
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Psychotropic Drugs; Quetiapine Fumarate; Registries; Retrospective Studies; Risk; Risperidone; United States; Veterans | 2015 |
Chemotherapy-induced acute psychosis in a patient with malignant germ cell tumour.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Benzodiazepines; Chemotherapy, Adjuvant; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Olanzapine; Ovarian Neoplasms; Psychotic Disorders; Risperidone; Treatment Outcome | 2015 |
Implications of atypical antipsychotic prescribing in the intensive care unit.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Delirium; Disorders of Excessive Somnolence; Female; Humans; Inappropriate Prescribing; Intensive Care Units; Male; Middle Aged; Olanzapine; Patient Discharge; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survivors; Thiazoles | 2015 |
A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cost-Benefit Analysis; Drug Costs; Haloperidol; Health Care Costs; Humans; Middle Aged; Olanzapine; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Uganda | 2015 |
Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case Report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Humans; Injections, Intramuscular; Male; Olanzapine; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics].
Topics: Adult; Antipsychotic Agents; Atherosclerosis; Benzodiazepines; Dibenzothiazepines; Electrocardiography; Female; Humans; Lipid Metabolism; Lipoproteins, VLDL; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia, Paranoid; Weight Gain; Young Adult | 2015 |
Concurrent determination of olanzapine, risperidone and 9-hydroxyrisperidone in human plasma by ultra performance liquid chromatography with diode array detection method: application to pharmacokinetic study.
Topics: Administration, Oral; Adult; Benzodiazepines; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Linear Models; Male; Olanzapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Young Adult | 2016 |
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brain; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neostriatum; Olanzapine; Positron-Emission Tomography; Prolactin; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; HLA-A Antigens; Humans; Linkage Disequilibrium; Male; Olanzapine; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Pressure; Body Weights and Measures; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Olanzapine; Quality of Life; Risperidone; Schizophrenia | 2016 |
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Brain; Carbon Radioisotopes; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Positron-Emission Tomography; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Tandem Mass Spectrometry | 2016 |
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Topics: Animals; Aripiprazole; Benzodiazepines; Cannabidiol; Dizocilpine Maleate; Dopamine Antagonists; Male; Memory; Models, Animal; Olanzapine; Rats; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Social Behavior | 2015 |
Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.
Topics: Amides; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Disease Models, Animal; Female; Male; Mice; Olanzapine; Pregnancy; Pregnancy Complications; Risperidone; Teratogenesis | 2015 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
[Eating disorders in psychiatric patients during treatment with second generation antipsychotics].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Feeding and Eating Disorders; Female; Humans; Male; Obesity; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2015 |
Antipsychotic-induced metabolic effects in the female rat: Direct comparison between long-acting injections of risperidone and olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Half-Life; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; Weight Gain | 2015 |
Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Finland; Humans; Male; Olanzapine; Paliperidone Palmitate; Risperidone; Schizophrenia | 2016 |
Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Genetic Association Studies; Humans; Male; Middle Aged; Olanzapine; Orexin Receptors; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; United States; Weight Gain; White People; Young Adult | 2016 |
Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Olanzapine; Parkinson Disease, Secondary; Quetiapine Fumarate; Risperidone | 2015 |
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; CD36 Antigens; Cohort Studies; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Humans; Interleukin-10; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2016 |
Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats.
Topics: Age Factors; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Depression; Female; Male; Motor Activity; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; Sex Factors; Time Factors | 2016 |
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Monitoring; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone | 2016 |
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections, Intramuscular; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; State Medicine; United Kingdom | 2015 |
Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Bridged Bicyclo Compounds, Heterocyclic; Consciousness; Cyclic S-Oxides; Evoked Potentials, Auditory; Male; Olanzapine; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Risperidone | 2016 |
In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; Benzodiazepines; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Clozapine; Haloperidol; Male; Neuropharmacology; Olanzapine; Paliperidone Palmitate; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Risperidone | 2016 |
Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acutely relapsed patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Recurrence; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
[Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation].
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Depression; Drug Therapy, Combination; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Prolactin; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult | 2015 |
ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Isoxazoles; Male; Maze Learning; Mice; Motor Activity; Olanzapine; Punishment; Rats, Wistar; Reaction Time; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Sulfonamides | 2016 |
Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
Topics: Adult; Alleles; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; China; Clozapine; Female; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Linkage Disequilibrium; Logistic Models; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Risperidone; Schizophrenia; Sterol Regulatory Element Binding Protein 1 | 2016 |
Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.
Topics: Adolescent; Aripiprazole; Arousal; Benzodiazepines; Child; Cohort Studies; Female; Humans; Male; Olanzapine; Patient Outcome Assessment; Psychomotor Agitation; Quetiapine Fumarate; Risperidone; Schizophrenia, Childhood; Schizophrenic Psychology; Wakefulness | 2016 |
Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Hospitalization; Humans; Olanzapine; Paliperidone Palmitate; Portugal; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia | 2016 |
The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Child, Preschool; Female; Follow-Up Studies; Ghrelin; Homocysteine; Humans; Insulin; Leptin; Male; Obesity; Olanzapine; Prospective Studies; Risperidone; Time Factors; Treatment Outcome; Weight Gain | 2017 |
Pica associated with initiation of atypical antipsychotic drugs: Report of two cases.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Middle Aged; Olanzapine; Pica; Risperidone | 2016 |
Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.
Topics: Antioxidants; Antipsychotic Agents; Benzodiazepines; Biphenyl Compounds; Clozapine; Free Radical Scavengers; Haloperidol; Humans; Models, Biological; Neutrophil Activation; Neutrophils; Olanzapine; Picrates; Piperazines; Quetiapine Fumarate; Reactive Oxygen Species; Risperidone; Tetradecanoylphorbol Acetate; Thiazoles | 2016 |
Post authorization safety study comparing quetiapine to risperidone and olanzapine.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mortality; Netherlands; Olanzapine; Product Surveillance, Postmarketing; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2016 |
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Specimen Collection; Capillaries; Female; Fingers; Half-Life; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Risperidone; Schizophrenia; Veins; Young Adult | 2016 |
Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Quebec; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2016 |
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Databases, Factual; Dementia; Drug Prescriptions; Female; Humans; Italy; Male; Olanzapine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; United Kingdom | 2016 |
Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Autoradiography; Benzodiazepines; Female; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia | 2016 |
Cognition and Dopamine D
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Cognitive Dysfunction; Corpus Striatum; Female; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychotic Disorders; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia | 2017 |
[Cognitive effectiveness of risperidone and olanzapine in first-episode schizophrenia].
Topics: Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Humans; Olanzapine; Risperidone; Schizophrenia | 2016 |
Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Drug Substitution; Female; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Patient Satisfaction; Prospective Studies; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome | 2017 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Sulpiride; Thioredoxins; Young Adult | 2017 |
Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Caudate Nucleus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Hippocampus; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Synaptic Transmission; Time Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2016 |
Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Olanzapine; Primary Health Care; Propensity Score; Quetiapine Fumarate; Risperidone; Schizophrenia; United Kingdom; Young Adult | 2017 |
Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Belgium; Benzodiazepines; Cross-Sectional Studies; Drug Industry; Drug Prescriptions; Drug Utilization Review; Female; Humans; Male; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia | 2017 |
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States | 2017 |
Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control Strategies.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2017 |
Importance of intervention timing in the effectiveness of antipsychotics.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Disease Models, Animal; Dopamine; Male; Motor Activity; Nucleus Accumbens; Olanzapine; Prepulse Inhibition; Random Allocation; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Sexual Maturation; Social Isolation; Time Factors | 2018 |
Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia; Young Adult | 2017 |
Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Prospective Studies; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Treatment Outcome | 2017 |
Priapism Associated With Antipsychotic Medication Use: Case Report.
Topics: Antipsychotic Agents; Fluphenazine; Humans; Male; Middle Aged; Olanzapine; Priapism; Risperidone | 2017 |
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.
Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2017 |
Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
Topics: Acute Disease; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Humans; Male; Middle Aged; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2017 |
A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; DNA, Mitochondrial; Female; Genes, Mitochondrial; Genome-Wide Association Study; Humans; Male; Olanzapine; Pharmacogenomic Testing; Pharmacogenomic Variants; Prospective Studies; Quetiapine Fumarate; Risk Factors; Risperidone; Weight Gain; White People | 2017 |
Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
Topics: Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Autonomic Nervous System Diseases; Benzodiazepines; Cross-Sectional Studies; Electrocardiography; Female; Heart Rate; Humans; Japan; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2018 |
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
Topics: Adolescent; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Female; Genotype; Humans; Male; Neoplasm Proteins; Olanzapine; Pediatrics; Polymorphism, Genetic; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Haloperidol; Humans; Netherlands; Olanzapine; Paliperidone Palmitate; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia | 2017 |
Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Middle Aged; Norway; Olanzapine; Quetiapine Fumarate; Risperidone; Sex Factors; Young Adult | 2017 |
Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells.
Topics: Adipogenesis; Animals; Antipsychotic Agents; Cell Differentiation; Cells, Cultured; Clozapine; Cytosol; Fatty Acids; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Mesenchymal Stem Cells; Olanzapine; Rats, Inbred Lew; Risperidone; Sterol Regulatory Element Binding Proteins | 2017 |
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cost Savings; Delayed-Action Preparations; Female; Health Care Costs; Hospitalization; Humans; Injections; Long-Term Care; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Paliperidone Palmitate; Practice Patterns, Physicians'; Risperidone; Schizophrenia; United States; Young Adult | 2017 |
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance.
Topics: Antipsychotic Agents; Benzodiazepines; Guidelines as Topic; Humans; Olanzapine; Psychotic Disorders; Relief Work; Risperidone; United Nations | 2017 |
Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Brain Waves; Central Nervous System Stimulants; Cerebral Cortex; Clozapine; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; Male; Nerve Net; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone | 2017 |
Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood; Clozapine; Female; Humans; Lipid Peroxidation; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Thiobarbituric Acid Reactive Substances; Young Adult | 2018 |
Frontal activity measured by near-infrared spectroscopy in patients taking different atypical antipsychotic drugs: A cross-sectional study.
Topics: Adult; Antipsychotic Agents; Case-Control Studies; Cross-Sectional Studies; Female; Frontal Lobe; Hemodynamics; Humans; Male; Olanzapine; Oxyhemoglobins; Risperidone; Schizophrenia; Spectroscopy, Near-Infrared | 2018 |
Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Female; Humans; Male; Metabolic Diseases; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Triglycerides; Young Adult | 2018 |
The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Comorbidity; Depressive Disorder, Major; Female; Humans; Incidence; Infant; Male; Mental Disorders; Norway; Olanzapine; Prevalence; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
Quantitative structure -retention relationship modeling of selected antipsychotics and their impurities in green liquid chromatography using cyclodextrin mobile phases.
Topics: Antipsychotic Agents; Benzodiazepines; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Drug Contamination; Green Chemistry Technology; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Molecular Docking Simulation; Olanzapine; Risperidone | 2018 |
Quantitative determination of risperidone, paliperidone and olanzapine in human serum by liquid chromatography-tandem mass spectrometry coupled with on-line solid-phase extraction.
Topics: Benzodiazepines; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Linear Models; Olanzapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Solid Phase Extraction; Tandem Mass Spectrometry | 2018 |
Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
Topics: Administration, Oral; Adult; Algorithms; Antipsychotic Agents; Clozapine; Commitment of Mentally Ill; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Methotrimeprazine; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Failure; Treatment Outcome | 2019 |
Olanzapine-induced and Risperidone-induced Leukopenia: A Case of Synergistic Adverse Reaction?
Topics: Antipsychotic Agents; Drug Synergism; Female; Humans; Leukopenia; Middle Aged; Olanzapine; Risperidone; Schizophrenia | 2018 |
The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Autoradiography; Benzodiazepines; Brain; Brain Chemistry; Female; Male; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Risperidone; Sex Factors | 2018 |
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles; Young Adult | 2018 |
Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
Topics: Benzodiazepines; Bupropion; Cyproheptadine; Dopamine Uptake Inhibitors; Drug Overdose; Fluoxetine; Humans; Male; Olanzapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Serotonin Syndrome; Time Factors; Trazodone; Young Adult | 2018 |
Olanzapine vs. Risperidone in Schizophrenia: A Cross-sectional Comparison of Quality of Life of Caregivers.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Caregivers; Cross-Sectional Studies; Humans; Middle Aged; Olanzapine; Quality of Life; Risperidone; Schizophrenia; Surveys and Questionnaires; Young Adult | 2016 |
Medication and physical activity and physical fitness in severe mental illness.
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Exercise; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Physical Fitness; Risperidone; Sedentary Behavior; Surveys and Questionnaires | 2018 |
High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Body Mass Index; Cholesterol, HDL; Correlation of Data; Female; Humans; Japan; Male; Middle Aged; Olanzapine; Overweight; Prevalence; Risperidone; Schizophrenia; Surveys and Questionnaires; Waist Circumference | 2018 |
Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.
Topics: Adolescent; Antipsychotic Agents; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Risk Factors; Risperidone; Schizophrenia; Weight Gain | 2018 |
[Using the cumulative odds Logit model to explore the application of the questionnaire derived from PANSS].
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Logistic Models; Olanzapine; Risperidone; Schizophrenia; Surveys and Questionnaires | 2016 |
Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Body Weight; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Olanzapine; Primary Health Care; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; United Kingdom; Weight Gain | 2018 |
The affinity of antipsychotic drugs to dopamine and serotonin 5-HT
Topics: Amisulpride; Animals; Antipsychotic Agents; Corpus Striatum; Dose-Response Relationship, Drug; Magnetic Resonance Imaging; Male; Neural Pathways; Neuroimaging; Olanzapine; Prefrontal Cortex; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Serotonin, 5-HT2; Risperidone | 2018 |
Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Autonomic Nervous System; Cross-Sectional Studies; Female; Heart Rate; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia | 2018 |
Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Glycogen Synthase Kinase 3 beta; Male; Nucleus Accumbens; Olanzapine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Risperidone; Signal Transduction | 2018 |
Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cerebral Cortex; Clozapine; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult | 2018 |
Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Cytokines; Female; Gene Expression; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Receptors, Cytokine; Risperidone; Up-Regulation; Young Adult | 2019 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational Study.
Topics: Adult; Aged; Anesthesia Recovery Period; Antiemetics; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Postoperative Nausea and Vomiting; Propensity Score; Protective Factors; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Time Factors | 2020 |
l-Arginine metabolism before and after 10 weeks of antipsychotic treatment in first-episode psychotic patients.
Topics: Agmatine; Antipsychotic Agents; Arginine; Case-Control Studies; Citrulline; Female; Humans; Male; Olanzapine; Ornithine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Risperidone; Young Adult | 2019 |
Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.
Topics: Amisulpride; Antipsychotic Agents; Apoptosis; Aripiprazole; beta Catenin; Cell Line; Humans; Olanzapine; Osteoblasts; Resveratrol; Risperidone; Wnt Signaling Pathway | 2019 |
Pathological Concentration of C-reactive Protein is Correlated to Increased Concentrations of Quetiapine, But Not of Risperidone, Olanzapine and Aripiprazole in a Naturalistic Setting.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; C-Reactive Protein; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Young Adult | 2020 |
Atypical neuroleptic malignant syndrome - A case report.
Topics: Adult; Antipsychotic Agents; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone | 2019 |
Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor.
Topics: Animals; Antipsychotic Agents; Body Weight; Female; Ghrelin; Hyperglycemia; Leptin; Mice; Mice, Inbred BALB C; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Weight Gain | 2019 |
Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Female; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia | 2019 |
Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; China; Female; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Young Adult | 2019 |
Fos expression induced by olanzapine and risperidone in the central extended amygdala.
Topics: Animals; Antipsychotic Agents; Brain; Male; Olanzapine; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; Risperidone | 2019 |
Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Body Weight; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Weight Gain; Young Adult | 2020 |
In vivo 5-HT
Topics: Adult; Antipsychotic Agents; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Putamen; Quetiapine Fumarate; Quinolines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin; Sulfones; Young Adult | 2020 |
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.
Topics: Animals; Antipsychotic Agents; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Heart Disease Risk Factors; Male; Mice, Inbred C57BL; Myocardium; Olanzapine; Oxygen Consumption; Proteomics; Risperidone | 2020 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
Prolactin response to antipsychotics: An inpatient study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Female; Humans; Hyperprolactinemia; Inpatients; Male; Middle Aged; Olanzapine; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Sex Factors; Time Factors | 2020 |
Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Databases, Factual; Female; Humans; Incidence; Male; New Zealand; Olanzapine; Parkinson Disease, Secondary; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk Assessment; Risk Factors; Risperidone; Time Factors | 2020 |
Situational analysis of prevailing practices in the management of first-episode psychosis in Chennai, India.
Topics: Haloperidol; Humans; India; Olanzapine; Psychotic Disorders; Risperidone | 2021 |
Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Clozapine; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Netherlands; Olanzapine; Registries; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome | 2020 |
Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Inpatients; Kaplan-Meier Estimate; Male; Olanzapine; Patient Readmission; Quetiapine Fumarate; Retrospective Studies; Risperidone; Time Factors; Young Adult | 2020 |
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Female; Genotype; Humans; Male; Middle Aged; Olanzapine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2020 |
Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Plasma; Proteomics; Risperidone; Schizophrenia | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Female; Haloperidol; Lipid Metabolism; Male; Metabolome; Methylazoxymethanol Acetate; Olanzapine; Rats, Sprague-Dawley; Risperidone; Schizophrenia | 2020 |
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Disease Models, Animal; Female; Haloperidol; Intra-Abdominal Fat; Methylazoxymethanol Acetate; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Proteomics; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
A comprehensive entomological survey and evaluation of the efficacy of different therapies on a suspected delusional parasitosis case.
Topics: Adult; Antipsychotic Agents; Delusional Parasitosis; Humans; Iran; Male; Olanzapine; Risperidone | 2021 |
Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes.
Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Diabetes Mellitus; Endoplasmic Reticulum; Insulinoma; Male; Mice; Mice, Inbred BALB C; Olanzapine; Proinsulin; Protein Folding; Risperidone | 2020 |
Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Metabolic Diseases; Olanzapine; Prospective Studies; Republic of Korea; Risperidone; Schizophrenia | 2021 |
Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Humans; Olanzapine; Prescriptions; Psychotic Disorders; Risperidone | 2021 |
The side effect profile of Clozapine in real world data of three large mental health hospitals.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Databases, Factual; Female; Hospitals, Psychiatric; Humans; Infant; Male; Middle Aged; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles; Weight Gain | 2020 |
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice.
Topics: Animals; Antipsychotic Agents; Chemical and Drug Induced Liver Injury, Chronic; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Olanzapine; Proteome; Risperidone | 2020 |
Serotonin 2A (5-HT
Topics: Amphetamines; Animals; Antipsychotic Agents; Cell-Matrix Junctions; Chlorpromazine; HEK293 Cells; Humans; Mental Disorders; Olanzapine; Rats; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Stress Fibers | 2020 |
Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brazil; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; National Health Programs; Olanzapine; Risk Factors; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2021 |
Atypical diabetes mellitus caused by olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Humans; Olanzapine; Risperidone | 2021 |
Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study.
Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Duration of Therapy; Female; Finland; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
A Case of Self-Cannibalism: An Extremely Rare Type of Self-Mutilation With Multiple Risk Factors.
Topics: Adult; Antipsychotic Agents; Antisocial Personality Disorder; Cannibalism; Electroconvulsive Therapy; Humans; Male; Olanzapine; Prisoners; Risk Factors; Risperidone; Schizophrenia; Self Mutilation; Substance-Related Disorders; Suicide, Attempted | 2021 |
Typical versus Atypical Antipsychotics for Acute Mania: Psychopharmacological Considerations.
Topics: Antipsychotic Agents; Humans; Mania; Olanzapine; Risperidone | 2022 |
The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; China; Clozapine; COVID-19; Humans; Olanzapine; Pandemics; Retrospective Studies; Risperidone; SARS-CoV-2; Schizophrenia | 2021 |
The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cell Membrane; Ceramides; Female; Humans; Leukocytes, Mononuclear; Lipid Metabolism; Lysophospholipids; Male; Olanzapine; Psychotic Disorders; Risperidone; Sphingolipids | 2021 |
The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.
Topics: alpha-MSH; Animals; Antipsychotic Agents; Female; Hyperphagia; Hypothalamus; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Models, Animal; Neurons; Obesity; Olanzapine; Potassium; Receptor, Melanocortin, Type 4; Risperidone; Synaptic Potentials; Transcriptome; Weight Gain | 2021 |
Rethinking olanzapine therapy for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Risperidone; Schizophrenia | 2021 |
Comparative Study of Sexual Side Effects in Female Patients With Schizophrenia Receiving Risperidone or Olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Female; Humans; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology | 2021 |
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis.
Topics: Adult; Benzodiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Substance-Related Disorders; Thiazoles | 2021 |
Late-Onset Dystonia With Low-Dose Olanzapine in an Older Person: A Case Report.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dystonia; Female; Humans; Olanzapine; Risperidone | 2021 |
A comparative study of olanzapine, aripiprazole and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Retrospective Studies; Risperidone; Time Factors; Treatment Outcome | 2021 |
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients.
Topics: Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Humans; Olanzapine; Receptors, Dopamine D2; Risperidone | 2022 |
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Topics: Antipsychotic Agents; Benzodiazepines; COVID-19; Humans; Olanzapine; Quetiapine Fumarate; Risperidone; SARS-CoV-2 | 2022 |
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles | 2022 |
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Humans; Olanzapine; Perphenazine; Recurrence; Risperidone; Schizophrenia; Secondary Prevention | 2022 |
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Nitroprusside; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone | 2022 |
Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study.
Topics: Acute Kidney Injury; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Denmark; Hospitals; Humans; Incidence; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Humans; Longitudinal Studies; Olanzapine; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Risperidone; Weight Gain | 2022 |
Association Between Sexual Dysfunction and Dose of Atypical Antipsychotics: Essential to Learn the Basics.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Sectional Studies; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological | 2023 |
Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Mania; Olanzapine; Psychotic Disorders; Risperidone | 2022 |
The long-lasting effects of early antipsychotic exposure during juvenile period on adult behaviours - A study in a poly I:C rat model.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Poly I-C; Pregnancy; Rats; Risperidone | 2022 |
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid | 2022 |
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse.
Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Menopause; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia | 2023 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Japan; Lamotrigine; Lithium Carbonate; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
Integrating machine learning with electronic health record data to facilitate detection of prolactin level and pharmacovigilance signals in olanzapine-treated patients.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Electronic Health Records; Humans; Machine Learning; Male; Olanzapine; Pharmacovigilance; Prolactin; Risperidone | 2022 |
[Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Risperidone | 2022 |
Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D
Topics: Adolescent; Adult; Alzheimer Disease; Antipsychotic Agents; Bayes Theorem; Benzodiazepines; Dopamine; Humans; Olanzapine; Risperidone; United States; United States Food and Drug Administration | 2022 |
Predicting serotonin toxicity in serotonin reuptake inhibitor overdose.
Topics: Adult; Drug Overdose; Female; Humans; Male; Moclobemide; Olanzapine; Retrospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors | 2023 |
The impact of adjunctive aripiprazole on QT interval: A 12-week open label study in patients on olanzapine, clozapine or risperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Humans; Olanzapine; Piperazines; Prospective Studies; Risperidone | 2023 |
Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Erectile Dysfunction; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Mentally Ill Persons; Olanzapine; Pregnancy; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone | 2023 |
Practice of prescribing antipsychotics in schizophrenia during 2013-2018 based on data from the National Health Fund.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Olanzapine; Risperidone; Schizophrenia | 2022 |
Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Humans; Olanzapine; Risperidone; Schizophrenia; Weight Gain | 2023 |
Therapeutic outcomes wide association scan of different antipsychotics in patients with schizophrenia: Randomized clinical trials and multi-ancestry validation.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Hyperprolactinemia; Lipids; Olanzapine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome | 2023 |
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Multiomics; Olanzapine; Phospholipases; Precision Medicine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2023 |
Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Male; Olanzapine; Rhabdomyolysis; Risperidone | 2023 |
Sex-specific differences and similarities of olanzapine and risperidone on avoidance suppression in rats in the conditioned avoidance response test.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Female; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Risperidone; Sex Characteristics | 2023 |
Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
Topics: Aged; Antipsychotic Agents; Cohort Studies; Emergence Delirium; Female; Haloperidol; Hospital Mortality; Hospitals; Humans; Ischemic Attack, Transient; Male; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2023 |
Acute massive pulmonary embolism during antipsychotic treatment: case report with opinion.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Pulmonary Embolism; Risperidone | 2023 |